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2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) is an excellent oxidant for cleaving 
the carbon–hydrogen bond of allylic (or benzylic) ethers to generate oxocarbenium ions. When 
DDQ oxidation proceeds in a macrocyclic system that contains a sterically undemanding alkynyl 
group, the (Z)-geometry oxocarbenium ion dominates due to the geometric constraint of the 
macrocyclic core. The following nucleophilic addition of the appending enol acetate to this 
macrocyclic oxocarbenium ion yields the bridged 2,6-trans-disubstituted tetrahydropyran 
diastereoselectively. 
 
Based on the DDQ oxidation methodology, a one-pot process has been developed to access 
synthetically challenging spiroketal structures through combining simple dienes and aldehydes. 
After the initial hetero-Diels-Alder (HDA) reaction, the resulting tetrahydropyranyl enol silyl 
ethers are subjected to DDQ oxidation. The tetrahydropyranyl oxocarbenium ions are formed 
immediately, followed by the cleavage of the carbon–silicon bonds to produce the enones that go 
through an oxa-Michael addition to afford the spiroketals in excellent yields.  
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This one-pot process has been successfully applied to the construction of the spiroketal 
core during the convergent total synthesis of bioactive natural product bistramide A. The 2,6-trans-
tetrahydropyran in the righthand fragment was fast assembled through another novel one-pot 
process, which is composed of a hydroformylation, cyclization, and acetylation. Currently, our 
total synthesis of bistramide A holds the shortest synthetic sequence in the literature. 
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1.0 INTRODUCTION TO OXOCARBENIUM ION FORMATION 
 
Oxocarbenium ions are frequently proposed as intermediates in a number of organic 
transformations.1 These intermediates are a classic form of a carbocation that is stabilized by the 
lone pair on an adjacent oxygen atom. Due to this stabilization, oxocarbenium ions are commonly 
formed under mild conditions, which allow them to undergo nucleophilic additions from a vast 
range of nucleophiles and yield substituted ethers. Nevertheless, to date, there are only a few 
pathways for accessing these synthetically useful carbocations: 1) ethereal bond formation 
pathway,2 2) functional group departure pathway,3 3) enol ether functionalization pathway,4 4) 
hydride transfer pathway,5 and 5) oxidative electron transfer pathway (Figure 1-1).6 Several 
representative chemical transformations of the above approaches of oxocarbenium ion formation 
and their applications in complex molecule synthesis will be briefly discussed. 
 
Figure 1-1. Oxocarbenium ion formations and utilities 
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1.1 ETHEREAL BOND FORMATION 
 
The most common access to oxocarbenium ions is the dehydrative condensation of 
alcohols or silyl ethers with aldehydes or ketones in the presence of Brønsted or Lewis acids. One 
example is given by Maier and co-workers during their total synthesis of the cytotoxin neopeltolide 
(Scheme 1-1).7 In their route, the oxocarbenium ion 1.3 was formed by the condensation of 
aldehyde 1.1 with homoallylic alcohol 1.2 in the presence of trifluoroacetic acid. Subsequently 
attack by the pendent alkene formed the tetrahydropyran (THP) ring. Thereafter, the in situ formed 
tetrahydropyranyl cation was quenched by the trifluoroacetoxy anion to afford THP 1.4 in 72% 
yield with perfect diastereoselectivity. The installation of the trifluoroacetoxy group served as a 
useful handle on the THP ring. After removing the trifluoroacetyl group, the unprotected alcohol 
coupled with the oxazole fragment smoothly under Mitsunobu conditions. 
 
Scheme 1-1. Maier's synthesis of neopeltolide 
 
     Wong and co-workers disclosed an oxocarbenium ion formation through the coupling of an 
internal ketone and an oxidatively generated phenoxonium cation.8 This method is highlighted in 
  
 
 
3 
their convergent synthesis of the antimalarial natural products (±)-aculeatin A and B (Scheme 1-
2). Notably, the treatment of racemic substrate 1.6 with the oxidant phenyliodine trifluoroacetate 
produced the phenoxnium cation and deprotected the dithiane-masked ketone.9 After the coupling 
of these two newly generated species, oxocarbenium ion 1.8 was formed, then was captured by the 
internal alcohol to afford the target products in moderate overall yield.  
 
Scheme 1-2. Condensation of ketone and phenoxonium cation 
 
 
1.2 FUNCTIONAL GROUP DEPARTURE AT THE α-POSITIONS OF ETHERS 
 
The departure of a functional group causes an unsymmetrical cleavage of the carbon–
leaving group bond and results the oxocarbenium ion for the following target- or diversity-oriented 
synthesis.  
The precursors, acetals, can be easily converted to the oxocarbenium ions in the presence 
of Brønsted or Lewis acids, when alkoxy groups act as the leaving groups. This pathway was 
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illustrated by the Floreancig group in the total synthesis of (+)-dactylolide (Scheme 1-3).10 This 
synthesis is featured by the efficient construction of the THP 1.11 through a Prins-type reaction, 
in which the oxocarbenium ion 1.10 was generated by Lewis acid-ionization of one acetal oxygen. 
This transformation is a two-step sequence that started from the cerium(III) chloride-promoted 
addition of ((trimethylsilyl)methyl)magnesium chloride to the benzyl ester 1.8. The resulting 
tertiary alcohol 1.9 was quenched with base and subjected to pyridine/triflic acid and magnesium 
sulfate for the key Prins-type reaction. The excellent regioselectivity is attributed to the preference 
for the kinetically facile 6-endo cyclizaton over the 8-endo cyclization.11 
 
Scheme 1-3. Floreancig’s total synthesis of (+)-dactylolide 
 
The halogen anion is also a suitable leaving group in the oxocarbenium ion formation 
process. Jacobson and co-workers reported a chiral thiourea-catalyzed reaction to 
enantioselectively convert the carbon–chloride bonds on 1-chloroisochromans 1.13 to carbon–
carbon bonds (Scheme 1-4).12 The oxocarbenium ions 1.15 were formed through the dissociation 
of carbon–chloride bonds under the assistance of hydrogen-bond donor pyrrole-bearing thiourea 
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derivative 1.14, in their proposed mechanism. This anion binding between the oxocarbenium ions 
and the chiral thiourea-chloride complex enables the nucleophiles to attack 1.15 enantioselectively. 
 
Scheme 1-4. Enantioselective additions to isochroman oxocarbenium ions 
 
Carbon-centered leaving groups are also able to afford the oxocarbenium ions, which was 
demonstrated by Pagenkopf and coworkers in their total synthesis of (±)-goniomitine (Scheme 1-
5).13 In the key step, a TMSOTf-assisted cyclopropane ring-opening process was employed to 
afford oxocarbenium ion 1.18 at the initial stage. Thereafter, nitrile 1.19 was added onto 1.18 to 
afford nitrilium ion 1.20, followed by an intramolecular cyclization to yield the fused skeleton 
1.21. The isolated product 1.22 was obtained in 74% yield after methanol-elimination and 
tautomerization.   
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Scheme 1-5. Pagenkopf’s synthesis of (±)-goniomitine 
 
 
1.3 REACTIONS OF ENOL ETHERS WITH ELETROPHILES 
 
Prins-type reactions will produce oxocarbenium ion intermediates when enol ethers act as 
nucleophiles in the reactions. Based on extensive studies on the Prins-type reaction, the 
Rychnovsky group developed a Mukaiyama aldol-Prins cascade reaction.14 In this reaction, the 
key oxocarbenium ion 1.25 was formed through a nucleophilic addition of enol ether 1.23 to 
aldehyde 1.24 in the presence of BF3·OEt2 (Scheme 1-6). Consequentially, the intramolecular 
cyclization and desilylation proceeded to afford THP 1.26 in excellent yields. Subsequently, they 
applied this methodology as the key step to efficiently couple the fragment 1.27 and 1.28 in their 
formal syntheses of the bioactive natural product, leucascandrolide A (Scheme 1-6). 
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Scheme 1-6. Mukaiyama aldol/Prins reaction and its application in natural product synthesis 
 
Ghosh and co-workers demonstrated that imines are also susceptible to the nucleophilic 
attacks from enol ethers (Scheme 1-7).15 In their transformations, dihyrofurans 1.30 were added to 
the titanium(IV) chloride-activated N-sulfonyl imino ester 1.31 to afford oxocarbenium ions 1.32. 
Both intermolecular and intramolecular nucleophilic additions to 1.32 diastereoselectively yield 
multiply substituted tetrahydrofurans 1.33 and benzo-fused 8-oxabicyclo[3.2.1]octane 1.34 in 
excellent yields respectively. 
 
Scheme 1-7. Ghosh’s multiply substituted tetrahydrofuran syntheses 
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Protonation-mediated ionization of enol ethers is an alternative oxocarbenium formation 
method. Scheidt and co-workers disclosed a tandem isomerization/oxa-Pictet-Spengler protocol to 
illustrate this pathway (Scheme 1-8).16 Allylic ether 1.35 underwent an iridium(III)-catalyzed 
double bond migration to yield enol ether 1.37. Then, the in situ generated triflic acid protonated 
1.37 to furnish key oxocarbenium ion 1.38, which initiated the oxa-Pictet-Spengler reaction to 
yield pyran-fused indole 1.36. Interestingly, the authors observed that the double bond migration 
process was significantly accelerated when they added the bismuth triflate and iridium pre-catalyst 
simultaneously, which implies a cooperative catalysis affect in their system. Notably, an 
asymmetric oxa-Pictet-Spengler example was shown in the same paper by employing the chiral 
phosphoric acid 1.40 as Brønsted acid. The enantioselectivity is attributed to contact ion-pair 
interaction. 
 
Scheme 1-8. The tandem isomerization/oxa-Pictet-Spengler reaction 
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1.4 INTRAMOLECULAR HYDRIDE TRANSFER 
 
The carbon(sp3)–hydrogen bonds that are adjacent to the oxygen atoms have the potential 
to become hydride donors. When there are proper internal hydride acceptor, such as aldehydes, 
ketones, and esters, those potential hydride donors will transfer a hydride, forming the 
oxocarbenium ions in the presence of Lewis acids.5a,17 Due to their “green” nature, the 
development of hydride transfer reactions is a hot topic in current organic synthesis. 
Sames and co-workers disclosed the first example of the intramolecular hydride transfer 
reactions that involved oxocarbenium ion formation (Scheme 1-9).17a They conducted the 
intramolecular hydroalkylation through the treatment of ,-unsaturated aldehyde 1.42 and ,-
unsaturated ketone 1.43 with the Lewis acid BF3·OEt2. Excellent yields and moderate 
diastereoselectivities of the cyclized products 1.44 and 1.45 were obtained. The failure of ester 
1.46 in this reaction implies that higher acceptor-electrophilicity is required for the ester substrates. 
After installing an extra ester group on 1.46, ester 1.47 could undergo this annulation reaction 
smoothly in excellent yields. Notably, the geminal substitutions are not necessary for efficient 
annulation based on the result of substrate 1.48. 
 
Scheme 1-9. Sames’ intramolecular hydride transfer reactions 
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In connection with the results on ,-unsaturated aldehydes, ketones, and esters, Sames 
found that the saturated aldehydes and ketones are also suitable hydride acceptors (Scheme 1-
10).17b Aldehydes 1.51 and 1.52 underwent the BF3·OEt2-catalyzed hydride transfer process to 
produce the oxocarbenium ions 1.53 and 1.54. These oxocarbenium ions were attacked by internal 
alcohol nucleophiles to afford spiroketals 1.55 and 1.56 respectively in excellent yields. The 
remarkable diastereoselectivity of these reactions can be explained by the thermodynamical 
control of the reversible intramolecular cyclization process. 
 
Scheme 1-10. Spiroketal synthesis via hydride transfer reactions 
 
 
1.5 OXIDATIVE ELECTRON TRANSFER 
 
Ethers 1.57 will transfer one electron to proper oxidants and form radical cations 1.58 
(Scheme 1-11). Meanwhile, the C–R1 bonds of 1.57 are significantly weakened and can be cleaved 
to render radical species 1.59. After transferring another electron from 1.59, the oxocarbenium 
ions 1.60 are formed and ready to undergo the nucleophilic additions. Normally, these oxidative 
reactions proceed in neutral conditions, which avoid any issues associated with acid- or base-
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sensitive functional groups on the substrates. Electrochemical oxidation and chemical reagent-
mediated oxidation are two major methods in this approach. 
 
Scheme 1-11. The general mechanism of the oxidative oxocarbenium ion formation 
 
The Yoshida group has contributed pioneering and systematic studies of electrochemical 
oxidations.18 During their initial investigations, -silyl ethers were employed as the substrates 
(Figure 1-2).19 They passed a 10mA constant current through an undivided cell that was equipped 
with a carbon rod anode and cathode and contained a 0.2 M solution of -silyl ethers 1.62 and the 
electrolyte tetraethylammonium triflate. During this process, the oxocarbenium ions 1.66 were 
formed after two equivalents of electrons were transferred from 1.62 to the anode. Subsequent 
addition of methanol produced acetals 1.63 in good to excellent yields. The silyl groups played a 
vital role during this reaction. Not only did they significantly lower the oxidation potentials of 
1.62, but they also controlled the reaction chemoselectivity since the carbon–silicon bonds in 
radical cations 1.64 were largely weakened and selectively cleaved. Based on the success of 
electrochemical oxidation of -silyl ethers, Yoshida has extended the substrate scope, including 
-stannyl ethers,20 telluroglycosides,21 -germyl ethers,22 and thioethers23 (Scheme 1-12). 
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Figure 1-2. Electrochemical oxidation of α-silyl ethers 
 
Scheme 1-12. Electrochemical oxidation of substrates other than α-silyl ethers 
 
Recently, Yoshida and co-workers developed a novel “cation pool” method in which 
oxocarbenium ions are generated by low temperature electrolysis and accumulated in a 
nucleophile-free environment (Scheme 1-13).24 This method has effectively filled the deficiency 
on the characterization of simple alkyloxycarbenium ions in common organic reaction media. The 
thermal stability investigation showed that the oxocarbenium ion 1.68 is quite stable at 
temperatures lower than –50 °C, but decomposes dramatically at higher temperatures. In addition, 
the reaction of the oxocarbenium ion pool with various types of nucleophiles proceeded smoothly 
in moderate to excellent yield, although the diastereoselectivity is relatively low. 
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Scheme 1-13. The “cation pool” method 
 
Enol ethers are also electrochemical oxidation substrates. One example is given by Moeller 
and co-workers (Scheme 1-14).25 They observed that radical cation 1.71, generated from the enol 
ether 1.70 could be trapped by the internal alcohol to afford the tetrahydrofuran radical 1.72. One 
electron of 1.72 was removed by electrochemical oxidation to yield the oxocarbenium ion 1.73 
that underwent the solvolysis to furnish dimethylacetal 1.74 in excellent yield as a mixture of 5:1 
in favor of the trans-isomer. THPs could also be synthesized via this method; however, this 
reaction fails to yield seven-membered or larger ring systems. 
 
Scheme 1-14. Electrochemical oxidation of the electron-rich enol ether 
 
Besides the electrochemical oxidation protocol, many chemical reagents, such as 2,3-
dichloro-5,6-dicyanobenzoquinone (DDQ),26 di-tert-butyl peroxide (DTBP),27 N-
methylquinolinium hexafluorophosphate (NMQPF6),
28 and ceric ammonium nitrate (CAN),29 are 
able to oxidatively activate the carbon-hydrogen (C–H) bonds and carbon-carbon (C–C) bonds to 
form oxocarbenium ions. For instance, the DDQ-mediated p-methoxybenzyl ether deprotection 
protocol is a typical oxidative C–H bond activation process during which oxocarbenium ions are 
involved (Scheme 1-15).26a Mukaiyama successfully captured the DDQ-generated oxocarbenium 
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ion with allyltrimethylsilane instead of water to form a new C–C bond (Scheme 1-16).26b In this 
reaction, lithium perchlorate was proven to significantly improve the reaction yield, which was 
ascribed to the counter-ion effect. Later, Xu and co-workers smoothly installed an allyl group onto 
the isochroman in excellent yield and diastereoselectivity via the DDQ oxidation during their total 
synthesis of deoxyfrenolicin (Scheme 1-17).26c In 2006, a DDQ-based cross-dehydrogenative 
coupling (CDC) reaction was developed to couple benzyl ethers and carbonyl compounds by Li 
and co-workers (Scheme 1-18).26d,26e Interestingly, in their initial investigation, indium(III) 
chloride and copper bromide showed a synergistic effect in activating DDQ and the malonate 
substrate (Eq. (1-1)). Later, they found out that the CDC reaction could even proceed between 
benzyl ethers and ketones under heat without any other additives (Eq. (1-2)). 
 
Scheme 1-15. Oxidative deprotection of p-methoxybenzyl ether by DDQ 
 
Scheme 1-16. DDQ oxidation by employing allyltrimethylsilane as nucleophile 
 
Scheme 1-17. Xu’s application of DDQ oxidation to the synthesis of deoxyfrenolicin 
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Scheme 1-18. Li’s results of DDQ-mediated CDC reactions 
 
Recently, Lei reported a new method that oxidatively installed the aryl groups onto the 
carbons adjacent to the oxygen atoms (Scheme 1-19).27 Under the assistance of nickel catalyst, 
DTBP oxidatively cleaved the C–H bond at the -position of the inert solvent tetrahydrofuran 1.75 
to yield oxocarbenium ion 1.76. Simultaneously, the aryl radicals 1.78 were released from the 
arylboronic acids 1.77 and combined with 1.76. The resulting radical cations 1.79 underwent a 
radical abstraction from the solvent and delivered arylsubstituted tetrahydrofurans 1.80 in good to 
excellent yields. This proposed mechanism is supported by the fact that no desired products were 
collected when the radical-trapping reagent TEMPO was introduced into the reaction.  
 
Scheme 1-19. C–H bond activation of simple furan 
 
The Floreancig group has conducted extensive studies on oxidative activation of the C–C 
and C–H bonds.28,29,30 In 2001, according to the principle that the benzylic C–C bonds will be 
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significantly weakened in homobenzylic ether radical cations, Dr. Kumar et al. developed an 
electron transfer initiated cyclization (ETIC) to prepare cyclic acetals (Scheme 1-20).28a This 
reaction was initiated by the photo-activation of NMQPF6, which accepts one electron from the 
cosensitizer 1.85. The resulting radical cation 1.86 would accept one electron from substrate 1.81 
to afford the key intermediate, homobenzylic radical cation 1.83. Interestingly, at this stage, there 
are two cyclization pathways, which yield the same product 1.82: the associative pathway and the 
dissociative pathway. The former is an SN2-type cyclization that leads the stereochemical inversion 
at electrophilic center, whereas the latter is an SN1-type cyclization that generates the 
oxocarbenium ion 1.84 and scrambles the substrate stereochemical center. Based on the 
experimental results, the authors concluded that the dissociative pathway would favor the 
substrates that bear weak or bulky nucleophiles or could generate steric repulsion in the transition 
state. Later, a catalytic version of this reaction was developed, which performed more efficiently 
and enabled gram-scale reaction.28b  
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Scheme 1-20. Electron transfer initiated cyclizations 
 
The power of this ETIC reaction was showcased by Dr. Clausen et al. in their total synthesis 
of the protein phosphatase 2A inhibitor, lactodehyrothyrsiferol (Scheme 1-21).28j This synthetic 
route is highlighted by the NMQPF6-mediated cascade cyclization of the diepoxide 1.87, which 
regio- and stereo-selectively converted the linear molecule to the tricyclic intermediate 1.88 in 
moderate yield. Although this reaction terminated before the consumption of starting material, 
recycling the diepoxide 1.87 enabled the production of gram quantities of 1.88.   
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Scheme 1-21. Photoinitiated cyclization in the synthesis of lactodehydrothyrsiferol 
 
Although the ETIC reaction has shown excellent efficiency for substrates with oxygen-
centered nucleophiles, the applications to the substrates with carbon-centered nucleophiles, such 
as the electron-rich enol ethers, were unsuccessful. It is reasoned that the low oxidation potentials 
of enol ethers might reduce the chemoselectivity by transferring the electrons to the oxidants prior 
to the arene electroauxiliaries. However, directly lowering the oxidation potentials of the arene 
groups by placing electron-rich substitutions on the aromatic rings would lead to strengthening the 
benzylic bonds and obstructing the cleavage of these bonds. Dr Wang et al. devised two strategies 
to tackle this issue: 1) adding substitutions at benzylic position to weaken the benzylic bonds (Eq. 
(1-3)), 2) placing a vinyl group at the homobenzylic position to stabilize the oxocarbenium ions 
(Eq. (1-4)) (Scheme 1-22).29b,29b Moreover, the non-photoinitiated oxidant, CAN, was proven to 
have a higher efficiency than other oxidants during this process, which is attributed to the inner 
sphere electron-transfer mechanism. The CAN-mediated oxidation exhibited an excellent 
stereochemical selectivity in 6-endo-cyclization to yield the 2,6-cis-disubstituted THP as a single 
diastereomer (Eq. (1-5)). This observation is explained by the strong preference for chair transition 
states and an (E)-configuration for the oxocarbenium ions during the cyclization.31 
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Scheme 1-22. Carbon-carbon bond formation via ETIC 
 
During the Floreancig group’s exploration for a more atom-economic oxidation system, 
Dr. Tu et al. found that DDQ is an efficient oxidant to promote a cyclization of p-methoxybenzylic 
ether 1.89 to afford 2,6-cis-disubstituted THP 1.92 as single diastereomer in excellent yield 
(Scheme 1-23).30a This oxidation was initiated by an electron transfer from 1.89 to DDQ to form 
radical cation 1.90, which underwent either hydrogen atom abstraction pathway or proton 
abstraction then electron transfer pathway to form the chair-like oxocarbenium ion 1.91. Due to 
the oxocarbenium ion’s preference for an (E)-configuration, the trans-THP 1.92 was yielded 
exclusively in this reaction. A steric interaction was proposed to effectively restrict the conversion 
from radical cation 1.93 to corresponding oxocarbenium ion which could lead to the overoxidation 
product.33 Comparing to the harsh conditions and limited substrates scope of the DDQ-mediated 
C–C bond formations from other groups, this DDQ oxidation reaction can smoothly proceed at 
  
 
 
20 
room temperature and accommodate a wide scope of substrates, such as benzyl ethers,30b,30l allylic 
ethers,30d,30e,30f,30n and propargylic ethers.30d,30e,30o 
 
Scheme 1-23. C–H bond activation by DDQ oxidation 
 
Dr. Peh has successfully applied this DDQ-activated C–H functionalization to the total 
synthesis of clavosolide A (Scheme 1-24).30n This sequence is highlighted by the oxidative 
generation of vinylogous cyclopropyl carbinyl cation 1.95, which is considered to be acid-labile 
and will undergo a ring-opening process in the presence of Lewis acids. However, under the mild 
DDQ-mediated neutral environment, oxocarbenium ion 1.95 is sufficiently stable to furnish THP 
1.96.   
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Scheme 1-24. Dr. Peh’s synthesis of clavosolide A 
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2.0 SYNTHESIS OF MACROLACTONES BEARING BRIDGED 2,6-TRANS-
TETRAHYDROPYRANS THROUGH OXIDATIVE C–H BOND ACTIVATION 
 
2.1 INTRODUCTION 
 
Macrolides occupy a significant portion of biologically important natural products and 
pharmaceuticals.33  The structural diversities of macrolides, which are brought by various types of 
substructures on the large rings, induce the great interest among chemists to explore accesses 
toward these molecules. 2,6-trans-Disubstituted tetrahydropyrans (THPs) are commonly present 
in many bioactive macrolides (Figure 2-1).34 However, synthetic approaches to these trans-THP-
contained macrolides are limited due to the challenges introduced by the thermodynamically 
unfavored trans-THPs. A frequently used strategy is to construct the trans-THP fragments through 
known methodologies before the macrolactonization. One representative example of this protocol 
is illustrated in Floreancig group’s formal synthesis of leucascandrolide A (Scheme 2-1).35 
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Figure 2-1. Examples if bioactive macrolides bearing bridged 2,6-trans-THPs 
 
 
 
Scheme 2-1. Floreanicg group’s formal synthesis of leucascandrolide A 
 
In this synthesis, the trans-THP fragment 2.4 was accessed from homoallylic alcohol 2.1, 
which underwent a tandem hydroformylation/THP ring cyclization to afford THP 2.2 with a 
stereochemically undefined acetal carbon. The following dehydration proceeded smoothly with 
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the assistance of strong Lewis acid, bismuth(III) bromide, to yield key oxocarbenium ion 2.3. The 
allytrimethylsilane preferred an axial attack to this newly formed carbocation, thus yielded 2,6-
trans-disubstituted THP 2.4 as single stereoisomer in nearly quantitative yield. Later, a 
rhenium(VII) oxide-catalyzed macrolactonization confined this trans-THP subunit on the 
macrocycle of leucascandrolide A. 
Alternatively, transannular cyclization is a promising but barely developed protocol for 
direct formation of bridged 2,6-trans-disubstituted THPs on macrocyclic scaffolds.36 In 2004, the 
Maier group and the Rizzacasa group independently showed two different transannular cyclization 
reactions during their synthesis towards the natural product, apicularen A.37 In Maier’s route, the 
macrocyclic trans-THP 2.6 was constructed by a mercuric trifluoroacetate-promoted transannular 
cyclization across the 12-membered macrolactone 2.5 (Scheme 2-2).37a The high trans-selectivity 
in this reaction is attributed to the transition state of the kinetically controlled cyclization being 
product-like, thus leading to the less strained product. 
 
Scheme 2-2. Maier’s total synthesis of apicularen A 
 
  
 
 
25 
Rizzacasa’s transannular cyclization relied on the assistance of Amberlyst-15, which 
promoted the cyclization of enone 2.7 and distereoselectively delivered the trans-THP 2.8 in 90% 
yield (dr >10:1) (Scheme 2-3).37b Interestingly, both trans- and cis-THP products were formed at 
the initial stage, but the cis-isomer converted to the trans-isomer after 18 hours. 
 
Scheme 2-3. Rizzacasa’s formal synthesis of apicularen A 
 
The trans-THP products are rarely observed during the Floreancig group’s previous studies 
on THP synthesis through the oxidative carbon–hydrogen (C–H) bond or carbon–carbon (C–C) 
bond functionalization reactions.30 This is ascribed to the significant energy gap between the (E)-
geometry oxocarbenium ion and (Z)-geometry oxocarbenium ion, which are the cis-THP precursor 
and trans-THP precursor respectively (Figure 2-2).38 
 
Figure 2-2. Energy gap between (E) and (Z)-geometry oxocarbenium ions 
 
However, a significant percent yield of trans-THP 2.11 was observed by Dr. Liu when he 
was examining the propargylic ether 2.9 in the DDQ-mediated C–H bond activation reaction 
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(Scheme 2-4).30d In this process, the energetic difference between the (E)- and (Z)-oxocarbenium 
ions is expected to be minimized by the sterically undemanding nature of the alkynyl group, which 
explains the 25% isolated yield of 2.11 (Figure 2-3).  
 
Scheme 2-4. Dr. Liu’s observation of the trans-THP product through DDQ oxidation 
 
Figure 2-3. Explanation for the observation of trans-THP 
 
This observation inspired us to make an assumption that, for certain tether lengths, the 
geometric constraints of macrocyclic oxocarbenium ions could coerce alkynyl substitutents to 
adapt an axial orientation, which leads to producing the desired trans-THP containing bicyclic 
products (Figure 2-4). This chapter will demonstrate this assumption by employing DDQ as the 
oxidant and the macrocycles with appending nucleophiles as substrates. 
 
Figure 2-4. Our strategy to access the trans-THP in the macrocyclic system 
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2.2 SUBSTRATE PREPARATION 
 
Three general types of substrates (Figure 2-5) were proposed for the investigation of the 
oxidative transannular cyclization. Acyclic Type I substrates (2.12 to 2.14) were designed for 
detailed studies of the effect of alkynyl groups in DDQ-mediated C–H bond cleavage reactions. 
Type II substrates (2.15 to 2.19) were macrocyclic benzylic and allylic ethers bearing alkynyl 
groups for testing the trans-THP-oriented strategy. Type III macrocycles (2.20 to 2.25) were 
relatively inert propargylic ethers for exploring the scope of the oxidative transannular cyclization. 
 
Figure 2-5. Three types of proposed substrates 
 
Benzylic ethers 2.12 and 2.13 were accessed from propargylic alcohol 2.26 (Scheme 2-5). 
This primary alcohol was converted to secondary alcohol 2.27 through a sequential Parikh-Doering 
oxidation39 and a sonochemical Barbier-type reaction.40 A La(OTf)3-catalyzed etherification
41 and 
a Williamson etherification42 were employed to convert 2.27 to ether 2.29a and 2.29b respectively. 
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A ruthenium(II)-catalyzed enol acetate formation43 furnished the desired substrates from ethers 
2.29 in moderate yields.  
The preparation of 2.14 was initiated by forming an acetal intermediate through refluxing 
triethyl orthoformate and ethyl propiolate with a catalytic amount of ZnI2 (Scheme 2-5).
44 This 
newly generated acetal was deprotected by formic acid and followed by a sonochemical reaction 
to give homopropargyl alcohol 2.31, which was subjected to sucessive La(OTf)3-catalyzed 
etherification and enol acetate formation to yield substrate 2.14. 
 
Scheme 2-5. Synthesis of Type I substrates 
 
The synthesis of substrates 2.15, 2.16 and 2.17 shared a similar route as shown in Scheme 
2-6. Suzuki coupling45 between the known aldehyde 2.32 and esters 2.33 afforded the ortho-
substituted anisaldehydes, which were reduced by NaBH4 to give benzyl alcohols 2.34. These 
benzyl alcohols were treated with Cl3CCN and DBU to yield trichloroacetimidates 2.35, followed 
by La(OTf)3-promoted etherification and desilylation to afford the macrolactonization precursors 
2.37. After hydrolysis, the carboxylic acid from ester 2.37a was subjected to a Yamaguchi 
macrolactonization46 and enol acetate formation successively to yield the marcocycle 2.15 in fair 
yield. Considering the low efficiency of Yamaguchi macrolactionization, we turned to the 
Mukaiyama protocol,47 which led to a significant improvement of the yields. 
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The (Z)-configured alkenyl group on macrocycle was accessed by taking advantage of 
natural extract, nerol (2.38), which was converted to aldehyde 2.39 through acetylation, 
epoxidation, and oxidation procedures (Scheme 2-6).48 Subsequently, aldehyde 2.39 was further 
oxidized to the carboxylic acid, which was esterified with iodomethane after a deacetylation. The 
union of trichloroacetimidate 2.40 and fragment 2.41 was catalyzed by TMSOTf to produce both 
(Z)-allylic ether 2.42 and (E)-allylic ether 2.43. These two isomers were subjected to the regular 
macrolactone formation sequence and enol acetate formation reaction to deliver the desired 
substrate 2.18 and its E-isomer 2.44. 
The preparation of the phenyl-substituted allylic ether 2.19 began with a carboxylic acid 
protection protocol that would facilitate the following homologation process (Scheme 2-6). The 
homologation product underwent the carboxylic acid deprotection, methylation, and 
hydrosilylation successively to form vinylsilane 2.48, which was subjected to the Hiyama 
coupling49 in the presence of iodobenzene. The resulting vinylphenyl intermediate was converted 
to the trichloroacetimidate and coupled with fragment 2.41, followed by a TBAF-promoted 
desilylation to furnish the macrolactonization precursor 2.49. Mukaiyama macrolactonization and 
enol acetate formation completed the synthesis of 2.19. 
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Scheme 2-6. Synthesis of Type II substrates 
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The assemblies of substrates 2.20 and 2.21 shared the same route (Scheme 2-7). Alcohols 
2.50 were converted into propargyl bromides 2.51 in good yields by successive alcohol protection, 
homologation, and bromination. The Williamson ether synthesis was utilized to couple the 
bromides 2.51 with homopropargyl alcohol 2.52, followed by selective desilylation and Dess-
Martin oxidation50 to afford aldehydes 2.53. The syntheses of substrates 2.20 and 2.21 were 
achieved after a mild oxidation, desilylation, Mukaiyama macrolactonization, and enol acetate 
formation. Substrates 2.22 and 2.23 shared a similar synthetic sequence with 2.20 and 2.21, except 
for some minor modifications of the starting materials. During the synthesis of 2.22, 2.50a and 
2.52 were replaced by but-3-yn-1-ol and 7-((tert-butyldiphenylsilyl)oxy)hept-1-yn-4-ol. During 
the synthesis of 2.23, the primary alcohol of 2.51a was protected with TBDPS instead of TBS, and 
the secondary alcohol of 2.52 was protected with TBS instead of TBDPS. 
The synthetic sequences for substrates 2.24 and 2.25 are shown in Scheme 2-7, which are 
highlighted by the AlMe3-promoted methylation of the cyclic acetal 2.56.
51 The methylated 
product 2.57 was converted to substrates 2.24 and 2.25 after several functional group 
manipulations, macrolactonization, and enol acetate formation. 
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Scheme 2-7. Synthesis of Type III substrates 
 
 
2.3 RESULTS AND DISCUSSION 
 
 p-Methoxybenzylic ether 2.12 was treated with DDQ in 1,2-dichloroethane (DCE) at room 
temperature. The reaction went to completion in one hour as expected, and it furnished a mixture 
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of trans- and cis-THPs with a surprising ratio of nearly three to one of trans-THP 2.59a to cis-
THP 2.59b (Scheme 2-8).  
 
Scheme 2-8. DDQ-mediated oxidation of p-methoxybenzylic ether 2.12 
 
The initial results strongly demonstrated that the alkynyl groups are able to adapt the axial 
orientation in the oxocarbenium ion transition state. Moreover, an electrostatic interaction between 
the -electrons of the alkynyl group and the partially positive charged hydrogen at the -position 
of the ether is proposed to promote the trans-stereochemical selectivity (Figure 2-6).52 This 
electrostatic model is validated by the performance of different benzylic ether analogs and solvents 
in the DDQ oxidative cyclization (Table 2-1). 
 
Figure 2-6. The hypothesized electrostatic interaction during the transition state 
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                       Table 2-1. Investigation of the electronic effectsa 
 
 
A slight increase of the trans-selectivity was observed through replacing the para-
substitution of arene from methoxyl group to methyl group (entry 1 vs entry 2). It is reasoned that 
the weaker electron-donating nature of methyl group destabilizes the intermediate cation. This 
destabilization increases the partial positive charge on the -hydrogen in the electrostatic model 
and results a stronger interaction between the -hydrogen and -electrons. A reduction of the 
trans-selectivity was expected for the cyclization of ester 2.14 (entry 3). The terminal electron-
withdrawing group of the alkynyl group lowers the -electron density, and thus decreases its ability 
to participate in the electrostatic interaction. In addition, when the reaction was conducted in the 
polar solvent nitromethane instead of DCE, the trans-selectivity diminished (entry 4). It is 
attributed to that the increase in attractive interaction between the -hydrogen and solvent weakens 
the electrostatic interaction between the -hydrogen and -electrons, which is an additional 
support for our proposed electrostatic model. 
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The preference for the axial orientation of the alkynyl groups was confirmed, which 
strongly encouraged us to move the pursuit of trans-selectivity forward to the macrocyclic 
substrates. The initial results are shown in Table 2-2. To our delight, p-methoxybenzylic ether 2.17 
underwent DDQ-mediated transannular cyclization smoothly at room temperature and afforded 
the desired 2,6-trans-disubstituted-THP 2.65 as a single diastereomer in 72% yield (entry 1). 
Higher substrate reactivity was observed when the p-methoxybenzylic ether analogs with longer 
tether lengths were subjected to the cyclization reaction (entries 2 and 3). This is attributed to the 
reduction of strain in these macrocyclic systems, which stabilizes the intermediate oxocarbenium 
ions.53 Interestingly, the 2,6-cis-isomer was observed as a minor product in the reaction of the 20-
membered ring substrate 2.19 (entry 2). This is consistent with the initial trans-selectivity-oriented 
strategy shown in Figure 2-4. The allylic ethers were also effective substrates for the DDQ 
oxidation. All of them can be cyclized at room temperature to furnish the trans-THPs as single 
diastereomers (entries 4 to 6). However, the reaction rates vary significantly based on the substrate 
oxidation potentials and the stability of the intermediate cations.54 Due to the higher oxidation 
potential of allylic ethers than p-methoxybenzylic ethers, substrate 2.18 exhibited a much slower 
rate and yield 2.65 (entry 4). Its corresponding E-isomer 2.44 produced the same product as the 
only diastereomer with slower reaction rate (entry 5), which is ascribed to the strain-induced 
destabilization of the intermediate cation. Moreover, the product configuration of isomer 2.44 also 
suggests that the rotation of the -bonds is facile in oxocarbenium ions. The addition of an 
oxocarbenium ion-stabilizing group, such as a phenyl group, on the alkene elevated the reaction 
rate dramatically (entry 6).  
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      Table 2-2. Synthesis of the macrolactions bearing bridged 2,6-trans-disubstituted THPsa 
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Encouraged by the success of the cyclizations of benzylic and allylic ethers, the substrate 
scope exploration was expanded to the propargylic ethers that exhibited lower reactivity in the 
DDQ oxidation (Table 2-3).   
 
       Table 2-3. DDQ-mediated cyclization of macrocyclic substrate 2.20a 
 
 
Macrocycle 2.20 was subjected to the oxidative cyclization at 50 °C with four equivalents 
of DDQ. After a prolonged period (62 hours), 2.20 was fully consumed and afford 2,6-trans-
disubstituted THP 2.67 in 30% yield as single diastereomer (entry 1). The structure and 
stereochemistry of 2.67 were confirmed by single crystal diffraction (Figure 2-7). No by-product 
was collected from this reaction, which hints that the modest yield could be attributed to 
nonspecific decomposition of carbocations rather than the overoxidation. The addition of lithium 
perchlorate slightly improved the reaction yield (entry 2), which is explained by the formation of 
a more electrophilic carbocation-perchlorate ion-pair.26b Higher temperatures significantly 
shortened the reaction time, but diminished the reaction yield (entry 3). A slightly lower yield was 
obtained after one-month stirring of the reaction at room temperature (entry 4).  
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Figure 2-7. Single crystal diffraction of 2,6-trans-disubstituted THP 2.67 
 
The low reactivity of proparylic ether 2.20 in the DDQ oxidation can be attributed to two 
reasons: 1) The relatively higher oxidation potentials of alkynes make the proparylic substrates 
more resistant to losing electrons than corresponding benzylic and allylic substrates. 2) The 
macrocyclic constrains limit radical cation 2.68 from adopting a coplanar geometry of the alkynyl 
-system, C-H bond at -position of ether, and the lone electron pair on the ether oxygen atom, 
which slows down the oxocarbenium formation.32 
The scope of propargylic substrates was explored and shown in Table 2-4. As we observed 
in Table 2-2, the substrate with longer tether length exhibits higher reactivity. Compare to substrate 
2.20, the 16-membered macrocycle 2.21 underwent the oxidative transannular cyclization at lower 
temperature and rendered THP products in a higher yield, in which the cis-isomer was present as 
minor product (entries 1 and 2). Moving the lactone group one carbon away from the 
oxocarbenium ion did not bring about any visible impact to either reactivity or yield (entry 1 vs 
entry 3). However, a significant reactivity reduction was observed when the carbonyl group of the 
lactone was moved closer to the oxocarbenium ion (entry 1 vs entry 4, entry 5 vs entry 6). It was 
interpreted that the carbonyl group has a greater contribution to intermediate carbocation 
destabilization compared to the oxygen atom. The methyl groups at -position of ethers are 
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proposed to provide stabilization impact to the intermediate oxocarbenium ions. Therefore, tertiary 
ethers 2.22 and 2.23 reacted at lower temperature in this oxidation reaction than other substrates 
and but afforded the desired trans-THPs with similar yields (entries 5 and 6). 
Although alkynyl groups rarely appear in the macrolides, they are able to accept versatile 
functionalizations and be subjected to diversity-oriented synthesis. Herein, we provided a “formal 
E-selective hydrogenation” example to demonstrate the utilities of the alkyne-contained 
macrocycles. Alkyne 2.62 underwent a hydrosilylation/desilylation-based reduction55 sequence to 
access the synthetically challenging (E)-alkene 2.75 in 49% yield. 
 
Scheme 2-9. (E)-selective formal hydrogenation of macrocyclic alkyne 
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       Table 2-4. Examination of the macrocyclic propargylic ethers in DDQ-mediated cyclizationa 
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2.4 SUMMARY 
 
Bridged 2,6-trans-disubstituted THPs were synthesized through the DDQ-promoted 
transannular cyclization reactions in macrocyclic systems. The excellent stereoselectivity of this 
reaction is ascribed to ring strains that coerce the sterically undemanding alkynyl groups to adapt 
axial orientations in the intermediate oxocarbenium ions. Macrocyclic benzylic, allylic, and 
propargylic substrates were examined. Although all of them produced the desired trans-THPs as 
major or single diastereomers, the reactivities were quite different. The benzylic and allylic ethers 
were highly reactive and produced the trans-THPs in good to excellent yields under mild 
conditions. Interestingly, the alkynyl groups in this type of substrates exhibited an electrostatic 
interaction with the -hydrogen of oxocarbenium ions, which further favored the axial orientation 
of the alkynyl groups. The macrocyclic propargylic ethers were quite inert toward DDQ oxidation. 
Harsher reaction conditions were employed to furnish the trans-THPs in significantly lower yields 
compared to the benzylic and allylic ethers. In addition, the high functionalization potential of the 
alkynyl groups enable the transannular cyclization products to be extremely useful intermediates 
for the preparation of a number of compounds.   
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3.0 ONE-POT STRATEGY FOR SPIROKETAL SYNTHESIS 
 
3.1 INTRODUCTION 
 
Spiroketals are abundant in numerous biologically important natural products (Figure 3-
1).56 In the past decades, a significant number of approaches have been developed for both target- 
and diversity-oriented spiroketal syntheses.57 These methods can be classified into two general 
categories: 1) a cascade process that cyclizes a functionalized linear molecule in the presence of 
Brønsted or Lewis acids;58 2) a stepwise protocol that constructs the two rings of a spiroketal 
separately.59 Several examples are briefly discussed below.  
 
Figure 3-1. Selected natural products that contain spiroketal substructures 
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3.1.1 Cascade Cyclization of Functionalized Linear Molecules 
 
As the most common spiroketal precursors, dihydroxyketones can be easily converted to 
spiroketals through an acid-catalyzed dehydrative cyclization. Ley and co-workers illustrated this 
method during the synthesis of the C1-C28 fragment 3.8 of the natural product, spongistatin 1 
(Scheme 3-1).60 Both of the spiroketal scaffolds with different configurations in 3.8 were 
constructed from -ketodithianes in the presence of perchloric acid. -Ketodithiane 3.1 produced 
the double-anomerically stabilized spiroketal 3.3 smoothly as a single diastereomer in excellent 
yield. Whereas the dehydrative cyclization of -ketodithiane 3.2 yielded a mixture of the desired 
partially anomerically stabilized spiroketal 3.4 and its stereoisomer 3.5 in a ratio of 1:4. Based on 
Smith’s protocol, the distribution of 3.4 and 3.5 can be re-equilibrated as a 2.2:1 mixture in favor 
of 3.4 with the assistance of Ca2+ ions.61 Thus, spiroketal 3.4 was collected in 84% yield after three 
rounds of the calcium(II)-catalyzed epimerization. Moreover, the 1,3-dithiane units are crucial to 
the spiroketalizations. The corresponding 1,3-dione performed capriciously in this 
spiroketalization reaction.  
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Scheme 3-1. Ley’s synthesis of the C1-C28 fragment of spongistatin 1 
 
3.1.2 Stepwise Protocol for Spiroketal Formation 
 
Compared to the one-step spiroketalization approach, the stepwise protocol can assemble 
the two rings of spiroketals through different cyclization methods, which enables a wider scope of 
spiroketals to be synthetically accessible. Tan and co-workers developed a spirocyclization 
reaction to kinetically control the configurations of the spiroketal products (Scheme 3-2).62 Their 
construction of spiroketals began with an asymmetric hetero-Diels-Alder (HDA) reaction that 
stereoselectively formed the first ring 3.9. After several modifications on 3.9, the resulting 
epoxides 3.10 and 3.13 underwent a methanol-induced or Lewis acid-catalyzed epoxide ring-
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opening/cyclization process to selectively furnish the C1-inversion and C1-retention spiroketals 
3.12 and 3.17 respectively. The methanol-involved process was proposed to undergo a SN2 or SN2-
like pathway, in which the hydrogen-bonding model 3.11 was proposed to explain the 
diastereoselectivity.62b From this model, the two hydrogen-bonds contributed by the upper 
methanol and both the tetrahydropyran oxygen and side chain oxygen disfavor the oxocarbenium 
ion-mediated SN1 pathway. When the spirocyclization proceeds in the presence of titanium 
isopropoxide, the SN1 pathway is preferred.
62c During this process, the Lewis acid not only opens 
the epoxide, but also serves as a noncovalent tether that connects the epoxide oxygen and side 
chain oxygen to facilitate the kinetic formation of 3.17. 
 
Scheme 3-2. Spirocyclization of glycal epoxides 
 
Rizzacasa and co-workers sequentially employed an acid-promoted lactonization and 
inverse electron demand HDA to construct the 6,6-spiroketal 3.21 in their synthesis of reveromycin 
B (Scheme 3-3).63 During the HDA reaction, the oxygen atom of aldehyde 3.20 predominantly 
approached to THP 3.19 in axial manner due to the anomeric effect, which explains the high 
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distereoselectivity of this reaction. Interestingly, after the epoxidation of 3.21, the labile product 
3.22 underwent a rearrangement to form more thermodynamically stable 5,6-spiroketal 3.23 in 
excellent yield under acidic conditions. A mechanism containing a ring-opening/carbocation-
formation/re-cyclization process was proposed to illustrate this rearrangement.  
 
Scheme 3-3. Rizzacasa’s access toward 5,6-spiroketal in the synthesis of reveromycin B 
 
3.1.3 Designing a One-Pot Strategy for Spiroketal Formation 
 
Although the stepwise protocol significantly expands the scope of synthetically accessible 
spiroketals, it lengthens the synthetic sequence by at least one step. We were exploring a solution 
to this issue, which could allow us to construct the two rings of a spiroketal through different 
cyclization reactions but in a one-pot process. 
Based on the Floreancig group’s previous studies on DDQ oxidation,30 we predicted that 
the C–H bond at -position of the enol silane 3.24 could be oxidatively cleaved by DDQ to form 
the oxocarbenium ion 3.25 (Scheme 3-4). In the absence of a nucleophile, 3.25 will rapidly convert 
to enone 3.26, which is an excellent Michael acceptor. We envisioned that if the enone contained 
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a side chain with an alcohol group at the end, such as enone 3.27, spiroketal scaffold 3.28 would 
be easily furnished under acidic conditions. Additionally, the THP-based enol silyl ethers are 
readily available from a transition metal-catalyzed HDA reaction.64 Thus, a one-pot strategy that 
combines these three reactions was conceived. 
 
Scheme 3-4. One-pot strategy for spiroketal formation 
 
 
3.2 SYNTHESIS OF SPIROKETALS THROUGH A ONE-POT PROCESS 
 
Dienes 3.30 to 3.32 and 3.34, aldehydes 3.33 and 3.34, and Jacobsen catalysts 3.37 and 
3.38 were prepared for initial investigation (Scheme 3-5). Synthesis of these dienes followed the 
sequence of alcohol protection, alkene cross-metathesis,65 and enol silane formation. The 
preparation of aldehydes 3.35 and 3.36 started with a single alcohol protection of ethylene glycol, 
followed by a Parikh-Doering oxidation.39 Catalysts 3.37 and 3.38 were assembled by known 
procedures.66  
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Scheme 3-5. Substrates and catalysts for initial investigation 
 
The initial results are shown in Table 3-1. The first attempt of the one-pot process began 
with the addition of catalyst 3.37 into the mixture of diene 3.30, aldehyde 3.35, molecular sieves, 
and acetone. The resulting slurry was stirred at room temperature until diene 3.30 was consumed, 
then was diluted by dichloromethane. The diluted reaction mixture was treated with DDQ in one 
portion, followed by the addition of PTSA when the TLC indicated the completion of enone 
formation and PMB deprotection. The resulting mixture was stirred at room temperature until the 
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desired spiroketal was fully formed. After purification, spiroketal 3.39 was isolated in a moderate 
yield as a single diastereomer (entry 1). Different enol silyl groups did not significantly impact the 
yield of this reaction (entries 1, 2, and 4). Acetone as the solvent is unnecessary for the HDA 
reaction (entry 1 vs entry 3). The employment of catalyst 3.38 led to a slight decrease of yield, 
which might be attributed to the acceleration of the side reactions, such as aldehyde condensation 
and diene decomposition, due to the stronger Lewis acidity of 3.38 (entry 4 vs entry 5). In order to 
suppress the possible oxidative decompositions in the reaction, a lower loading amount of oxidant 
is preferred. Thus, TES was employed instead of PMB as the protecting group of the primary 
alcohol of diene substrate, which reduced the loading amount of DDQ by half, and thus led to a 
significant improvement of yield (entry 6). This observation might also be reasoned by the higher 
efficiency of TES deprotection as compared to PMB deprotection. Aldehyde 3.36 bearing a 
TBDPS protecting group brought a significant improvement of product ee value and also a slight 
increase in reaction yield (entry 7). 
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           Table 3-1. Initial investigation of the one-pot spiroketal formation reactiona       
 
 
Several representative dienes were designed and synthesized in order to comprehensively 
evaluate the potential synthetic value of this spiroketal formation reaction (Scheme 3-6). Diene 
3.41 shared a similar synthetic route with diene 3.34. The in situ generated Grignard reagent from 
4-bromobut-1-ene opened the ring of (S)-(–)-propylene oxide to afford secondary alcohol 3.42, 
which underwent a silyl protection, alkene cross-metathesis, and enol silane formation to yield 
diene 3.44. Diene 3.47 was accessed from (E)-but-2-ene, which underwent a Brown crotylation,67 
silyl protection, Suzuki coupling,45 and enol silane formation to deliver the desire substrate. The 
hex-5-enoic acid was converted to amide 3.48 by a two-step amination,68 which was followed by 
an alkene cross-metathesis and enol silane formation to furnish diene 3.49. 
  
 
 
51 
 
Scheme 3-6. Synthesis of the diene substrates 
 
The performances of these dienes with aldehdye 3.36 in the one-pot process are listed in 
Table 3-2. All of the spiroketals were isolated as single diastereomers. Diene 3.41 with shortened 
carbon chain can undergo the HDA, DDQ oxidation, and oxa-Michael cyclization smoothly to 
afford 5,6-spiroketal 3.50 in similar yield with diene 3.34 (entry 1). The excellent yields of 
spiroketals 3.44 and 3.47 imply that the secondary alcohols are as effective nucleophiles as the 
primary alcohols in oxa-Michael cyclization; and the multiple substituted dienes are also suitable 
substrates for the spiroketal formation process (entries 2 and 3). Moreover, spiroketals 3.51 and 
3.52 are nearly enantiopure compounds because an ee enhancement occurs when two 
enantiomerically enriched molecules are coupled, which is referred as the Horeau principle.69 The 
one-pot process was most likely obstructed at the initial stage for diene 3.49 (entry 4), which might 
be attributed to the possible coordination effect between transition metal catalyst and the nitrogen 
atom of amide. 
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                Table 3-2. Diene scope explorationa 
 
 
Different types of aldehydes were also subjected to our spiroketal formation protocol. The 
results are shown in Scheme 3-7. Although a prolonged HDA reaction was necessary, heptanal, a 
nonfunctionalized aliphatic aldehyde was able to yield spiroketal 3.53 in moderate yield but with 
an extremely high ee value (Eq (3-1)). Benzaldehyde also required a long period to undergo the 
HDA reaction, followed by rapid oxidation and cyclization to afford spiroketal 3.54 in moderate 
yield and with a slightly lower ee value (Eq (3-2)). The attempt of acrolein was unsuccessful (Eq 
(3-3)). The volatile aldehyde disappeared rapidly from the reaction mixture, leaving behind the 
unreacted diene, which gradually decomposed in the presence of the catalyst. The [4+2] cyclized 
product from diene 3.34 and the acrolein alkene was not observed either.  
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Scheme 3-7. Performances of different aldehydes in the spiroketal formation reaction 
 
 
3.3 DISCUSSION 
 
3.3.1 Proposed Mechanism for the One-Pot Process 
 
A proposed mechanism of the spiroketal formation reaction is shown in Scheme 3-8. At 
the HDA stage, diene 3.34 and aldehyde 3.36 are combined to form enol silylether 3.55 in a 
concerted [4+2] manner. The Jacobsen group ruled out the possibility of the Mukaiyama aldol 
condensation mechanism for this [4+2] cyclization through treating the intermediacy of a 
Mukaiyama aldol condensation adduct with Jacobsen catalyst, which failed to yield any cyclized 
product.70 The second stage is initiated by a one-electron transfer from 3.55 to DDQ, which 
generates radical cation 3.57 and radical anion 3.56. Oxocarbenium ion 3.59 was formed through 
either a hydrogen atom abstraction pathway, or a successive proton abstraction and electron 
  
 
 
54 
transfer pathway. During this process, radical anion 3.56 is further reduced to anion 3.58. A rapid 
desilylation of oxocarbenium ion 3.59 furnishes enone intermediate 3.61 and mono-silylated 1,4-
dihydroxybenzene 3.60. During the last stage, the TES group of 3.61 is selectively removed due 
to its acid lability. The resulting enone 3.62 is protonated and forms oxocarbenium ion 3.63, which 
is attacked by the free internal alcohol to give the spiroketal scaffold 3.64. The desired spiroketal 
3.40 is formed after the tautomerization of 3.64. Interestingly, the stoichiometric amount of 1,4-
dihydroxybenzene 3.60 derived from DDQ creates a buffer-like system in the reaction, thus 
requiring more than one equivalent of PTSA to initiate the oxa-Michael cyclization.  
 
Scheme 3-8. Proposed mechanism for the one-pot spiroketal formation 
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3.3.2 Stereochemical Analysis 
 
The one-pot process exhibits exclusive diastereoselectivity because the oxa-Michael 
cyclization undergoes a pathway that is both kinectically and thermodynamically favored (Scheme 
3-9). For the intermediate 3.63, the equatorial attack by internal alcohol on the oxocarbenium ion 
is disfavored due to the generation of the unstable twisted-boat conformer. There are two possible 
axial-attack pathways as shown in Scheme 3-9. The 1,3-syn-pentane interaction kinetically 
disfavors pathway A.71 Moreover, compared to the double-anomerically stabilized spiroketal 3.40 
obtained through pathway B, partially anomerically stabilized spiroketal 3.65 is considered as the 
thermodynamically unfavored product. Therefore, pathway A is fully suppressed during the oxa-
Michael cyclization. 
 
Scheme 3-9. Analysis of the diastereoselectivity of oxa-Michael cyclization 
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3.3.3 Synthesis of Bridged Bicyclic Ethers through the One-Pot Process 
 
We also initiated a simple trial of the one-pot process that was targeted to yield a bridged 
bicyclic ether (Scheme 3-10). Successively treating aldehyde 3.66 and diene 3.67 with catalyst 
3.37, DDQ, PTSA, and HF, the desired bicyclic ether 3.68 was obtained in a 25% yield, while the 
uncyclized precursor 3.69 was also collected in a 53% yield. Interestingly, a silyl transfer was 
observed during the DDQ oxidation. The TES group from the enol silyl moiety transferred to the 
PMB deprotected alcohol, which could not be desilylated until HF was added. With a prolonged 
time, furan 3.70 was obtained, accompanied by a significant consumption of 3.68 and 3.69. 
Moreover, when pure isolated 3.68 or 3.69 was treated with PTSA, both 3.68 and 3.69 were 
observed and 3.70 would also be formed after several hours. We proposed that there is a labile 
equilibrium between 3.68 and 3.69 and 3.69 is irreversibly converted to 3.70 under acidic 
conditions. 
 
Scheme 3-10. Access toward bridged bicyclic ethers through the one-pot process 
 
The proposed furan formation mechanism is shown in Scheme 3-11. After the nucleophilic 
attack of the alcohol to the protonated carbonyl group, bicyclic hemi-acetal 3.72 is formed. This 
intermediate is protonated to form oxocarbenium ion 3.73, which accepts the nucleophilic attack 
by water to afford diol 3.74. The THP ring of 3.74 opens under acidic conditions to form 
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tetrahydrofuran 3.76. Two dehydrations convert 3.76 to the furan that was collected in the one-pot 
process. 
 
Scheme 3-11. Proposed mechanism for the formation of furan 3.70 
 
 
3.4 SUMMARY 
 
We have demonstrated that the synthetically useful spiroketals can be easily and 
diastereoselectively accessed through a one-pot process that combines a HDA reaction, a DDQ 
oxidation, and an oxa-Michael cyclization. Non-cyclic dienes and aldehydes were employed as the 
starting materials, which were easily prepared. The multiple-substituted dienes performed 
excellently in the spiroketal formation reaction as well as the diene bearing a shorter tether length. 
Both of the non-functionalized aldehydes and aromatic aldehydes are suitable substrates, although 
a prolonged time is necessary for the initial HDA reaction. For the mechanism proposal, we 
hypothesized that the telescoped DDQ oxidative C–H bond activation of the concerted [4+2] 
cyclization product generates oxocarbenium ion intermediates, which are rapidly converted to 
enones. The oxa-Michael cyclization occurs to yield the desired products when the acid is added. 
The stereoselectivity is attributed to the kinetically and thermodynamically favored pathway. 
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Moreover, an attempt to produce the bridged bicyclic ether was initiated, and a moderate yield of 
the desired product was collected.  
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4.0 TOTAL SYNTHESIS OF BISTRAMIDE A 
 
4.1 INTRODUCTION OF BISTRAMIDE A 
 
The bistramide family represents a novel class of bioactive cyclic polyethers from the 
marine ascidian Lissoclinum bistratrum.72 To date, five members of this family have been isolated 
and characterized (Figure 4-1). Bistramide A was first discovered by the Gouiffès group in 
1988,72a,72b while the isolation of the other four members were conducted by the Biard group in 
1994.72c 
 
Figure 4-1. Members of the bistramide family 
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The Gouiffès group conducted the initial structure determination of bistramide A through 
extensive 2D NMR analysis.72a A linear structure for bistramide A was suggested based on the 
assignments of all crucial connectivity assisted by 1H-13C and 1H-1H COSY in combination with 
1H-13C COLOC and relayed 1H-1H-13C COSY. Later, the Hawkins group claimed a structure 
revision for bistramide A according to their observation of three key long-range 1H-13C 
correlations (Figure 4-2).72b They proposed an alternative three-dimensional structure that contains 
two bridged macrocycles and one bridged furan. The correct structure of bistramide A was not 
revealed until the Ireland group published their reassignment of bistramide A based on the 
automated analysis of a 2D INADEQUATE experiment data.73 
 
Figure 4-2. Structure determination of bistramide A 
 
However, Ireland’s bistramide A structure does not provide any information related to the 
absolute configuration, which is extremely important for the effective exploration of its biological 
activities. In 2000, Solladié et al. determined the absolute configuration of C4 in bistrmide D via 
Mosher’s method.74 Moreover, they also assigned the relative configurations of the 
tetrahydropyran ring and spiroketal skeleton based on the NOESY spectral data (Figure 4-3). Later, 
the Wipf group fully assigned the absolute configuration of bistramide C through the combination 
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of organic synthesis and NMR spectroscopy.75 Kozmin’s first total synthesis of bistramide A 
uncovered the C37 stereochemistry and confirmed Wipf’s assignment.76 
 
Figure 4-3. Relative configuration determination of the substructures of bistramide A 
 
Bistramide A is initially demonstrated to possess significant cytotoxicity towards P388 
leukemia, B16 melanoma, HT29, and non-small-cell lung carcinoma (NSCLC-N6) cell lines with 
an IC50 of 0.4 to 4.5 nM, and is able to selectively activate the  isotype of protein kinase C (PKC) 
in human promyelocytic leukemia (HL-60) and human malignant melanoma (MM96E), which 
leads to the inhibition of cytokinesis and growth arrest.77 However, Kozmin showed the low bind 
affinity between bistramide A and PKC recently, and proved the existence of the interaction 
between bistramide A and actin by crystallographic studies, which explains the potent 
antipoliferative effects of bistramide A and makes it be a potential antitumor drug.78  Therefore, 
the total synthesis of this promising potential drug has attracted the attention of many synthetic 
groups.76,79 
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4.2 PREVIOUS TOTAL SYNTHESIS OF BISTRAMIDE A 
 
Five groups have independently reported total syntheses of bistramide A.76,79 These five 
routes shared the similar retrosynthetic plans that disconnected bistramide A at the two amide 
bonds (Figure 4-4). However, the resulting three subunits were constructed through different 
routes. Each bistramide A synthesis is summarized in this section chronologically. 
 
Figure 4-4. General retrosynthetic analysis of the previous total syntheses of bistramide 
 
4.2.1 Kozmin’s Total Synthesis of Bistramide A 
 
Kozmin and co-workers accomplished the first total of bistramide A in 2004.76 During their 
efforts toward spiroketal fragment 4.6a, homoallylic alcohols 4.9 and 4.10 were connected through 
cyclopropene acetal 4.11 in the presence of Grubbs catalyst (2nd generation) (Scheme 4-1). The 
resulting dienone 4.12 was exposed to hydrogen gas and palladium to generate the 
dihydroxyketone intermediate in situ, which underwent a spiraketalization reaction and subsequent 
Dess-Martin oxidation to yield the key spiroketal scaffold 4.13. After a Cr(II)-mediated 
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olefination,80 the Itsuno-Corey reduction81 introduced the desired stereochemistry at carbon C37, 
and completed the synthesis of fragment 4.6a. 
 
Scheme 4-1. Spiroketal fragment synthesis in Kozmin’s synthesis 
 
The -amino acid 4.7a was assembled from the oxidative cleavage of terminal alkene 4.14, 
followed by the removal of Boc and acetonide protecting groups and installation of an Fmoc group 
on the amine. The 2,6-trans-disubstituted THP ring of fragment 4.8a was constructed through a 
consecutive acrylation, ring-closing metathesis, hydrogenation, reduction, acylation, and SN1 
substitution process in a 37% overall yield from homoallylic alcohol 4.16. After the desilylation 
of 4.18, the unprotected alcohol was exposed to periodic acid to afford the carboxylic acid 
intermediate, which was converted to 4.8a by coupling with N-hydroxysuccinimide. 
 
Scheme 4-2. Syntheses of subunits 4.7a and 4.8a 
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After the removal of the phthalimide group, spiroketal 4.6a was combined with Fmoc 
protected amino acid 4.7a to furnish 4.19. An Fmoc deprotection of amide 4.19 enabled this 
fragment to be coupled with trans-THP 4.8a and complete the total synthesis of bistramide A. 
 
Scheme 4-3. Completion of Kozmin’s bistramide A synthesis 
 
4.2.2 Crimmins’ Total Synthesis of Bistramide A 
 
Two years after Kozmin’s accomplishment of bistramide A synthesis, Crimmins and co-
workers published their route toward this natural product.79a They trisected bistramide A into the 
three same pieces as Kozmin’s synthesis. Spiroketal 4.6a was constructed through a stepwise 
strategy (Schme 4-4). The lactonization of hydroxyester 4.20 in the presence of PTSA constructed 
the first ring of the spiroketal and results the lactone 4.22, on which an alkynyl chain was installed. 
Subsequently, a palladium-catalyzed hydrogenation reduced the alkynyl group, deprotected the 
benzyl group, and cyclized the second ring of spiroketal 4.23. Subunit 4.6a was formed after a few 
side chain functional group manipulations on 4.23. The chiral centers of subunit 4.7a were 
introduced to allylic alcohol 4.24 by a Sharpless epoxidation, followed by a methylation to open 
the resulting epoxide to yield diol 4.25. The THP scaffold of subunit 4.8a was also formed by a 
PTSA-catalyzed lactonization of hydroxyester 4.26. The resulting THP 4.27 was converted to 4.8a 
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in four steps. In the end, these three pieces were coupled by two simple amide formation reactions 
to yield bistramide A. 
 
Scheme 4-4. Crimmins’ protocol toward the synthesis of bistramide A 
 
4.2.3 Panek’s Total Synthesis of Bistramide A 
 
The Panek group established the total synthesis of bistramide A as a perfect showcase of 
their [4+2] and [3+2] annulations between allylsilanes and aldehydes (Scheme 4-5).79a,79b,82 
Spiroketal 4.6b was sourced from allylsilane 4.28, which underwent a [4+2] annulation with 
aldehyde 4.29 to diastereoselectively afford cis-THP 4.30 in excellent yield. This THP was 
coupled with fragment 4.31 to form alkene 4.32 after several functional group manipulations. 
Wilkinson’s catalyst selectively reduced the less hindered double bond of 4.32, followed by an 
oxidative deprotection of the PMB group, which facilitated the spirocyclization reaction. The 
resulting spiroketal intermediate underwent a Birch reduction and a Mitsunobu reaction to yield 
the desired spiroketal subunit. Allylsilane 4.33 was subjected to a [3+2] annulation with aldehyde 
4.34 to afford tetrahydrofuran 4.35, which underwent an SbCl5-catalyzed ring-opening process to 
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yield ester 4.36. After a few modifications, 4.36 was successfully converted to amino acid 4.7b. 
The trans-THP subunit 4.8b was also synthesized from a [4+2] annulation of allylsilane 4.37 and 
aldehyde 4.29.  
 
Scheme 4-5. Showcase of the annulation reactions in the total synthesis of bistramide A 
 
4.2.4 Yadav’s Total Synthesis of Bistramide A 
 
Yadav’s synthesis of bistramide A is highlighted by employing dialkylated tosylmethyl 
isocyanide derivative 4.42 as the surrogate of the dihydroxyketone to rapidly construct the 
spiroketal 4.43 in excellent yield (Scheme 4-6).79c,83 This spiroketalization precursor was 
synthesized by two successive butyllithium-promoted alkylations that installed iodides 4.39 and 
4.41 on the tosylmethyl isocyanide. Spiroketal 4.43 was converted to subunit 4.6b through several 
side chain manipulations. The amino acid fragment 4.7b and trans-THP fragment 4.8b were 
combined with the assistance of PyBOP, followed by another PyBOP-promoted amide formation 
to couple with subunit 4.6b to yield silyl protected bistramide A. A simple desilylation smoothly 
removed the silyl groups to furnish bistramide A in good yield. 
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Scheme 4-6. Yadav’s alcomplishment of bistramide A synthesis 
 
4.2.5 Lord and Goekjian’s Total Synthesis of Bistramide A 
 
Recently, Lord and Goekjian published their approach toward the synthesis of bistramide 
A.79e Their total synthesis is highlighted by a novel enol ether-forming reaction for spirocyclization 
and a trans-oriented kinetic oxa-Michael cyclization (Scheme 4-7). Under the optimized 
conditions, lactone 4.45 and Julia-Kocienski reagent 4.46 joined together to form the enol ether 
4.47, followed by PTSA-promoted cyclization to yield spiroketal 4.48. The trans-THP ring was 
formed by an oxa-Michael cyclization of substrate 4.49. During this reaction, a nearly quantitative 
yield of cyclized products was collect as a 3:1 mixture of isomers in favor of trans-THP 4.50, 
which was converted to subunit 4.8a in 7 steps. The synthesis of amino acid 4.7a was similar to 
Kozmin’s protocol. 
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Scheme 4-7. Lord and Goekjian’s synthesis of bistramide A 
 
However, the current synthetic sequences for bistramide A are quite long. Even the shortest 
sequence that comes from Kozmin’s group needs 17 steps for the longest linear sequence and 45 
overall steps from commercially available starting materials. A more convergent synthetic route is 
necessary to access to this potential drug candidate. The one-pot spiroketal formation process that 
was described previously in Chapter 3 will significantly shorten the sequence through dramatically 
increasing the molecular complexity in one step. Moreover, the 2,6-trans-THP fragment can also 
be assembled more efficiently through another novel one-pot process, which subsequently 
proceeds a hydroformylation, a cyclization, and an acetylation. We believe these two strategies 
will provide us a highly concise synthetic protocol to synthesize bistramide A. 
 
4.3 RETROSYNTHETIC ANALYSIS 
 
Our retrosynthetic analysis is shown in Figure 4-5. We envisioned bistramide A could be 
obtained through a simple amide formation that couples amine 4.51 and succinimide-activated 
carboxylic acid 4.52. Aldehyde 4.53 and diene 4.54 were designed to undergo a one-pot spiroketal 
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formation process that was described previously in Chapter 3. Diene 4.54 can be further dissected 
into vinyl iodide 4.55 and secondary alcohol 4.56. For the righthand fragment synthesis, we planed 
to disconnect it at the amide linkage, separating it into amino acid subunit 4.57 and trans-THP 
subunit 4.59. Subunit 4.57 can be easily accessed from secondary alcohol 4.58 through a 
ruthenium(III) chloride-mediated terminal alkene oxidation. The THP ring of 4.59 can be 
constructed through a successive hydroformylation/cyclization/subsitition process that began with 
secondary alcohol 4.60. 
 
Figure 4-5. Retrosynthetic plan of bistramide A 
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4.4 TOTAL SYNTHESIS OF BISTRAMIDE A 
 
4.4.1 Lefthand Fragment Synthesis 
 
Commercially available alcohol 4.61 underwent Swern oxidation84 to afford aldehyde 4.62 
in excellent yield (Scheme 4-8). Secondary alcohol 4.56 was collected in 67% yield and 83% ee 
value that was determined by Mosher ester analysis85 through Brown crotylboration67 of aldehyde 
4.62. Vinyl iodide 4.55 was generated through a facile hydroiodination of ketone 4.63.86 In order 
to access the chiral center on aldehyde 4.53, we took the advantage of natural extract (+)--
citronellene by conducting a regioselective ozonolysis.87 
 
Scheme 4-8. Synthesis of fundamental units 4.53, 4.55, and 4.56 for the lefthand fragment 
 
Diene 4.54 was easily accessed through a straightforward sequence that consisted of a silyl 
protection, a Suzuki coupling,45 and an enol silane formation (Scheme 4-9). Water was proven to 
be crucial in this Suzuki coupling. It quenched the hydroboration reaction and prevented the 
palladium catalysis cycle from being deactivated by the unreacted borane. 
  
 
 
71 
 
Scheme 4-9. Synthesis of diene 4.54 
 
With diene 4.54 and aldehyde 4.53 in hand, we were able to initiate our investigation of 
the key step, the spiroketal formation (Table 4-1). To our delight, desired spiroketal 4.66 was 
collected as a single diastereomer during our first attempt, in which diene 4.54 was simply mixed 
with aldehyde 4.53 and catalyst 4.67 and stirred at room temperature for 60 hours before being 
treated with DDQ and PTSA (entry 1). The relatively long time for the HDA reaction was 
attributed to the low reactivity of aliphatic aldehyde 4.53. Several side reactions were proposed to 
occur during the HDA reaction. Under the highly concentrated conditions, aldehyde 4.53 might 
undergo a condensation process with the assistance of Lewis acid to form oligomers or polymers 
that stayed at the baseline of the TLC plates. Simultaneously, catalyst 4.67 would promote the 
cleavage of then enol silane on diene 4.54 to form enone intermediate 4.69 due to the presence of 
adventitious water in the system (Scheme 4-10). This enone was subjected to PTSA to yield a 
significant amount of by-product 4.70. Adding molecular sieves and increasing the equivalents of 
aldehyde 4.53 effectively improved the yield of the desired spiroketal (entry 2). Interestingly, 
catalyst 4.68 significantly shortened the HDA reaction time, but still afforded the spiroketal with 
similar yield (entry 3). It might be rationalized by the stronger Lewis acidity of 4.68, which 
accelerated both the spiroketal formation reaction and the side reactions. Replacing the enol silane 
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with silyl groups that are less labile to the acids did not bring any significant improvement to the 
results (entries 4 and 5). A sight increase of the yield was obtained by adjusting the detailed 
procedure of the HDA reaction (entry 6). Molecular sieves, catalyst 4.68, and two equivalents of 
aldehyde 4.53 were mixed and stirred for 5 minutes before adding diene 4.54 and another two 
equivalents of aldehyde 4.53 in order to evenly distribute the catalyst and pre-activate the aldehyde. 
 
                     Table 4-1. Construction of the key spiroketal corea 
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Scheme 4-10. Generation of by-product 4.70 in the spiroketal formation reaction 
 
A mild variant of the Wolff-Kishner reduction,88 known as Caglioti reaction,89 was 
employed to deoxygenate the ketone on the spiroketal core (Scheme 4-11). It is a three-step 
sequence that started with the treatment of spiroketal 4.66 with p-tosylhydrazine to afford 
tosylhydrazone intermediate 4.71, followed by a hydride reduction to render tosylhydrazine 
derivative 4.72. The resulting tosylhydrazine eliminated a p-toluenesulfinic acid (TsH) under 
slightly basic condition with heat to form diazene intermediate 4.73, which decomposed to desired 
hydrocarbon 4.74. 
 
Scheme 4-11. Deoxygenation of ketone 4.66 through Caglioti 
 
The deoxygenation product 4.74 was sequentially subjected to alkene cross metathesis 
reaction to couple with ketone 4.75, which turned out to be unsuccessful (Scheme 4-12). When 
methacrolein was employed in the presence of Hoveyda-Grubbs catalyst (2nd generation),65e a 
moderate yield of coupling product 4.76 was collected. Moreover, Grela-Grubbs catalyst 
significantly lifted the efficiency of the metathesis reaction to produce 4.76 in 68% yield.90 
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However, regardless of the Grubbs catalyst chosen, this metathesis reaction generated an 
inseparable Z-isomer 4.77 that had an approximate 1:9 ratio with 4.76. 
 
Scheme 4-12. Installation of methacrolein onto 4.74 via alkene cross metathesis reaction 
 
Treating the -unsaturated aldehyde 4.76 (with contaminant 4.77) with dimethyl zinc 
reagent in the presence of (–)-morpholino isoborneol (MIB) asymmetrically added a methyl group 
on the aldehyde, which afforded a mixture of diastereomers 4.78 and 4.79 in 85% yield (Scheme 
4-13).91 However, (Z)-isomer 4.79 was still unable to be isolated under normal laboratory 
technologies. Unfortunately, when the mixture of 4.78 and 4.79 were directly subjected to the 
following steps, the undesired isomer was still inseparable. Through analyzing the structures of 
isomers 4.76 and 4.77, we hypothesized that (Z)-isomer 4.77 might have a much higher reactivity 
in the methylation than (E)-isomer 4.76 in order to relieve the steric interaction between the 
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carbonyl group and C34 methyl group. Thus, the mixture of 4.76 and 4.77 were subjected to the 
methylation with reduced loading amount of dimethyl zinc and (–)-MIB. As expected, pure (E)-
isomer 4.76 was obtained in an 83% recovery, which was re-subjected to methylation to afford 
pure 4.78 in 86% yield.  
 
Scheme 4-13. Dimethylzinc-mediated asymmetric methylation 
 
The proposed mechanism for the asymmetric methylation is also shown in Scheme 4-14.92 
The (–)-MIB reacts with one equivalent of dimethyl zinc and coordinates with another molecule 
of dimethyl zinc to form the bimetallic intermediate 4.80. When aldehyde 4.76 coordinates to this 
bimetallic intermediate, the larger group occupies the less hindered position and orients the 
hydrogen upwards as shown in model 4.81. Then, the addition of the internal methyl group forms 
the desired chiral center in model 4.82, which converted to 4.78 upon work up. Due to the reported 
instability of the lefthand fragment,79d the synthesis of this fragment was temporarily halted at 
azide 4.83 which was formed by the convertion of the chloride on 4.78 to an azido group (Scheme 
4-15).93 
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Scheme 4-14. Proposed mechanism of asymmetric 
 
Scheme 4-15. Synthesis of the precursor of the lefthand fragment 
 
4.4.2 Righthand Fragment Synthesis 
 
The righthand fragment synthesis began with the assembly of chiral homoallylic alcohol 
4.60, which was sourced from 1,3-propanediol, followed by monosilylation, Parikh-Doering 
oxidation, and Brown crotylation (Scheme 4-16). 
 
Scheme 4-16. Synthesis of homoallylic alcohol 4.60 
Inspired by the trans-THP construction during the formal synthesis of leucascandrolide A 
in the Floreancig group (Scheme 2-1),35 a creative one-pot process was invented to directly convert 
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homoallylic alcohol 4.60 to THP 4.84 (Scheme 4-17). At the initial stage, the hydroformylation 
extended the carbon chain of 4.60 by one carbon with the assistance of rhodium catalyst in the 
presence of Breit’s exceptional DPPon ligand 4.85.94 The resulting aldehyde 4.86 cyclized to form 
THP intermediate 4.87, which was treated with acetic anhydride to yield THP 4.84 as a mixture of 
diastereomers. Compared to Kozmin’s four-step sequence that constructed the same THP product 
(Scheme 4-2), this one-pot process is exceedingly more efficient. 
 
Scheme 4-17. The one-pot process to access THP 4.84 
 
The substitution of the acetoxy group of 4.84 with an -unsaturated ketone was promoted 
by TMSOTf (Scheme 4-18). This reagent generated the tetrahydropyranyl carbocation 
intermediate from 4.84, which accepted the nucleophilic attack from the in situ generated enol 
trimethylsilyl ether to form a 2,6-trans-THP intermediate. Moreover, during the quenching 
process, TMSOTf was hydrolyzed by water and released triflic acid that deprotected the silyl group 
to yield alcohol 4.88. A CrO3/H5IO6 oxidation converted the resulting alcohol to the carboxylic 
acid, which was subsequently activated by N-hydroxysuccinimide to form 4.59. 
 
Scheme 4-18. Synthesis of trans-THP 4.59 
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The synthesis of -amino acid hydrochloride salt 4.57 essentially followed Kozmin’s 
protocol except the Fmoc protection step, which was unnecessary for our total synthesis (Scheme 
4-19). Neutralizing 4.57 with Hünig’s base enabled it to couple with trans-THP 4.59 smoothly. 
The resulting carboxylic acid was activated by coupling with N-hydroxysuccinimide to form the 
righthand fragment 4.52. 
 
Scheme 4-19. Synthesis of amino acid hydrochloride salt 4.57 and righthand fragment 4.52 
 
4.4.3 Completion of the Total Synthesis 
 
The end game of this total synthesis was initiated by reductively converting the azido group 
of lefthand fragment to the primary amino group in the presence of trimethylphosphine, followed 
by coupling with righthand fragment without any assisting reagent (Scheme 4-20). This two-step 
sequence delivered natural product bistramide A in a 68% overall yield. 
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Scheme 4-20. Completion of total synthesis of bistramide A 
 
 The spectroscopic data (1H NMR and 13C NMR) for the synthetic bistramide A were 
closely matched with those data for natural bistramide A (Table 4-2),72c which indicates the 
success of the total synthesis of bistramide A. 
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 Table 4-2. Comparison of the NMR data of natural bistramide A to synthetic bistramide  
Carbon # 
Natural 
Bistramide A, 
13C NMR, ppm, 
100 MHz 
Synthetic 
Bistramide A, 
13C NMR, ppm, 
125 MHz 
Natural 
Bistramide A, 
1H NMR, 
ppm, 400 MHz 
Synthetic 
Bistramide A, 
1H NMR, 
ppm, 400 MHz 
1 18.43 18.63 
1.91 (dd, 3H, J 
= 1.4, 6.8 Hz) 
1.93 (dd, 3H, J 
= 1.6, 6.8 Hz) 
2 144.50 144.72 
6.90 (dq, 1H, J 
= 6.8, 15.7 Hz) 
6.91 (dd, 1H, J 
= 6.8, 15.6 Hz) 
3 132.07 132.33 
6.15 (dq, 1H, J 
= 1.5, 15.7Hz) 
6.13 (dd, 1H, J 
= 1.6, 15.6 Hz) 
4 198.89 199.13 — — 
5 45.24 45.49 
2.91 (dd, 1H, J 
= 8.8, 17.0 Hz), 
2.53 (dd, 1H, J 
= 3.0, 17.0 Hz) 
2.91 (dd, 1H, J 
= 8.8, 16.8 Hz), 
2.53 (dd, 1H, J 
= 2.8, 17.2 Hz) 
6 64.80 64.98 
4.20-4.19 (m, 
1H) 
4.22-4.18 (m, 
1H) 
7 30.78 31.10 
1.73-1.42 (m, 
1H), 1.41-1.29 
(m, 1H) 
1.86-1.42 (m, 
1H), 1.41-1.12 
(m, 1H) 
8 26.52 26.73 
1.73-1.42 (m, 
1H), 1.41-1.29 
(m, 1H) 
1.86-1.42 (m, 
1H), 1.41-1.12 
(m, 1H) 
9 33.32 33.55 1.92 (m, 1H) 
1.86-1.42 (m, 
1H) 
10 17.14 17.36 
0.86 (d, 3H, J = 
7.0 Hz, 3H) 
0.89 (d, 3H, J = 
6.8 Hz) 
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11 74.82 75.05 
4.06 (dd, 1H, J 
= 4.8, 11.2 Hz) 
4.07 (dd, 1H, J 
= 4.8, 11.2 Hz) 
12 32.33 32.52 
2.75 (dd, 1H, J 
= 11.7, 15.1 
Hz) 
2.76 (dd, 1H, J 
= 11.6, 14.8 
Hz) 
13 173.42 173.72 — — 
14 44.85 44.92 
3.50 (dt, 1H, J 
= 5.8, 14.0 Hz), 
3.24 (dt, 1H, J 
= 5.7, 14.0 Hz) 
3.51 (dt, 1H, J 
= 5.4, 14.0 Hz), 
3.24 (dt, 1H, J 
= 6.0, 14.0 Hz) 
15 73.81 74.10 
3.72 (dt, 1H, J 
= 10.3, 5.1 Hz) 
3.72 (q, 1H, J = 
4.8 Hz) 
16 43.36 43.56 
2.38 (dq, 1H, J 
= 5.0, 7.0 Hz) 
2.42-2.34 (m. 
1H) 
17 15.57 15.78 
1.26 (d, 3H, J = 
7.0 Hz) 
1.26 (t, 3H, J = 
6.8 Hz) 
18 175.14 175.37 — — 
19 39.49 39.71 
3.30 (dt, 2H, J 
= 6.8, 12.7 Hz) 
3.31 (dt, 2H, J 
= 6.8, 12.8 Hz) 
20 25.86 26.09 
1.83-1.82 (m, 
1H), 1.73-1.42 
(m, 1H) 
1.86-1.42 (m, 
2H) 
21 30.44 30.66 
1.73-1.42 (m, 
1H), 1.41-1.29 
(m, 1H) 
1.86-1.42 (m, 
1H), 1.41-1.12 
(m, 1H) 
22 74.26 74.47 
3.15 (dt, 1H, J 
= 1.8, 9.6 Hz) 
3.16 (dt, 1H, J 
= 2.0, 9.6 Hz) 
23 34.89 35.09 
1.41-1.29 (m, 
1H) 
1.41-1.12 (m, 
2H) 
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24 17.94 18.22 
0.76 (d, 3H, J = 
6.6 Hz) 
0.82 (d, 3H, J = 
6.4 Hz) 
25 27.87 28.12 
1.73-1.42 (m, 
2H) 
1.86-1.42 (m, 
2H) 
26 36.10 36.31 
1.73-1.42 (m, 
2H) 
1.86-1.42 (m, 
2H) 
27 95.44 95.67 — — 
28 35.47 35.70 
1.73-1.42 (m, 
1H), 1.41-1.29 
(m, 1H) 
1.86-1.42 (m, 
1H), 1.41-1.12 
(m, 1H) 
29 19.23 19.44 
1.83-1.82 (m, 
1H), 1.73-1.42 
(m, 1H) 
1.86-1.42 (m, 
2H) 
30 31.34 31.56 
1.73-1.42 (m, 
1H), 1.13 (m, 
1H) 
1.86-1.42 (m, 
1H), 1.41-1.12 
(m, 1H) 
31 69.07 69.29 3.45 (m, 1H) 3.45 (m, 1H) 
32 34.09 34.32 
1.73-1.42 (m, 
1H), 1.41-1.29 
(m, 1H) 
1.86-1.42 (m, 
1H), 1.41-1.12 
(m, 1H) 
33 33.48 33.69 
1.41-1.29 (m, 
2H) 
1.41-1.12 (m, 
2H) 
34 31.88 32.09 2.36 (m, 1H) 
2.42-2.34 (m. 
1H) 
35 20.97 21.17 
0.96 (d, 3H, J = 
6.8 Hz) 
0.96 (d, 3H, J = 
6.8 Hz) 
36 131.32 131.61 
5.20 (d, 1H, J = 
9.2 Hz) 
5.19 (d, 1H, J = 
9.6 Hz) 
37 137.16 137.39 — — 
  
 
 
83 
38 11.82 12.01 
1.62 (d, 3H, J = 
1.3 Hz) 
1.63 (d, 3H, J = 
1.2 Hz) 
39 73.26 73.53 
4.20-4.19 (m, 
1H) 
4.22-4.18 (m, 
1H) 
40 21.75 21.96 
1.25 (d, 3H, J = 
6.3 Hz) 
1.26 (t, 3H, J = 
6.8 Hz) 
NH (13/14)   
7.30 (br.t, 1H, J 
= 5.8 Hz) 
7.32 (br.t, 1H, J 
= 6.0 Hz) 
NH (18/19)   
6.95 (br.t, 1H, J 
= 5.5 Hz) 
6.96-6.94 
(br.m, 1H) 
OH (4)   — — 
OH (11)   — — 
OH (15)   
4.61 (d, OH, J 
= 5.3 Hz) 
4.62 (br.s, 1H) 
OH (39)   3.70 (br) — 
 
 
 
4.5 SUMMARY 
 
We have established a convergent route toward the biologically active natural product 
bistramide A. It is currently the shortest synthetic sequence to access this molecule, which takes 
14 steps from commercially available starting materials for the longest linear sequence and 31 total 
steps from commercially available starting materials for the total synthesis. The corresponding 
steps for the shortest previous synthesis are 17 steps and 45 steps. 
Our total synthesis of bistramide A is highlighted by two one-pot processes. The one-pot 
spiroketal formation process successfully combined two relatively simple acyclic pieces to form 
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the highly complex spiroketal in good yield, which is also a perfect showcase of the spiroketal 
formation methodology illustrated in Chapter 3. The one-pot hydroformylation, cyclization, and 
acetylation process significantly accelerated the assembly of the 2,6-trans-disubstituted-THP ring. 
Additionally, a kinetic separation was conducted during the asymmetric methylation process, 
which isolated the undesired Z-isomer and ensured the purity of the final natural product. 
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APPENDIX A 
 
SYNTHESIS OF MACROLACTONES BEARING BRIDGED 2,6-TRANS-
TETRAHYDROPYRANS THROUGH OXIDATIVE C–H BOND ACTIVATION 
 
General Experimental: Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded on a Bruker Avance 300 spectrometer at 300 MHz and 75 MHz, a Bruker 
Avance 400 spectrometer at 400 MHz and 100 MHz, a Bruker Avance 500 spectrometer at 500 
MHz and 125 MHz. The chemical shifts are reported in parts per million (ppm) on the delta (δ) 
scale. The solvent peak was used as a reference value, for 1H NMR: CDCl3 = 7.27 ppm, for 
13C 
NMR: CDCl3 = 77.23. Data are reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; 
qunit = quintet; sept = septet; dd = doublet of doublets; ddd = doublet of doublet of doublets; dddd 
= doublet of doublet of doublet of doublet; td = triplet of doublets; dtd = doublet of triplet of 
doublets; br = broad). High resolution and lowresolution mass spectra were recorded on a VG 7070 
spectrometer. Infrared (IR) spectra were collected on a Mattson Cygnus 100 spectrometer. 
Samples for IR were prepared as a thin film on a NaCl plate by dissolving the compound in CH2Cl2 
and then evaporating the CH2Cl2. Tetrahydrofuran and diethyl ether were distilled from sodium 
and benzophenone. Methylene chloride was distilled under N2 from CaH2. Analytical TLC was 
performed on E. Merck pre-coated (25 mm) silica gel 60F-254 plates. Visualization was done 
under UV (254 nm). Flash chromatography was done using ICN SiliTech 32-63 60 Å silica gel. 
Reagent grade ethyl acetate, diethyl ether, toluene and hexanes (commercial mixture) were 
purchased from EM Science and used as is for chromatography. All products in this manuscript 
are racemic mixtures but are drawn as single enantiomers to indicate their relative stereochemistry. 
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Trideca-1,5-diyn-4-ol (2.27)  
To a solution of dec-2-yn-1-ol (2.6 g, 17 mmol) and NEt3 (6.9 mL, 50 mmol) in 
dry DMSO (16 mL) and dry CH2Cl2 (12 mL) was added sulfur trioxide pyridine 
complex (4.0 g, 25 mmol) in one portion at rt. The dark brown solution was stirred 
for 1.5 h, then was quenched with H2O. The aqueous layer was extracted with ether (3x). The 
combined organic phases were dried over Na2SO4, filtered, and concentrated. The residue was 
purified by flash chromatography (hexanes:EtOAc = 25:1) to give dec-2-ynal as a yellow oil (2.0 
g, 79%). A mixture of zinc powder (4.3 g, 66 mmol), 1,2-diiodoethane (3.7 g, 13 mmol), dec-2-
ynal (2.0 g, 13 mmol), and 3-bromo-1-propyne (2.3 g, 20 mmol) in anhydrous THF (60 mL) was 
sonicated in a commercial ultrasonic cleaning bath for 2 h, then was quenched with 1.0 M HCl 
solution, followed by the extraction with ether (3x). The combined organic layers were washed 
with brine, dried over Na2SO4, filtered, and concentrated. The residue was purified by flash 
chromatography (hexanes:EtOAc = 20:1 to 12:1) to give 2.27 as a yellow oil (2.2 g, 87%). 1H 
NMR (300 MHz, CDCl3)  4.48 (qt, 1H, J = 2.1, 6.0 Hz), 2.58-2.52 (m, 3H), 2.18 (td, 2H, J = 1.8, 
6.9 Hz), 2.08 (t, 1H, J = 2.7 Hz), 1.50-1.43 (m, 2H), 1.37-1.24 (m, 8H), 0.86 (t, 3H, J = 6.3 Hz). 
 
1-Methoxy-4-((trideca-1,5-diyn-4-yloxy)methyl)benzene (2.29a)  
A solution of trichloroacetimidate 2.28 (2.1 g, 7.5 mmol) and 
homopropargyl alcohol 2.27 (0.96 g, 5.0 mmol) in toluene (120 mL) 
was treated with La(OTf)3 (142 mg, 0.250 mmol). The resulting 
suspension was stirred at rt for 1.5 h, then was quenched with silica gel. After filtration, the filtrate 
was concentrated in vacuo and purified by flash chromatography (hexanes:EtOAc = 50:1) to afford 
desired ether 2.29a (1.5 g, 94%) as a yellow oil. 1H NMR (300 MHz, CDCl3)  7.35 (d, 2H, J = 
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8.4 Hz), 6.92 (d, 2H, J = 8.7 Hz), 4.79 (d, 1H, J = 11.4 Hz), 4.54 (d, 1H, J = 11.4 Hz), 4.25 (tt, 1H, 
J = 1.8, 6.6 Hz), 3.82 (s, 3H), 2.65 (ddd, 2H, J = 1.5, 2.7, 6.6 Hz), 2.31 (td, 2H, J = 1.8, 6.9 Hz), 
2.10 (t, 1H, J = 2.4 Hz), 1.62-1.58 (m, 2H), 1.52-1.41 (m, 2H),  1.38-1.28 (m, 6H), 0.95 (t, 3H, J 
= 7.2 Hz). 
 
4-(4-Methoxybenzyloxy)tridec-1-en-5-yn-2-yl acetate (2.12)  
To a suspension of [(p-cymene)RuCl2]2 (115 mg, 0.190 mmol), 
Na2CO3 (75 mg, 0.71 mmol), tri(2-furyl)phosphine (87 mg, 0.38 
mmol), and 1-decyne (0.85 mL, 4.7 mmol) in toluene (30 mL) was 
added the first portion of acetic acid (0.55 mL, 9.4 mmol). The mixture was heated to 80 °C and 
stirred for 1 h. The second portion of acetic acid (0.55 mL, 9.4 mmol) and 2.29a (1.5 g, 4.7 mmol) 
in toluene (5 mL) were added into the reaction through syringe. The reaction was stirred at the 80 
°C for 3 h. Then crude mixture was loaded onto a small plug of silica gel and eluted with EtOAc 
(3x). The residue was concentrated and purified by flash chromatography (hexanes:EtOAc = 40:1 
to 20:1) to give the desired enol acetate (0.78 g, 45%) as a colorless oil. 1H NMR (300 MHz, 
CDCl3)  7.31-7.28 (m, 2H), 6.90-6.87 (m, 2H), 4.85 (s, 2H), 4.72 (d, 1H, J = 11.4 Hz), 4.45 (d, 
1H, J = 11.4 Hz), 4.22 (ddt, 1H, J = 2.1, 6.3, 7.2 Hz), 3.81 (s, 3H), 2.66 (dd, 2H, J = 5.4, 7.2 Hz), 
2.25 (td, 2H, J = 1.8, 6.9 Hz)  2.05 (s, 3H), 1.59-1.49 (m, 2H), 1.44-1.29 (m, 8H), 0.90 (t, 3H, J = 
6.9 Hz); 13C NMR (100 MHz, CDCl3)  169.3, 159.4, 152.3, 130.1, 129.9, 113.9, 104.3, 87.4, 78.2, 
70.1, 66.1, 55.5, 40.6, 32.0, 29.0, 28.9, 22.8, 21.2, 18.9, 14.3; IR (neat) 2930, 2857, 1758, 1667, 
1613, 1586, 1514, 1464, 1369, 1341, 1302, 1249, 1206, 1137, 1081, 1036, 965, 875, 823, 758, 721 
cm-1; HRMS (ESI) m/z calcd for C23H32O4Na [M+Na]
+ 395.2198, found 395.2190. 
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4-(4-Methylbenzyloxy)tridec-1-en-5-yn-2-yl acetate (2.13) 
NaH (60%, 84 mg, 2.1 mmol) was added to a solution of 
homopropargyl alcohol 2.27 (0.26 g, 1.4 mmol) in anhydrous THF (5 
mL) at 0 °C. The resulting suspension was stirred at rt for 30 min, 
followed by adding n-Bu4NI (52 mg, 0.14 mmol) and p-methyl benzyl bromide (0.26 g, 1.4 mmol) 
successively. The resulting mixture was stirred at rt for 24 h, then was quenched with water. The 
aqueous phase was extracted with Et2O (3x). The combined organic layers were washed with brine, 
dried over Na2SO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography to give ether 2.29b (0.47 g, 99%). To a suspension of [(p-cymene)RuCl2]2 (18 
mg, 0.029 mmol), Na2CO3 (11 mg, 0.11 mmol), tri(2-furyl)phosphine (14 mg, 0.058 mmol) and 
1-decyne (0.13 mL, 0.72 mmol) in toluene (6.5 mL) was added the first portion of acetic acid 
(0.080 mL, 1.4 mmol). The mixture was heated to 80 °C and stirred for 1 h. The second portion of 
acetic acid (0.080 mL, 1.4 mmol) and ether 2.29b (0.21 g, 0.72 mmol) in toluene (1 mL) were 
added to the reaction through syringe. The reaction was stirred at the 80 °C for 3 h. Then crude 
mixture was loaded onto a small plug of silica gel and eluted with EtOAc. The filtrate was 
concentrated. The residue was purified by flash chromatography to give the desired enol acetate 
(149 mg, 58%) as a colorless oil. 1H NMR (400 MHz, CDCl3)  7.25 (d, 2H, J = 8.0 Hz), 7.15 (d, 
2H, J = 8.0 Hz), 4.85 (s, 2H), 4.74 (d, 1H, J = 11.6), 4.48 (d, 1H, J = 11.6 Hz), 4.23 (t, 1H, J = 6.8 
Hz), 2.66 (app dd, 2H, J = 6.8, 8.0 Hz), 2.35 (s, 3H), 2.24 (app dd, 2H, J = 5.6, 6.8 Hz), 2.05 (s, 
3H), 1.56-1.49 (m, 2H), 1.42-1.37 (m, 2H), 1.34-1.26 (m, 6H), 0.90 (t, 3H, J = 6.8 Hz); 13C NMR 
(125 MHz, CDCl3)  169.3, 152.3, 137.5, 135.0, 129.2, 128.4, 104.3, 87.5, 78.2, 70.3, 66.3, 40.6, 
32.0, 29.0, 28.9, 22.9, 21.4, 21.3, 18.9, 14.3; IR (neat) 2928, 2857, 1759, 1668, 1458, 1433, 1369, 
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1340, 1204, 1083, 1020, 874, 803 cm-1; HRMS (ESI) m/z calcd for C23H32O3Na [M+Na]
+ 
379.2249, found 379.2222 
 
Ethyl 6-acetoxy-4-(4-methoxybenzyloxy)hept-6-en-2-ynoate (2.14) 
Ethyl propynoate (5.0 g, 51 mmol), triethyl orthoformate (11 g, 74 
mmol), and ZnI2 (0.2 g) were placed in a fractional distillation 
apparatus. The reaction was carefully heated for 2.5 h to maintain the 
distillate temperature between 50 to 100 °C. Then the thick brown residue was cooled down and 
poured to hexane (100 mL). After filtration, the filtrate was concentrated in vacuo. The residue 
was purified by the fractional distillation under reduced pressure to give target acetal, ethyl 4,4-
diethoxybut-2-ynoate (4.3 g, b.p. 90 °C/2-7 torr ) as a colorless liquid. A mixture of ethyl 4,4-
diethoxybut-2-ynoate (2.0 g, 10 mmol) and formic acid (4 mL) was stirred at 40 ºC for 3 h, then 
was poured to ice water. The resulting mixture was neutralized by NaHCO3 powder, and followed 
by extraction with Et2O. The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo. The crude aldehyde (10 mmol) was re-dissolved in anhydrous THF (40 
mL). To the resulting solution were added propargyl bromide (1.8 g, 15 mmol), Zn powder (3.2 g, 
50 mmol), and 1,2-diiodoethane (2.8 g, 10 mmol) successively. The resulting suspension was 
sonicated in a commercial ultrasonic cleaning bath for 2 h. After the sonication, the reaction was 
quenched with 1.0 M HCl solution and followed by extraction with ether (3x). The combined 
organic layers were washed with brine, dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash chromatography to give the desired 
homopropargyl alcohol 2.31 (466 mg, with impurities) as a yellow oil. To the solution of alcohol 
2.31 (0.50 g, 3.0 mmol) and trichloroacetimidate 2.28 (1.3 g, 4.5 mmol) in toluene (60 mL) was 
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added La(OTf)3 (88 mg, 0.15 mmol) in one portion. The resulting suspension was stirred for 12 
hours at rt, and then quenched with silica gel. After filtration, the filtrate was concentrated and 
purified by flash chromatography (hexanes:EtOAc = 20:1) to give the target benzylic ether (with 
impurities). To a suspension of [(p-cymene)RuCl2]2 (33 mg, 0.054 mmol), Na2CO3 (21 mg, 0.20 
mmol), tri(2-furyl)phosphine (25 mg, 0.11 mmol) and 1-decyne (0.24 mL, 1.3 mmol) in toluene 
(12 mL) was added the first portion of acetic acid (0.15 mL, 2.7 mmol). The mixture was heated 
to 80 °C and stirred for 1 h. The second portion of acetic acid (0.15 mL, 2.7 mmol) and the newly 
formed benzylic ether (0.38 g, 1.3 mmol) in toluene (3 mL) were added into the reaction through 
syringe. The reaction was stirred at the 80 °C for 4 h. Then crude mixture was loaded onto a small 
plug of silica gel and eluted with EtOAc. The filtrate was concentrated. The residue was purified 
by flash chromatography (hexanes:EtOAc = 20:1 to 15:1) to give the desired enol acetate (170 mg, 
4% over 5 steps) as a colorless oil. 1H NMR (500 MHz, CDCl3)  7.29 (d, 2H, J = 8.5 Hz), 6.89 
(d, 2H, J = 9.0 Hz), 4.90 (d, 1H, J = 2.0 Hz), 4.89 (s, 1H), 4.75 (d, 1H, J = 11.0 Hz), 4.46 (d, 1H, 
J = 11.0 Hz), 4.33 (t, 1H, J = 6.5 Hz), 4.26 (q, 2H, J = 7.0 Hz), 3.81 (s, 3H), 2.73-2.72 (m, 2H), 
2.06 (s, 3H), 1.34 (t, 3H, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3)  169.2, 159.7, 153.4, 150.9, 
130.1, 129.1, 114.0, 105.3, 85.0, 78.2, 71.1, 65.5, 62.4, 55.5, 39.5, 21.2, 14.2; IR (neat) 2938, 2869, 
2839, 2235, 1757, 1713, 1669, 1613, 1514, 1465, 1369, 1301, 1250, 1208, 1086, 1034, 882, 823, 
752 cm-1; HRMS (ESI) m/z calcd for C19H22O6Na [M+Na]
+ 369.1314, found 369.1331. 
 
Methyl 4-(2-(hydroxymethyl)-5-methoxyphenyl)butanoate (2.34a) 
To a solution of methyl but-3-enoate (1.2 g, 12 mmol) in anhydrous THF 
(6.7 mL) at 0 °C was added 9-BBN (35 mL, 0.5 M in THF, 17 mmol). 
The reaction was warmed to rt and stirred for 4 h, then was diluted with anhydrous DMF (67 mL) 
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and treated with PdCl2(dppf)•CH2Cl2 (0.27 g, 0.33 mmol), 2-bromo-4-methoxybenzaldehyde (2.3 
g, 11 mmol), and K2CO3 (3.0 g, 22 mmol). The mixture was heated to 50 °C and stirred overnight. 
The reaction was quenched by pouring the crude mixture into H2O. The aqueous layer was 
extracted with EtOAc (3x). The combined organic layer was washed with H2O, dried over Na2SO4, 
filtered, and concentrated. The residue was purified by flash chromatography (hexanes:EtOAc = 
20:1) to give the desired product (2.7 g, contaminated by borate derivatives). The crude product 
was dissolved in MeOH (25 mL) and treated with NaBH4 (0.43 g, 11 mmol) at 0 °C. The resulting 
mixture was stirred at 0 °C for 10 min, then was quenched with sat. aq. NaHCO3. The crude 
mixture was extracted with EtOAc (3x). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated. The residue was purified by flash chromatography (hexanes:EtOAc = 
4:1) to give 2.34a (2.1 g, 80% over two steps). 1H NMR (400 MHz, CDCl3)  7.27 (d, 1H, J = 8.4 
Hz), 6.76 (s, 1H), 6.75 (d, 1H, J = 16.0 Hz), 4.66 (d, 2H, J = 5.6 Hz), 3.82 (s, 3H), 3.68 (s, 3H), 
2.73 (t, 2H, J = 8.0 Hz), 2.42 (t, 2H, J = 7.2 Hz), 2.04 (t, 1H, J = 5.6 Hz), 1.97 (p, 2H, J = 7.6 Hz). 
 
Methyl 6-(2-(hydroxymethyl)-5-methoxyphenyl)hexanoate (2.34b) 
Same procedure with the preparation of 2.34a. 1H NMR (300 MHz, 
CDCl3)  7.26 (d, 1H, J = 7.5), 6.75-6.72 (m, 2H), 4.65 (s, 2H), 3.81 (s, 
3H), 3.67 (s, 3H), 2.68 (t, 2H, J = 7.8 Hz), 2.33 (t, 2H, J = 7.2 Hz), 1.73-1.59 (m, 4H), 1.48-1.37 
(m, 2H). 
 
Methyl 11-(2-(hydroxymethyl)-5-methoxyphenyl)undecanoate (2.34c) 
Same procedure with the preparation of 2.34a.  1H NMR (400 MHz, 
CDCl3)  7.27 (d, 1H, J = 8.4 Hz), 6.77-6.72 (m, 2H), 4.65 (d, 2H, J = 
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5.6 Hz), 3.81 (s, 3H), 3.67 (s, 3H), 2.67 (t, 2H, J = 8.0 Hz), 2.31 (t, 2H, J = 7.6 Hz), 1.64-1.56 (m, 
4H), 1.45 (t, 1H, J = 5.6 Hz), 1.39-1.29 (m, 12H). 
 
Methyl 4-(5-methoxy-2-((2,2,2-trichloro-1-iminoethoxy)methyl)phenyl)butanoate (2.35a) 
To a solution of 2.34a (345 mg, 1.45 mmol) in CH2Cl2 (3 mL) were added 
DBU (0.32 mL, 2.2 mmol) and Cl3CCN (0.44 mL, 622 mg) at 0 °C. The 
reaction mixture was warmed to rt and stirred for 1 h at this temperature. The mixture was directly 
concentrated in vacuo and purified by flash chromatography (hexanes:EtOAc = 15:1, hexane 
contained 1% NEt3) to give 2.35a (304 mg, 55%). 
1H NMR (300 MHz, CDCl3)  8.37 (s, 1H), 
7.35 (d, 1H, J = 8.1 Hz), 6.78-6.75 (m, 2H), 5.28 (s, 2H), 3.82 (s, 3H), 3.68 (s, 3H), 2.73 (t, 2H, J 
= 7.8 Hz), 2.39 (t, 2H, J = 7.5 Hz), 1.98 (p, 2H, J = 7.8 Hz). 
 
Methyl 6-(5-methoxy-2-((2,2,2-trichloro-1-iminoethoxy)methyl)phenyl)hexanoate (2.35b) 
Same procedure with the preparation of 2.35a. 1H NMR (300 MHz, 
CDCl3)  8.37 (s, 1H), 7.35 (d, 1H, J = 8.4 Hz), 6.78-6.73 (m, 2H), 5.28 
(s, 2H), 3.82 (s, 3H), 3.67 (s, 3H), 2.69 (t, 2H, J = 7.8 Hz), 2.32 (t, 2H, J = 7.5 Hz), 1.72-1.61 (m, 
4H), 1.47-1.36 (m, 2H). 
 
Methyl 11-(5-methoxy-2-((2,2,2-trichloro-1-iminoethoxy)methyl)phenyl) undecanoate 
(2.35c) 
Same procedure with the preparation of 2.35a. 1H NMR (400 MHz, 
CDCl3)  8.36 (s, 1H), 7.34 (d, 1H, J = 8.4 Hz), 6.79 (d, 1H, J = 2.8 Hz), 
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6.75 (dd, 1H, J = 2.8, 8.4 Hz), 5.30 (d, 2H, J = 12.0 Hz), 3.82 (s, 3H), 3.67 (s, 3H), 2.67 (t, 2H, J 
= 8.0 Hz), 2.31 (t, 2H, J = 7.2 Hz), 1.66-1.59 (m, 4H), 1.37-1.28 (m, 12H). 
 
Methyl 4-(2-((7-hydroxyhepta-1,5-diyn-4-yloxy)methyl)-5-methoxyphenyl)butanoate  
(2.37a) 
Trichloroacetimidate 2.35a (1.6 g, 4.1 mmol) and secondary alcohol 
2.36 (0.98 g, 4.1 mmol) were dissolved in anhydrous toluene (70 mL) at 
rt. La(OTf)3 (0.12 g, 0.2 mmol) was added. The resulting mixture was 
stirred overnight. The reaction was quenched with silica gel, then was filtered using Et2O as the 
eluant. The filtrate was concentrated and purified by flash chromatography (hexanes:EtOAc = 20:1 
to 10:1) to give the desired homopropargylic ether (1.0 g, contaminated by some impurities). The 
crude was dissolved in MeOH (30 mL) and treated with TsOH•H2O (200 mg) at rt. After stirring 
for 30 min, the solution was concentrated and purified by flash chromatography (hexanes:EtOAc 
= 10:1 to 1:1) to give the desired product (595 mg, 42% over two steps). 1H NMR (300 MHz, 
CDCl3)  7.29-7.26 (m, 1H), 6.75 (s, 1H), 6.73 (dd, 1H, J = 2.7, 8.1 Hz), 4.80 (d, 1H, J = 11.1 Hz), 
4.48 (d, 1H, J = 11.1 Hz), 4.36 (d, 2H, J = 4.5 Hz), 4.28 (tt, 1H, J = 1.8, 5.4 Hz), 3.80 (s, 3H), 3.70 
(s, 3H), 2.74 (dd, 1H, J = 0.9, 9.3 Hz), 2.72 (d, 1H, J = 9.3 Hz), 2.64 (ddd, 2H, J = 1.5, 2.7, 6.6 
Hz), 2.48 (t, 1H, J = 6.6 Hz), 2.42 (t, 2H, J = 7.2 Hz), 2.06 (t, 1H, J = 2.7 Hz), 1.96 (p, 2H, J = 7.8 
Hz). 
 
 
 
  
 
 
94 
Methyl 6-(2-((7-hydroxyhepta-1,5-diyn-4-yloxy)methyl)-5-methoxyphenyl)hexanoate 
(2.37b) 
Same procedure with the preparation of 2.37a. 1H NMR (300 MHz, 
CDCl3)  7.26 (d, 1H, J = 8.4 Hz), 6.75-6.69 (m, 2H), 4.78 (d, 1H, J 
= 11.1 Hz), 4.46 (d, 1H, J = 11.1 Hz), 4.37 (d, 2H, J = 1.5 Hz), 4.27 
(tt, 1H, J = 1.5, 6.6 Hz), 3.80 (s, 3H), 3.68 (s, 3H), 2.69 (t, 2H, J = 8.1 Hz), 2.63 (ddd, 2H, J = 1.2, 
2.7, 6.6 Hz), 2.34 (t, 2H, J = 7.2 Hz), 2.06 (t, 1H, J = 2.7 Hz), 1.74-1.59 (m, 4H), 1.48-1.38 (m, 
2H). 
 
Macrolactone substrate 2.15 
To a solution of 2.37a (0.1 g, 0.3 mmol) in a mixed solvent of THF, 
MeOH, and H2O (0.9 mL, 0.3 mL, and 0.3 mL respectively) at rt was 
added LiOH•H2O (50 mg, 1.2 mmol). The resulting mixture was stirred at 
rt for 1 h, then was acidified with 0.5 M HCl until the pH fell into the 
range of 3 to 4. The aqueous solution was extracted with EtOAc (3x), and the combined organic 
layers were dried over Na2SO4, filtered, and concentrated. The residue was re-dissolved in 
anhydrous THF (2 mL), followed by the addition of anhydrous NEt3 (0.2 mL) at rt. The mixture 
was stirred for 20 min, then a solution of trichlorobenzoyl chloride (106 mg, 0.43 mmol) in 
anhydrous THF (2 mL) was added. Precipitates were formed after a few minutes. The mixture was 
stirring for 2 h at rt, followed by a filtration. The precipitates were washed with toluene (135 mL 
total). The toluene solution of filtrate was added dropwise into a solution of DMAP (146 mg, 1.2 
mmol) in toluene (40 mL) at 65 °C over a period of 4 h. After addition, the mixture was 
concentrated, re-dissolved in Et2O, and washed with sat. aq. NaHCO3. The organic layer was dried 
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over Na2SO4, filtered, and concentrated. The residue was purified by flash chromatography to give 
the desired macrolactone (27 mg, 29% over 2 steps). To a mixture of [(p-cymene)RuCl2]2 (8.3 mg, 
0.014 mmol), Na2CO3 (5.4 mg, 0.051 mmol), tri(2-furyl)phosphine (6.5 mg, 0.028 mmol), and 1-
decyne (60 μL, 0.34 mmol) in toluene (2.2 mL) was added the first portion of acetic acid (39 μL, 
0.68 mmol). The mixture was heated to 80 °C and stirred for 1 h. The second portion of acetic acid 
(39 μL, 0.68 mmol) and the newly prepared macrolactone (106 mg, 0.34 mmol) in toluene (1 mL) 
were added into the reaction through syringe. The reaction was stirred at the 80 °C for 3 h. Then 
crude mixture was loaded onto a small plug of silica gel and eluted with EtOAc. The filtrate was 
concentrated and the residue was purified by flash chromatography (hexanes:EtOAc = 10:1) to 
give enol acetate 2.15 (49 mg, 11% over 3 steps). 1H NMR (300 MHz, CDCl3)  7.21 (d, 1H, J = 
7.8 Hz), 6.74-6.70 (m, 2H), 4.89 (s, 1H), 4.85 (d, 1H, J = 1.5 Hz), 4.77 (d, 2H, J = 2.1), 4.76 (d, 
1H, J = 9.6 Hz), 4.30 (tt, 1H, J = 2.1, 6.9 Hz), 4.17 (d, 1H, J = 9.3 Hz), 2.93-2.83 (m, 1H), 2.68 
(dd, 1H, J = 6.9, 15.0), 2.62-2.37 (m, 3H), 2.08 (s, 3H), 2.00-1.88 (m, 2H); 13C NMR (75 MHz, 
CDCl3)  173.3, 169.0, 160.0, 151.4, 143.1, 132.7, 127.1, 115.4, 111.2, 104.6, 84.8, 81.2, 68.0, 
67.1, 55.2, 52.0, 39.4, 34.4, 31.2, 29.3, 21.1; IR (neat) 2922, 2852, 1745, 1667, 1611, 1579, 1503, 
1461, 1439, 1368, 1324, 1258, 1215, 1132, 1110, 1044, 1025 cm-1; HRMS (ESI) m/z calcd for 
C21H24O6Na [M+Na]
+ 395.1471, found 395.1475. 
 
Macrolactone substrate 2.16 
To a solution of 2.37b (94 mg, 0.25 mmol) in a mixed solvent of THF, 
MeOH, and H2O (0.78 mL, 0.26 mL, and 0.26 mL, respectively) at rt was 
added LiOH•H2O (42 mg, 1.0 mmol). The resulting mixture was stirred 
at rt for 1 h, and then was acidified with 0.5 M HCl until the pH fell in the range of 3 to 4. The 
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aqueous solution was extracted with EtOAc (3x), and the combined organic layers were dried over 
Na2SO4, filtered, and concentrated. The residue was re-dissolved in anhydrous MeCN (200 mL), 
followed by the addition of anhydrous NEt3 (0.35 mL) at rt. The resulting mixture was added to a 
refluxing solution of 2-chloro-1-methylpyridinium iodide (322 g, 1.26 mmol) in MeCN (400 mL) 
over 10 h. The resulting brown solution was cooled down and concentrated in vacuo. The residue 
was purified by flash chromatography (hexanes:EtOAc = 20:1) to afford the desired macrolactone 
(61 mg). To a mixture of [(p-cymene)RuCl2]2 (5.1 mg, 0.0084 mmol), Na2CO3 (3.3 mg, 0.032 
mmol), tri(2-furyl)phosphine (3.9 mg, 0.017 mmol) and 1-decyne (37 μL, 0.21 mmol) in toluene 
(2 mL) was added the first portion of acetic acid (24 μL, 0.42 mmol). The mixture was heated to 
80 °C and stirred for 1 h. The second portion of acetic acid (24 μL, 0.42 mmol) and the newly 
prepared macrolactone (71 mg, 0.21 mmol) in toluene (1 mL) were added into the reaction through 
syringe. The reaction was stirred at the 80 °C for 5 h. Then crude mixture was loaded onto a small 
plug of silica gel and eluted with EtOAc. The filtrate was concentrated and the residue purified by 
flash chromatography (hexanes:EtOAc = 20:1 to 10:1) to give the enol acetate 2.16 (36 mg, 30% 
over 3 steps) as a yellowish oil. 1H NMR (400 MHz, CDCl3)  7.23 (d, 1H, J = 8.8 Hz), 6.72-6.69 
(m, 2H), 4.91 (s, 1H), 4.88 (d, 1H, J = 1.6 Hz), 4.84 (d, 1H, J = 10.4 Hz), 4.79 (d, 2H, J = 2.0 Hz), 
4.36 (tt, 1H, J = 2.0, 6.4 Hz), 4.33 (d, 1H, J = 10.6 Hz), 3.79 (s, 3H), 2.77-2.71 (m, 2H), 2.65 (dd, 
1H, J = 6.0, 14.8 Hz), 2.60-2.52 (m, 1H), 2.42-2.38 (m, 2H), 2.09 (s, 3H), 1.78-1.72 (m, 2H), 1.65-
1.49 (m, 4H); 13C NMR (100 MHz, CDCl3)  173.0, 169.3, 159.6, 151.7, 143.5, 130.8, 127.6, 
115.1, 110.9, 104.9, 84.4, 81.0, 68.6, 66.8, 55.4, 51.7, 39.9, 33.8, 33.1, 30.4, 28.8, 24.5, 21.3; IR 
(neat) 2923, 2853, 1745, 1667, 1610, 1579, 1502, 1462, 1369, 1325, 1259, 1209, 1135, 1111, 1067, 
1032 cm-1; HRMS (ESI) m/z calcd for C23H28O6Na [M+Na]
+ 423.1784, found 423.1768. 
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Macrolactone substrate 2.17 
Same procedure with the preparation of 2.16. 1H NMR (400 MHz, CDCl3) 
 7.28 (d, 1H, J = 7.6 Hz), 6.73-6.71 (m, 2H), 4.88 (d, 2H, J = 3.6 Hz), 
4.79 (d, 1H, J = 10.8 Hz), 4.76 (s, 2H), 4.36 (d, 1H, J = 10.8 Hz), 4.38-
4.35 (m, 1H), 3.80 (s, 3H), 2.70 (dd, 2H, J = 7.2, 13.2 Hz), 2.64 (dd, 2H, J = 6.8, 10.0 Hz), 2.38 
(t, 2H, 6.4 Hz), 2.06 (s, 3H), 1.72-1.68 (m, 2H), 1.62-1.58 (m, 2H), 1.38-1.26 (m, 12H); 13C NMR 
(100 MHz, CDCl3)  173.4, 169.3, 159.5, 151.8, 143.4, 130.9, 127.7, 115.1, 111.1, 104.9, 85.2, 
80.7, 68.4, 67.1, 55.4, 52.4, 40.2, 33.9, 33.2, 31.5, 29.2, 28.2, 27.8, 27.6, 27.5, 27.2, 24.5, 21.3; IR 
(neat) 2928, 2856, 1753, 1668, 1611, 1579, 1503, 1461, 1370, 1342, 1207, 1114, 1077, 1023, 875, 
818 cm-1; HRMS (ESI) m/z calcd for C28H38O6Na [M+Na]
+ 493.2566, found 493.2559. 
 
(Z)-3-Methyl-6-oxohex-2-enyl acetate (2.39) 
To a solution of nerol (9.3 g, 60 mmol) in CH2Cl2 (30 mL) were added NEt3 
(16.7 mL, 120 mmol) and DMAP (188 mg, 1.54 mmol), followed by a slow 
addition of Ac2O (8.4 mL, 90 mmol). The reaction mixture was stirred at rt for 1 h, then was diluted 
with Et2O. The mixture was washed with sat. aq. CuSO4 (3x), H2O, and brine, dried over Na2SO4, 
filtered, and concentrated in vacuo to afford (Z)-3,7-dimethylocta-2,6-dienyl acetate (17.6 g, 
100%) as a pale yellow oil. m-CPBA (5.6 g, 33 mmol) was added to a solution of (Z)-3,7-
dimethylocta-2,6-dienyl acetate (5.8 g, 30 mmol) in CH2Cl2 (40 mL) at 0 °C. The reaction mixture 
was allowed to warm to rt slowly, and stirred at rt for 4 h. The reaction was quenched with aq. 
NaOH (3.0 M, 50 mL), extracted with CH2Cl2 (3x). The combined organic layers were dried over 
Na2SO4, filtered, concentrated. The residue was purified by flash chromatography (hexanes:EtOAc 
= 15:1 to 10:1) to afford (Z)-3,7-dimethyl-6,7-epoxyoct-2-enyl acetate (4.8 g, 76%) as a clear oil. 
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A solution of H5IO6 (5.7 g, 25 mmol) in water (20 mL) was added to the solution of (Z)-3,7-
dimethyl-6,7-epoxyoct-2-enyl acetate (4.8 g, 23 mmol) in THF (34 mL) at 0 °C. The reaction 
mixture was stirred at 0 °C for 2 h, then was concentrated in vacuo. The residue was diluted with 
Brine, then was extracted with Et2O (3x). The combined organic layers were washed with aq. 
NaHCO3, dried over Na2SO4, filtered, and concentrated. The residue was purified by flash 
chromatography to afford desired product (3.4 g, 88%) as a colorless oil. 1H NMR (400 MHz, 
CDCl3)  9.80 (t, 1H, J = 1.6 Hz), 5.41 (t, 1H, J = 7.2 Hz), 4.59 (d, 2H, J = 7.2 Hz), 2.59-2.55 (m, 
2H), 2.44 (t, 2H, J = 7.6 Hz), 2.06 (s, 3H), 1.77 (d, 3H, J = 1.2 Hz). 
 
(Z)-Methyl 4-methyl-6-(2,2,2-trichloro-1-iminoethoxy)hex-4-enoate (2.40) 
A mixture of aldehyde 2.39 (6.0 g, 35 mmol), NaH2PO4 (11 g, 78 mmol), 2-methyl-
2-butene (12.4 g, 176 mmol), tBuOH (120 mL), and H2O (60 mL) was cooled to -
10 °C in salt-ice bath. NaClO2 (12.8 g, 141 mmol) was added in 3 portions over 30 
min. The mixture was allowed to warm to rt slowly over 3 h, then was added sat. aq. Na2S2O3. The 
resulting mixture was stirred for 20 min at rt. After extraction with EtOAc (3x), the combined 
organic layers were dried over MgSO4, filtered, and concentrated in vacuo. The crude acid (35 
mmol) was re-dissolved in MeOH (100 mL) and treated with K2CO3 (7.3 g, 53 mmol). After 
stirring at rt for 2 h, the reaction was quenched with 1.0 M HCl and extracted with EtOAc (3x). 
The combined organic phases were dried over MgSO4, filtered, and concentrated. The residue was 
re-dissolved in acetone (160 mL). K2CO3 (5.4 g, 39 mmol) and MeI (2.8 mL, 46 mmol) were added 
successively. The resulting suspension was stirred for 25 h at rt, followed by a filtration through a 
pad of Celite®. The filtrate was concentrated in vacuo and purified by flash chromatography to 
afford desired (Z)-allylic alcohol (2.4 g, with impurities) as yellowish oil. Cl3CCN (4.4 mL, 46 
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mmol) and DBU (2.8 mL, 20 mmol) were added successively to the solution of the newly 
generated allylic alcohol (2.4 g, 15 mmol) in anhydrous CH2Cl2 (28 mL). The resulting black 
mixture was stirred at rt for 3 h, then was concentrated under reduced pressure. The residue was 
purified through flash chromatography (hexanes:EtOAc = 10:1, 1% NEt3 in hexane) to give 
trichloroacetimidiate 2.40 (2.8 g, 29% over 4 steps) as yellow oil. 1H NMR (400 MHz, CDCl3)  
8.28 (s, 1H), 5.54 (t, 1H, J = 6.8 Hz), 4.81 (d, 2H, J = 6.8 Hz), 3.68 (s, 3H), 2.47-2.45 (m, 4H), 
1.80 (s, 3H). 
 
(Z)-Methyl 6-(9-(tert-butyldiphenylsilyloxy)nona-1,5-diyn-4-yloxy)-4-methylhex-4-enoate 
(2.42) 
To a solution of trichloroacetimidiate 2.40 (1.7 g, 5.7 mmol) and 
secondary alcohol 2.41 (2.3 g, 5.7 mmol) in anhydrous cyclohexane (36 
mL) was added TMSOTf (0.1 mL, 0.6 mmol) at 0 °C. The resulting 
mixture was allowed to warm to rt slowly and stirred at rt for 2 h, then 
was filtered and concentrated. The residue was purified by flash chromatography to afford both 
(Z)-product 2.42 (549 mg, 18%) and (E)-product 2.43 (632 mg, 21%). 3.45: 1H NMR (400 MHz, 
CDCl3)  7.68-7.66 (m, 4H), 7.45-7.37 (m, 6H), 5.40 (t, 1H, J = 6.8 Hz), 4.21-4.16 (m, 2H), 4.02 
(dd, 1H, J = 7.6, 11.2 Hz), 3.75 (t, 2H, J = 6.0 Hz), 3.65 (s, 3H), 2.57-2.50 (m, 2H), 2.47-2.29 (m, 
6H), 1.98 (t, 1H, J = 2.8 Hz), 1.79 (p, 2H, J = 6.4 Hz), 1.75 (s, 3H), 1.05 (s, 9H). 
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(E)-Methyl 6-(9-(tert-butyldiphenylsilyloxy)nona-1,5-diyn-4-yloxy)-4-methylhex-4-enoate 
(2.43) 
1H NMR (400 MHz, CDCl3)  7.68-7.66 (m, 4H), 7.45-7.36 (m, 6H), 
5.35 (t, 1H, J = 6.8 Hz), 4.22-4.12 (m, 2H), 4.03 (dd, 1H, J = 7.6, 12.0 
Hz), 3.76 (t, 2H, J = 6.0 Hz), 3.68 (s, 3H), 2.57-2.54 (m, 2H), 2.47-2.33 
(m, 6H), 1.99 (t, 1H, J = 2.4 Hz), 1.78 (p, 2H, J = 6.4 Hz), 1.68 (s, 3H), 1.05 (s, 9H). 
 
Macrolactone substrate 2.18 
To a solution of 2.42 (0.55 g, 1.0 mmol) in a mixed solvent of THF, MeOH, 
and H2O (3 mL, 1 mL, and 1 mL, respectively) at rt was added LiOH•H2O 
(174 mg, 4.12 mmol). The resulting mixture was stirred at rt for 2 hours, and 
then was acidified with 1.0 M HCl until the pH was between 3 and 4. The aqueous solution was 
extracted with EtOAc (3x), and the combined organic layers were dried over Na2SO4, filtered, and 
concentrated in vacuo. Then the crude acid was re-dissolved in anhydrous THF (15 mL) followed 
by an addition of TBAF (1.0 M in THF, 2.6 mL, 2.6 mmol). The resulting organic solution was 
stirred at rt for 1.5 h, then was acidified by 1.0 M HCl until the pH fell into the range of 3 to 4. 
The aqueous solution was extracted with EtOAc (3x). The combined organic layers were dried 
over Na2SO4, filtered, and concentrated. The residue was dissolved in anhydrous MeCN (100 mL) 
contained NEt3 (1.4 mL, 10 mmol). The resulting solution was added dropwise to a refluxing 
solution of 2-chloro-1-methylpyridinium iodide (1.3 g, 5.2 mmol) in MeCN (500 mL) over 6 h. 
The resulting brown solution was cooled down and concentrated. The residue was purified by flash 
chromatography (hexanes:EtOAc = 10:1) give desired macrolactone (78 mg, contaminated by 
TBDPS derivatives) as yellowish oil. To a suspension of [(p-cymene)RuCl2]2 (7.3 mg, 0.012 
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mmol), Na2CO3 (4.8 mg, 0.045 mmol), tri(2-furyl)phosphine (5.6 mg, 0.024 mmol), and  1-decyne 
(54 μL, 0.30 mmol) in toluene (2 mL) was added first portion of acetic acid (34 μL, 0.60 mmol). 
The mixture was heated to 80 °C and stirred for 1 h. The second portion of acetic acid (34 μL, 0.60 
mmol) and the newly obtained macrolactone (78 mg, 0.30 mmol) in toluene (1 mL) were added 
into the reaction through syringe. The reaction was stirred at the 80 °C for 4.5 h. The crude mixture 
was loaded onto a small plug of silica gel and eluted with EtOAc (3x). The filtrate was 
concentrated. The residue purified by flash chromatography (hexanes:EtOAc = 25:1 to 10:1) to 
give the enol acetate 2.18 (36 mg, 11%, over four steps) as yellowish oil. 1H NMR (400 MHz, 
CDCl3)  5.44 (td, 1H, J = 1.2, 7.6 Hz), 4.88 (s, 1H), 4.85 (d, 1H, J = 1.6 Hz), 4.30-4.17 (m, 4H), 
3.95 (dd, 1H, J = 7.2, 10.4 Hz), 2.62 (dd, 2H, J = 4.8, 6.4 Hz), 2.59-2.49 (m, 3H), 2.47-2.43 (m, 
2H), 2.42-2.35 (m, 1H), 2.14 (s, 3H), 1.90-1.84 (m, 2H), 1.79 (s, 3H); 13C NMR (100 MHz, CDCl3) 
 173.3, 169.3, 152.2, 142.6, 121.8, 104.3, 86.4, 79.3, 66.1, 64.6, 64.0, 40.4, 34.7, 28.2, 26.8, 23.4, 
21.3, 17.2; IR (neat) 2924, 2856, 1755, 1733, 1667, 1433, 1369, 1338, 1249, 1203, 1065, 1019, 
969, 879 cm-1; HRMS (ESI) m/z calcd for C18H24O5Na [M+Na]
+ 343.1521, found 343.1566. 
 
Macrolactone substrate 2.44 
Same procedure with the preparation of 2.18. 1H NMR (400 MHz, CDCl3)  
5.55 (td, 1H, J = 1.2, 6.4 Hz), 4.85 (s, 1H), 4.84 (d, 1H, J = 1.6 Hz), 4.37 (dd, 
1H, J = 6.0, 14.0 Hz), 4.27-4.12 (m, 3H), 4.02 (dd, 1H, J = 6.0, 14.0 Hz), 2.62-
2.56 (m, 2H), 2.53-2.47 (m, 2H), 2.46-2.42 (m, 2H), 2.38-2.35 (m, 2H), 2.14 (s, 3H), 1.79 (p, 2H, 
J = 6.0 Hz), 1.66 (s, 3H); 13C NMR (100 MHz, CDCl3)  173.6, 169.3, 152.2, 134.8, 124.0, 104.4, 
84.1, 81.9, 67.8, 67.5, 62.3, 40.8, 35.1, 32.5, 25.0, 21.3, 16.1, 15.4; IR (neat) 2924, 2856, 1734, 
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1669, 1574, 1433, 1368, 1343, 1206, 1069, 1022, 969, 882 cm-1; HRMS (ESI) m/z calcd for 
C18H24O5Na [M+Na]
+ 343.1521, found 343.1515. 
 
4-Methyl-1-(pent-4-ynyl)-2,6,7-trioxabicyclo[2.2.2]octane (2.47) 
To a solution of hex-5-ynoic acid (10 g, 89 mmol), (3-methyloxetan-3-yl)methanol 
(10 g, 98 mmol), and DMAP (1.1 g, 8.9 mmol) in CH2Cl2 (150 mL) was added DCC 
(18 g, 89 mmol) in one portion at 0 °C. White precipitates were formed. The mixture 
was stirred at ice bath for 1.5 h, then was filtered through a Celite® pad. The filtrate was 
concentrated in vacuo and the residue was purified by flash chromatography (hexanes:EtOAc = 
10:1 to 6:1, hexane contained 2% NEt3) to give the desired ester (19.5 g) as colorless oil. This 
freshly prepared ester (19.5 g) was re-dissolved in CH2Cl2 (100 mL). BF3•OEt2 (3.1 mL, 25 mmol) 
was added to this solution slowly at 0 °C. The resulting solution was warmed to rt slowly and 
stirred at rt for 8 h. The reaction was quenched with NEt3 (15 mL) and diluted with Et2O (250 mL). 
The precipitates were filtered through a Celite® pad. The filtrate was concentrated and the residue 
was purified by flash chromatography (hexanes:EtOAc = 20:1, hexane contained 2% NEt3) to give 
pure product (12.4 g, 71% over 2 steps) as colorless oil. 1H NMR (400 MHz, CDCl3)  3.90 (s, 
6H), 2.22 (td, 2H, J = 2.4, 7.2 Hz), 1.94 (t, 1H, J = 2.4 Hz), 1.82-1.77 (m, 2H), 1.74-1.65 (m. 2H), 
0.80 (s, 3H). 
 
(E)-Methyl 5-(dimethyl(thiophen-2-yl)silyl)-7-hydroxyhept-5-enoate (2.48) 
To a solution of 2.47 (12.4 g, 63.2 mmol) in THF (130 mL) was added n-BuLi (1.6 
M in hexane, 43.4 mL, 69.5 mmol) at -78 °C. The resulting solution was allowed to 
warm to 0 °C slowly over 1.5 h. Paraformaldehyede (5.7 g, 0.19 mol) was added in 
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one portion at 0 °C. The resulting suspension was warmed to rt and stirred overnight. The reaction 
was quenched with aq. NH4Cl. The aqueous phase was extracted with Et2O (3x). The combined 
organic layers were washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. 
The residue was purified by flash chromatography to afford the desired propargyl alcohol (12 g, 
85%). The newly formed propargyl alcohol (6.4 g, 28 mmol) was dissolved in a mixed solvent 
AcOH/THF/H2O (160 mL/80 mL/40 mL). The resulting solution was stirred at rt for 2 h, then was 
concentrated in vacuo. The residue was re-dissolved in THF (200 mL), then was concentrated in 
vacuo. Repeated 2 more times to remove H2O from the product. The product was dissolved in 
MeOH (200 mL) and treated with K2CO3 (8.5 g, 62 mmol) in one portion. After being stirred at rt 
for 2 h, the reaction mixture was diluted with CH2Cl2, then was filtered through a silica gel pad. 
The filtrate was concentrated in vacuo and the residue was purified by flash chromatography to 
give pure ester (3.8 g, 85%) as yellow oil. 1H NMR (400 MHz, CDCl3)  4.24 (d, 2H, J = 2.0 Hz), 
3.68 (s, 3H), 2.45 (t, 2H, J = 7.2 Hz), 2.32-2.28 (m, 2H), 1.84 (p, 2H, J = 7.2 Hz), 1.76 (s, 1H). To 
a solution of this newly formed ester (1.7 g, 11 mmol) and dimethyl(thiophen-2-yl)silane (3.1 g, 
22 mmol) in THF (10 mL) was added H2PtCl6 solution (1.0x10
-3 M in THF, 5.4 mL, 5.4x10-3 
mmol) dropwise at rt. The resulting solution was stirred at 50 °C for 3.5 h, then was cooled to 0 
°C. 1.0 M HCl aq. (5 mL) was added and the reaction was stirred for 5 min at 0 °C before NaHCO3 
aq. was poured in. The aqueous layer was extracted with EtOAc (3x). The combined organic 
phases were dried over Na2SO4, filtered, concentrated. The residue was purified by flash 
chromatography to give desired product 2.48 (1.47 g, 45%) as yellowish oil. (The corresponding 
Z-isomer (1.38 g, 42%) was also separated.) 2.48: 1H NMR (400 MHz, CDCl3)  7.62 (d, 2H, J = 
4.8 Hz), 7.27 (d, 2H, J = 3.6 Hz), 7.19 (dd, 2H, J = 3.6, 4.8 Hz), 6.07 (t, 1H, J = 6.0 Hz), 4.28 (d, 
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2H, J = 6.0 Hz), 3.66 (s, 3H), 2.24 (t, 2H, J = 7.2 Hz), 2.18 (t, 2H, J = 8.0 Hz), 1.68 (s, 1H), 1.59-
1.52 (m, 2H), 0.44 (s, 6H). 
 
(E)-Methyl 7-(9-hydroxynona-1,5-diyn-4-yloxy)-5-phenylhept-5-enoate (2.49) 
To a solution of 2.48 (1.6 g, 5.4 mmol) in THF (45 mL) was added TBAF 
(1.0 M in THF, 11.9 mL, 11.9 mmol) at rt under argon. The resulting solution 
was stirred for 10 min, then was treated with PhI (1.3 g, 6.5 mmol) and 
Pd2(dba)3 (494 mg, 0.540 mmol). The resulting mixture was stirred at rt for 30 min, then was 
filtered through a pad of silica gel. The filtrate was concentrated in vacuo and the residue was 
purified by flash chromatography to give the desired allylic alcohol (0.96 g, 76%) as yellow oil. 
Cl3CCN (1.2 mL, 12 mmol) and DBU (0.75 mL, 5.3 mmol) were added successively to the solution 
of the newly generated allylic alcohol (0.96 g, 4.1 mmol) in anhydrous CH2Cl2 (13 mL). The 
resulting black mixture was stirred at rt for 1 h, then was concentrated under reduced pressure. The 
residue was purified through flash chromatography (hexanes:EtOAc = 20:1 to 15:1, 2% NEt3 in 
hexane) to give desired trichloroacetimidiate (1.4 g, 92%) as yellow oil. TMSOTf (69 µL, 0.38 
mmol) was added to a solution of homopropargyl alcohol 2.41 (2.2 g, 5.6 mmol) and the freshly 
prepared trichloroacetmidiate (1.4 g, 3.8 mmol) in anhydrous cyclohexane (30 mL) at 0 °C. The 
resulting mixture was stirred at 0 °C for 20 min, then was filtered through a pad of Celite®. The 
filtrate was concentrated and the residue was purified through flash chromatography 
(hexanes:EtOAc = 30:1 to 20:1) to give the desired ether (925 mg, 40%) as yellowish oil. The 
newly generated ether (925 mg, 1.52 mmol) was dissolved in THF (20 mL) and treated with TBAF 
(1.0 M in THF, 2.3 mL, 2.3 mmol). After stirring at rt for 30 min, the reaction solution was 
concentrated and the residue was purified by flash chromatography (hexanes:EtOAc = 4:1 to 2:1) 
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to give desired alcohol 2.49 (434.5 mg, 78%). 1H NMR (400 MHz, CDCl3)  7.41-7.25 (m, 5H), 
5.87 (t, 1H, J = 6.8 Hz), 4.20 (dd, 1H, J = 6.0, 12.4 Hz), 4.30-4.22 (m, 2H), 3.79 (t, 2H, J = 6.0 
Hz), 3.66 (s, 3H), 2.64-2.60 (m, 4H), 2.42 (td, 2H, J = 1.6, 6.8 Hz), 2.31 (t, 2H, J = 7.2 Hz), 2.08 
(t, 1H, J = 2.4 Hz), 1.80 (p, 2H, J = 6.8 Hz), 1.74-1.64 (m, 3H). 
 
Macrolactone substrate 2.19 
To a solution of 2.49 (0.22 g, 0.61 mmol) in a mixed solvent of THF, MeOH, 
and H2O (3 mL, 1 mL, and 1 mL, respectively) at rt was added LiOH•H2O 
(0.10 g, 2.4 mmol). The resulting mixture was stirred at rt for 2 h, then was 
acidified with 1.0 M HCl until the pH was below 3. The aqueous solution was extracted with 
EtOAc (3x). The combined organic layers were dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude acid was dissolved in anhydrous MeCN (20 mL) that contained NEt3 (0.85 mL, 
6.1 mmol). The resulting solution was added dropwise to a refluxing solution of 2-chloro-1-
methylpyridinium iodide (779 mg, 3.05 mmol) in MeCN (500 mL) over 7 h. After addition, the 
brown solution was cooled down and concentrated. The residue was purified by flash 
chromatography to give the desired macrolactone (94 mg, 46% over 2 steps) as yellowish oil. To 
a suspension of [(p-cymene)RuCl2]2 (6.7 mg, 0.011 mmol), Na2CO3 (4.4 mg, 0.042 mmol), tri(2-
furyl)phosphine (5.1 mg, 0.022 mmol) and  1-decyne (50 μL, 0.28 mmol) in toluene (2 mL) was 
added first portion of acetic acid (32 μL, 0.56 mmol). The mixture was heated to 80 °C and stirred 
for 1 h. The second portion of acetic acid (32 μL, 0.56 mmol) and the newly obtained macrolactone 
(94 mg, 0.28 mmol) in toluene (1 mL) were added into the reaction through syringe. The reaction 
was stirred at the 80 °C for 4.5 h. Then crude mixture was loaded onto a small plug of silica gel 
and eluted with EtOAc. The filtrate was concentrated and the residue was purified by flash 
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chromatography to give the desired enol acetate 2.19 (59 mg, 53%) as yellowish oil. 1H NMR (400 
MHz, CDCl3)  7.39-7.25 (m, 5H), 5.82 (t, 1H, J = 6.4 Hz), 4.90 (s, 1H), 4.87 (d, 1H, J = 1.6 Hz), 
4.39 (dd, 1H, J = 6.8 12.0 Hz), 4.35-4.28 (m, 3H), 4.18 (dd, 1H, J = 6.8, 12.0 Hz), 2.68-2.61 (m, 
4H), 2.59-2.43 (m, 2H), 2.40-2.28 (m, 2H), 2.13 (s, 3H), 1.96-1.84 (m, 2H), 1.81-1.64 (m, 2H); 
13C NMR (100 MHz, CDCl3)  174.2, 169.3, 152.1, 143.4, 141.6, 128.6, 127.6, 126.7, 125.2, 
104.6, 85.4, 80.0, 66.2, 64.9, 63.5, 40.3, 33.5, 28.8, 25.8, 24.1, 21.3, 16.2; IR (neat) 2929, 1755, 
1730, 1667, 1493, 1433, 1368, 1245, 1204, 1080, 1020, 964, 917, 880, 761 cm-1; HRMS (ESI) m/z 
calcd for C24H28O5Na [M+Na]
+ 419.1834, found 419.1841. 
 
(8-Bromooct-6-ynyloxy)(tert-butyl)dimethylsilane (2.51a) 
To a solution of hept-6-yn-1-ol (1.5 g, 13 mmol) in CH2Cl2 (30 mL) were 
added imidazole (2.3 g, 34 mmol) and TBSCl (4.0 g, 27 mmol) at rt. The resulting suspension was 
stirred at rt for 2 h. The reaction was quenched with H2O. The aqueous layer was extracted with 
CH2Cl2 (3x). The combined organic layers were washed with brine, dried over Na2SO4, filtered, 
and concentrated. The residue was purified by flash chromatography to yield the TBS protected 
alcohol (3.0 g, 100%) as colorless oil. A solution of this TBS protected alcohol (9.7 g, 43 mmol) 
in anhydrous THF (84 mL) was cooled to -78 °C, followed by the addition of n-BuLi (1.6 M in 
hexane, 31 mL, 49 mmol). The resulting brown mixture was allowed to warm to 0 °C over 1 h. 
Paraformaldehyde (4.10 g, 136 mmol) was added to the solution at 0 °C in one portion. The mixture 
was warmed to rt slowly and stirred overnight. The reaction was quenched with aq. NH4Cl. The 
aqueous layer was extracted with Et2O (3x). The combined organic layer was dried over Na2SO4, 
filtered, and concentrated. The residue was purified by flash chromatography (hexanes:EtOAc = 
20:1) to give the desired alcohol (10 g, 94% over 2 steps) as a colorless oil. A solution of the newly 
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obtained alcohol (10 g, 39 mmol) in CH2Cl2 (400 mL) was treated with PPh3 (11 g, 43 mmol) and 
CBr4 (16 g, 47 mmol) at 0 °C. The resulting solustion was stirred at 0 °C for 1 h, then was quenched 
with H2O. The aqueous layer was extracted with EtOAc (3x). The combined organic layers were 
washed with H2O, brine, dried over Na2SO4, filtered, and concentrated. The residue was purified 
by flash chromatography (hexanes:EtOAc = 100:0 to 100:1) to give product 2.51a (9.2 g, 74%) as 
a colorless oil. 1H NMR (400 MHz, CDCl3)  3.92 (t, 2H, J = 2.0 Hz), 3.61 (t, 2H, J = 6.4 Hz), 
2.25 (tt, 2H, J = 2.0, 6.8 Hz), 1.56-1.49 (m, 4H), 1.47-1.38 (m, 2H), 0.90 (s, 9H), 0.05 (s, 6H); 13C 
NMR (100 MHz, CDCl3)  88.3, 75.6, 63.2, 32.5, 28.4, 26.2, 25.3, 19.2, 18.6, 15.9, -5.1; IR (neat) 
2932, 2858, 1463, 1388, 1254, 1210, 1099, 1006, 836, 776 cm-1; HRMS (ESI) m/z calcd for 
C14H28OBr [M]
+ 319.1093, found 319.1084. 
 
(11-Bromoundec-9-ynyloxy)(tert-butyl)dimethylsilane (2.51b) 
Same procedure with the preparation of 2.51a. 1H NMR (400 MHz, CDCl3) 
 3.93 (t, 2H, J = 2.4 Hz), 3.60 (t, 2H, J = 6.8 Hz), 2.24 (tt, 2H, J = 2.4, 7.2 
Hz), 1.51 (p, 4H, J = 7.2 Hz), 1.40-1.35 (m, 2H), 1.33-1.30 (m, 6H), 0.90 (s, 9H), 0.05 (s, 6H); 13C 
NMR (100 MHz, CDCl3)  88.5, 75.5, 63.5, 33.0, 29.5, 29.3, 29.0, 28.6, 26.2, 26.0, 19.2, 18.6, 
16.0, -5.0.  
 
8-(1-(tert-Butyldiphenylsilyloxy)hex-5-yn-3-yloxy)oct-6-ynal (2.53a) 
NaH (60%, 0.38 g, 9.5 mmol) was added to a solution of 
secondary alcohol 2.52 (3.0 g, 8.6 mmol) in anhydrous THF (30 
mL) at 0 °C. The resulting suspension was stirred at 0 °C for 30 min, then was added n-Bu4NI (266 
mg, 0.72 mmol) and bromide 2.51a (2.3 g, 7.2 mmol). The brown mixture was allowed to warm 
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to rt slowly and stirred at rt overnight. The reaction was quenched with H2O. The aqueous phase 
was extracted with Et2O (3x). The combined organic phases were dried over Na2SO4, filtered, and 
concentrated in vacuo, followed by flash chromatography purification (hexanes:EtOAc = 100:1 to 
50:1) to give the desired ether as a yellow oil (2.8 g, 66%). This ether (5.1 g, 8.6 mmol) was re-
dissolved in a mixture of CH2Cl2 (40 mL) and MeOH (40 mL), followed by the addition of PPTS 
(2.4 g, 9.5 mmol) in one portion. After stirring at rt for 2 h, the solution was concentrated and the 
residue was purified by flash chromatography (hexanes:EtOAc = 10:1 to 6:1) to give desired 
alcohol as a colorless oil (3.1 g, 76%). The TBS deprotected product (2.1 g, 4.4 mmol) was 
dissolved in CH2Cl2 (100 mL), followed by the addition of NaHCO3 (1.8 g, 22 mmol) and DMP 
(2.8 g, 6.6 mmol). The resulting mixture was stirred for 1 h at rt., then was added aq. sat. Na2S2O3 
(75 mL) and aq. sat. NaHCO3 (75 mL). After stirring for 1 h, the aqueous phase was extracted with 
CH2Cl2 (3x). The combined organic phases were washed with brine, dried over Na2SO4, filtered, 
and concentrated. The residue was purified by flash chromatography (hexane: EtOAc, 20:1) to 
give the desired aldehyde as a colorless oil (1.5 g, 72%). 1H NMR (400 MHz, CDCl3)  9.74 (t, 
1H, J = 1.6 Hz), 7.72-7.69 (m, 4H), 7.44-7.38 (m, 6H), 4.22 (dt, 2H, J = 2.0, 6.4 Hz), 3.97-3.92 
(m, 1H), 3.91-3.84 (m, 1H), 3.82-3.76 (m, 1H), 2.49 (dd, 2H, J = 2.4, 5.6 Hz), 2.42 (td, 2H, J = 
1.6, 7.2 Hz), 2.22 (tt, 2H, J = 1.6, 7.2 Hz), 2.02 (t, 1H, J = 2.8 Hz), 1.98-1.83 (m, 2H), 1.76-1.68 
(m, 2H), 1.56-1.50 (m, 2H), 1.09 (s, 9H); 13C NMR (100 MHz, CDCl3)  202.2, 135.6, 133.9, 
133.8, 129.7, 129.7, 127.8, 85.9, 80.9, 76.8, 73.5, 70.3, 60.3, 57.3, 43.4, 36.8, 28.0, 27.0, 23.9, 
21.3, 19.3, 18.6; IR (neat) 3292, 3070, 3049, 2932, 2858, 2720, 1724, 1471, 1428, 1110, 1006, 
967, 823, 739, 705 cm-1; HRMS (ESI) m/z calcd for C30H38O3SiNa [M+Na]
+ 497.2488, found 
497.2492. 
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11-(1-(tert-Butyldiphenylsilyloxy)hex-5-yn-3-yloxy)undec-9-ynal (2.53b) 
Same procedure with the preparation of 2.53a. 1H NMR (400 
MHz, CDCl3)  9.77 (t, 1H, J = 1.6 Hz), 7.70-7.66 (m, 4H), 7.45-
7.36 (m, 6H), 4.20 (dt, 2H, J = 2.4, 5.6 Hz), 3.94-3.88 (m, 1H), 3.87-3.83 (m, 1H), 3.79-3.74 (m, 
1H), 2.48 (dd, 2H, J = 2.8, 5.6 Hz), 2.43 (td, 2H, J = 1.6, 7.2 Hz), 2.17 (tt, 2H, J = 2.0, 6.8 Hz), 
2.00 (t, 1H, J = 2.8 Hz), 1.96-1.81 (m, 2H), 1.63 (p, 2H, J = 7.2 Hz), 1.48 (p, 2H, J = 7.2 Hz), 1.40-
1.25 (m, 6H), 1.06 (s, 9H). 
 
Macrolactone substrate 2.20 
A mixture of aldehyde 2.53a (1.5 g, 3.2 mmol), NaH2PO4 (1.0 g, 7.0 mmol), 
2-methyl-2-butene (1.1 g, 16 mmol), t-BuOH (11 mL), and H2O (5.5 mL) was 
cooled to -10 °C in salt-ice bath. NaClO2 (1.1 g, 13 mmol) was added in 3 
portions over 30 min. The mixture was allowed to warm to rt slowly over 3 h, then was quenched 
at rt by adding sat. aq. Na2S2O3. The resulting mixture was stirred at rt for 20 min, then extracted 
with EtOAc (3x). The combined organic phases were dried over Na2SO4, filtered, and 
concentrated. The crude was re-dissolved in THF (40 mL) and treated with TBAF (1.0 M in THF, 
7.9 mL, 7.9 mmol). The resulting solution was stirred at rt overnight, then was acidified with 0.5 
M HCl until the pH fell into the range of 3 to 4. The aqueous layer was extrated with EtOAc (3x). 
The combined organic layers were dried over Na2SO4, filtered, and concentrated in vacuo. The 
crude hydroxyl acid was re-dissolved in MeCN (250 mL) and followed by adding NEt3 (4.4 mL, 
32 mmol). The resulting solution was added dropwise to a refluxing solution of 2-chloro-1-
methylpyridinium iodide (4.0 g, 16 mmol) in MeCN (500 mL) over 8 h. After addition, the brown 
solution was cooled down and concentrated. The residue was purified by flash chromatography 
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(hexanes:EtOAc = 15:1 to 10:1) to afford the desired macrolactone (525 mg, contaminated by 
TBDPS derivatives) as a yellowish oil. To a suspension of [(p-cymene)RuCl2]2 (55 mg, 0.090 
mmol), Na2CO3 (36 mg, 0.34 mmol), tri(2-furyl)phosphine (42 mg, 0.18 mmol), and 1-decyne 
(0.40 mL, 2.2 mmol) in toluene (20 mL) was added the first portion of acetic acid (257 μL, 4.50 
mmol). The mixture was heated to 80 °C and stirred for 1 h. The second portion of acetic acid (257 
μL, 0.6 mmol) and the newly obtained macrolactone (525 mg, 2.20 mmol) in toluene (5 ml) were 
added into the reaction through syringe. The reaction was stirred at the 80 °C for 5 h. Then crude 
mixture was loaded onto a small plug of silica gel and eluted with EtOAc. The filtrate was 
concentrated and the residue was purified by flash chromatography (hexanes:EtOAc = 10:1) to 
give the enol acetate 2.20 (321 mg, 35%, over four steps) as a yellowish oil. 1H NMR (400 MHz, 
CDCl3)  4.85 (d, 1H, J = 1.2 Hz), 4.83 (s, 1H), 4.30-4.19 (m, 2H), 4.14-4.05 (m, 3H), 2.58 (ddd, 
1H, J = 2.0, 7.6, 14.4 Hz), 2.47 (t, 2H, J = 4.8 Hz), 2.37 (dddd, 1H, J = 2.8, 5.6, 8.4, 17.2 Hz), 
2.22-2.17 (m, 1H), 2.17 (s, 3H), 2.16-2.00 (m, 2H), 1.90 (ddt, 1H, J = 3.2, 12.0, 14.8 Hz), 1.83-
1.76 (m, 1H), 1.74-1.67 (m, 2H), 1.51-1.44 (m, 1H); 13C NMR (100 MHz, CDCl3)  173.8, 169.2, 
153.0, 104.3, 86.0, 77.1, 69.6, 60.5, 56.8, 37.8, 35.0, 33.8, 27.7, 23.5, 21.3, 17.9; IR (neat) 2926, 
2854, 1755, 1731, 1665, 1434, 1369, 1259, 1200, 1152, 1053 cm-1; HRMS (ESI) m/z calcd for 
C16H22O5Na [M+Na]
+ 317.1365, found 317.1365.  
 
Macrolactone substrate 2.21 
Same procedure with the preparation of 2.20. 1H NMR (400 MHz, CDCl3)  
4.84 (s, 2H), 4.30-4.14 (m, 4H), 4.04 (p, 1H, J = 6.0 Hz), 2.47 (d, 2H, J = 5.6 
Hz), 2.34 (t, 2H, J = 6.8 Hz), 2.29-2.28 (m, 2H), 2.14 (s, 3H), 1.91-1.82 (m, 
2H), 1.78-1.65 (m, 2H), 1.57-149 (m, 4H), 1.44-1.33 (m, 4H); 13C NMR (100 MHz, CDCl3)  
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174.1, 169.2, 152.8, 104.5, 86.9, 76.4, 70.7, 60.8, 55.9, 36.6, 33.9, 33.3, 27.4, 26.9, 26.5, 26.0, 
24.0, 21.3, 18.2; IR (neat) 2930, 2857, 1756, 1733, 1666, 1435, 1369, 1199, 1065, 1022, 965, 878 
cm-1; HRMS (ESI) m/z calcd for C19H29O5 [M]
+ 337.2015, found 337.1962. 
 
Macrolactone substrate 2.22 
Similar procedure with the preparation of substrate 2.20. 1H NMR (400 MHz, 
CDCl3)  4.80 (s, 2H), 4.34 (ddd, 1H, J = 3.6, 5.2, 11.2 Hz), 4.28 (dt, 1H, J = 
2.0, 16.4 Hz), 4.12 (td, 1H, J = 2.8, 10.4 Hz), 4.04 (dt, 1H, J = 2.0, 16.4 Hz), 
3.84 (p, 1H, J = 6.0 Hz), 2.48-2.44 (m, 2H), 2.43-2.31 (m, 4H), 2.16 (s, 3H), 2.02-1.84 (m. 3H), 
1.83-1.73 (m, 2H), 1.61-1.52 (m, 1H); 13C NMR (100 MHz, CDCl3)  173.4, 169.3, 153.4, 103.9, 
84.8, 78.8, 75.0, 64.1, 57.5, 38.2, 33.7, 31.1, 23.7, 21.9, 21.3, 18.4; IR (neat) 2929, 2855, 2032, 
1962, 1754, 1732, 1666, 1574, 1436, 1369, 1201, 1159, 1069, 1019, 881 cm-1; HRMS (ESI) m/z 
calcd for C16H22O5Na [M+Na]
+ 317.1365, found 317.1325. 
 
Macrolactone substrate 2.23 
Smilar procedure with the preparation of 2.20. 1H NMR (400 MHz, CDCl3) 
 4.87 (d, 1H, J = 1.6 Hz), 4.83 (d, 1H, J = 1.6 Hz), 4.40-4.30 (m, 2H), 4.25 
(dt, 1H, J = 2.4, 16.4 Hz), 4.07-4.02 (m, 2H), 2.61 (dd, 1H, J = 2.0, 14.4 Hz), 
2.56 (dd, 1H, J = 4.8, 15.2 Hz), 2.45 (dd, 1H, J = 10.0, 14.4 Hz), 2.38 (dd, 1H, J = 7.2, 15.6 Hz), 
2.34-2.26 (m, 1H), 2.22-2.16 (m, 1H), 2.16 (s, 3H), 1.81-1.70 (m, 2H), 1.68-1.52 (m, 3H), 1.51-
1.42 (m, 1H); 13C NMR (100 MHz, CDCl3)  171.3, 169.2, 152.4, 104.7, 86.3, 72.4, 62.9, 56.6, 
41.5, 37.7, 26.8, 25.1, 22.5, 21.3, 18.2; IR (neat) 2926, 2865, 1738, 1666, 1580, 1454, 1370, 1245, 
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1192, 1072, 1021, 963 cm-1; HRMS (ESI) m/z calcd for C16H22O5Na [M+Na]
+ 317.1365, found 
317.1369.  
 
2-(8-(4-Methoxybenzyloxy)oct-1-ynyl)-4-(prop-2-ynyl)-1,3-dioxane (2.56) 
PMB protected alcohol 2.54 (11 g, 44 mmol) was dissolved in 
anhydrous THF (80 mL) and cooled to -78 °C, then was added n-
BuLi (1.6 M in hexane, 30 mL, 48 mmol) dropwise. The resulting brown mixture was allowed to 
warm to 0 °C over 1 h. Paraformaldehyde (3.9 g, 0.13 mol) was added to the solution at 0 °C in 
one portion. The resulting mixture was warmed to rt slowly and stirred at rt overnight, then was 
quenched with aq. NH4Cl. The aqueous layer was extracted with Et2O (3x). The combined organic 
layers were dried over Na2SO4, filtered, and concentrated. The residue was purified by flash 
chromatography to give the desired product (6.0 g, 50%) as colorless oil. The newly generated 
alcohol (6.0 g, 22 mmol) was re-dissolved in a mixture of CH2Cl2 (16 mL), DMSO (22 mL), and 
NEt3 (9.1 mL). Sulfur trioxide pyridine complex (5.2 g, 33 mmol) was added in one portion. The 
resulting brown mixture was stirred at rt for 2 h, then was quenched with H2O. The aqueous layer 
was extracted with Et2O (3x). The combined organic layers were dried over Na2SO4, filtered, 
concentrated. The residue was purified by flash chromatography to give 9-(4-
methoxybenzyloxy)non-2-ynal (3.9 g, 66%) as brown oil. To a stirring solution of hex-5-yne-1,3-
diol (420 mg, 3.70 mmol) in anhydrous DMF (25 mL) was added imidazole (1.3 g, 18 mmol). The 
reaction mixture was stirred for 5 min, then was added chlorotrimethylsilane (884 mg, 8.10 mmol) 
and 4-dimethylaminopyridine (26 mg) successively. The reaction mixture was stirred for 18 h, 
then was quenched with ice chips. The reaction mixture was extracted into hexanes and the 
aqueous layer was washed with hexanes. The combined organic layers were dried over Na2SO4, 
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filtered, and concentrated. The residue was re-dissolved in CH2Cl2 (28 mL). The resulting solution 
was cooled to -78 °C and added 9-(4-methoxybenzyloxy)non-2-ynal (1.0 g, 3.7 mmol) and 
TMSOTf (82 mg, 0.37 mmol). The reaction mixture was stirred for 30 min, followed by the 
addition of 0.1 eq.  TMSOTf (82 mg, 0.37 mmol). The resulting mixture was stirred for 2.5 h, then 
was quenched with pyridine (0.1 ml), warmed to rt, and washed with sat. aq. NaHCO3. The organic 
layer was dried over Na2SO4, filtered, and concentrated in vacuo. The residue was purified by flash 
chromatography to afford the desired acetal 2.56 (410 mg, 30%) as colorless oil. 1H NMR (400 
MHz, CDCl3)  7.26 (d, 2H, J = 8.0 Hz), 6.88 (d, 2H, J = 8.4 Hz), 5.23 (s, 1H), 4.43 (s, 2H), 4.18 
(dd, 1H, J =4.8, 11.6 Hz), 3.87-3.77 (m, 2H), 3.81 (s, 3H), 3.42 (t, 2H, J = 6.4 Hz), 2.61 (ddd, 1H, 
J = 2.4, 4.8, 16.8 Hz), 2.40 (ddd, 1H, J = 2.8, 8.4, 16.8 Hz), 2.24 (t, 2H, J = 6.8 Hz), 2.03 (t, 1H, J 
= 2.8 Hz), 1.84-1.71 (m, 2H), 1.62-150 (m, 4H), 1.42-1.36 (m, 4H). 
 
3-(10-(4-methoxybenzyloxy)dec-3-yn-2-yloxy)hex-5-yn-1-ol (2.57) 
To a solution of 2.56 (410 mg, 1.10 mmol) in toluene (20 mL) 
was added AlMe3 (2.0 M in hexane, 6.6 mL, 13 mmol) 
dropwise at 0 °C. The resulting solution was stirred at the 
same temperature for 2 h, then was poured to aq. NaOH (2.0 M, 100 mL). The aqueous layer was 
extracted with EtOAc (3x). The combined organic layers were dried over Na2SO4, filtered, 
concentrated. The residue was purified by flash chromatography (hexanes:EtOAc = 4:1) to afford 
the desired product (0.29 g, 68%) as a colorless oil. 1H NMR (400 MHz, CDCl3)  7.27 (d, 2H, J 
= 8.4 ), 6.88 (d, 2H, J = 8.4 Hz), 4.44 (s, 2H), 4.29 (q, 1H, J = 6.8 Hz), 3.93-3.87 (m, 1H), 3.81-
3.76 (m, 2H), 3.81 (s, 3H), 3.44 (t, 2H, J = 6.4 Hz), 2.73 (dt, 1H, J = 3.2, 16.8 Hz), 2.49 (ddd, 1H, 
J = 2.8, 8.4, 16.8 Hz), 2.20 (t, 2H, J = 6.8 Hz), 2.08 (t, 1H, J = 5.2 Hz), 2.01 (t, 1H, J = 2.8 Hz), 
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2.04-1.96 (m, 1H), 1.89-1.80 (m, 1H), 1.65-1.58 (m, 2H), 1.53-1.48 (m, 2H), 1.40 (d, 3H, J = 6.8 
Hz), 1.41-1.38 (m, 4H). 
 
Macrolactone substrate 2.25 
To a solution of alcohol 2.57 (0.29 g, 0.75 mmol) in CH2Cl2 (15 mL) at rt were 
added NaHCO3 (315 mg, 3.75 mmol) and Dess-Martin periodinane (477 mg, 
1.13 mmol) successively. The resulting suspension was stirred for 1.5 h, then 
was added sat. aq. NaHCO3 (10 mL) and sat. aq. Na2S2O3 (10 mL). The resulting mixture was 
stirred at rt for 1 h, then the aqueous layer was extracted with CH2Cl2 (3x). The combined organic 
layers were washed with brine, dried over Na2SO4, filtered, concentrated. The residue was purified 
by flash chromatography to give the desired aldehyde (0.24 g, 83%) as colorless oil. A mixture of 
newly formed aldehyde (0.24 g, 0.62 mmol), NaH2PO4 (189 mg, 1.37 mmol), 2-methyl-2-butene 
(217 mg, 3.10 mmol), tBuOH (2.3 mL), and H2O (1.2 mL) was cooled to -10 °C in salt-ice bath. 
NaClO2 (224 mg, 2.48 mmol) was added in 2 portions over 20 min. The mixture was allowed to 
warm to rt slowly over 3 h, then was quenched with sat. aq. Na2S2O3. The resulting mixture was 
stirred for 20 min and acidified with 1.0 M aq. HCl until pH was below 3. The aqueous layer was 
extracted with EtOAc (3x). The combined organic phases were dried over Na2SO4, filtered, and 
concentrated. The crude acid was re-dissolved in CH2Cl2 (6 mL) and treated with water (0.3 mL) 
and DDQ (155 mg, 0.680 mmol). After stirring at rt for 4 h, the reaction was quenched with sat. 
aq. NaHCO3. The aqueous layer was washed with EtOAc, then was acidified until pH was below 
3. The acidified aqueous layer was extracted with EtOAc (3x). The combined organic phases were 
dried over Na2SO4, filtered, and concentrated in vacuo. The residue was re-dissolved in MeCN (60 
mL) that contained NEt3 (0.9 ml, 6 mmol). The resulting solution was added dropwise to a 
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refluxing solution of 2-chloro-1-methylpyridinium iodide (792 mg, 3.10 mmol) in MeCN (600 
mL) over 6 hours. After addition, the brown solution was cooled down and concentrated. The 
residue was purified by flash chromatography (hexanes:EtOAc = 15:1) to give desired 
macrolactone (78 mg, 48% over 3 steps) as a yellowish oil. To a suspension of [(p-cymene)RuCl2]2 
(6.9 mg, 0.011 mmol), Na2CO3 (4.5 mg, 0.042 mmol), tri(2-furyl)phosphine (5.1 mg, 0.022 mmol) 
and 1-decyne (51 μL, 0.28 mmol) in toluene (2 mL) was added the first portion of acetic acid (32 
μL, 0.56 mmol). The mixture was heated to 80 °C and stirred for 1 h. The second portion of acetic 
acid (32 μL, 0.56 mmol) and the newly formed macrolactone (78 mg, 0.30 mmol) in toluene (1 
mL) were added into the reaction through syringe. The reaction was stirred at 80 °C for 3.5 h. Then 
crude mixture was loaded onto a small plug of silica gel and eluted with EtOAc. The filtrate was 
concentrated and the residue was purified by flash chromatography (hexanes:EtOAc = 40:1 to 
10:1) to give enol acetate 2.25 (59 mg, 61%) as a yellowish oil. 1H NMR (400 MHz, CDCl3)  
4.89 (d, 1H, J = 1.2 Hz), 4.85 (d, 1H, J = 1.2 Hz), 4.64-4.58 (m, 1H), 4.44 (ddt, 1H, J = 2.0, 6.4, 
12.8 Hz), 4.25 (ddd, 1H, J = 2.8, 8.0, 11.2 Hz), 4.12-4.07 (m, 1H), 2.71 (dd, 1H, J = 4.8, 14.0 Hz), 
2.50 (d, 2H, J = 6.4 Hz), 2.41 (dd, 1H, J = 6.8, 14.0 Hz), 2.30 (td, 2H, J = 1.6, 6.0 Hz), 2.15 (s, 
3H), 1.80-1.45 (m, 8H), 1.36 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3)  171.8, 169.2, 
152.8, 104.2, 87.2, 80.1, 69.8, 65.6, 62.5, 40.0, 39.8, 27.4, 26.8, 26.7, 26.0, 22.6, 21.4, 18.3; IR 
(neat) 2933, 2859, 1756, 1733, 1668, 1434, 1370, 1332, 1194, 1091, 1050, 1021, 877 cm-1; HRMS 
(ESI) m/z calcd for C18H27O5 [M]
+ 323.1858, found 323.1856. 
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Macrolactone substrate 2.24 
Similar procedure with the preparation of 2.25. 1H NMR (400 MHz, CDCl3) 
 4.88 (s, 1H), 4.83 (d, 1H, J = 1.2 Hz), 4.50 (ddt, 1H, J = 2.0, 6.4, 12.8 Hz), 
4.35-4.26 (m, 2H), 4.16 (td, 1H, J = 2.4, 11.6 Hz), 2.67 (dd, 1H, J = 3.2, 15.2 
Hz), 2.43-2.37 (m, 3H), 2.30-2.18 (m, 3H), 2.14 (s, 3H), 1.71-1.57 (m, 4H), 1.54-1.46 (m, 4H), 
1.37 (d, 3H, J = 6.4 Hz); 13C NMR (100 MHz, CDCl3)  173.7, 169.3, 153.4, 103.8, 86.9, 80.3, 
69.1, 61.9, 60.8, 38.1, 34.4, 31.4, 27.1, 26.8, 24.3, 22.8, 21.4, 18.2; IR (neat) 2933, 2862, 1754, 
1731, 1667, 1436, 1369, 1332, 1202, 1085, 1021, 966, 874 cm-1; HRMS (ESI) m/z calcd for 
C18H26O5Na [M+Na]
+ 345.1678, found 345.1668.  
 
Trans-2-(4-Methoxyphenyl)-6-(non-1-yn-1-yl)tetrahydro-4H-pyran-4-one (2.59a) 
To a suspension of substrate 2.12 (152 mg, 0.410 mmol), 2,6-
dichloropypyridine (241 mg, 1.60 mmol), and 4 Å molecular sieves 
(304 mg) in anhydrous DCE (4 mL) was added DDQ (186 mg, 0.820 
mmol) in one portion at rt. The mixture was stirred at rt for 1 h, then was quenched with NEt3 (0.1 
mL). The mixture was loaded directly onto a short plug of silica gel and eluted with CH2Cl2 and 
EtOAc. The filtrate was concentrated and the residue was purified by flash chromatography 
(hexanes:EtOAc = 30:1 to 15:1) to give the cyclized products (97 mg, total mass, trans-isomer/cis-
isomer = 2.8/1, 72% total yield). 2.59a: 1H NMR (300 MHz, CDCl3)  7.35-7.30 (m, 2H), 6.94-
6.89 (m, 2H), 5.26 (dd, 1H, J = 5.4, 8.4 Hz), 5.18 (ddt, 1H, J = 1.5, 1.8, 6.6 Hz), 3.82 (s, 3H), 2.81 
(dd, 1H, J = 6.9, 14.1 Hz), 2.64-2.61 (m, 2H), 2.53 (d, 1H, J = 14.1 Hz), 2.23 (td, 2H, J = 2.1, 6.9 
Hz), 1.54-1.47 (m, 2H), 1.40-1.26 (m, 8H), 0.89 (t, 3H, J = 6.9 Hz); 13C NMR (100 MHz, CDCl3) 
 205.3, 159.7, 132.8, 127.7, 114.2, 90.6, 76.6, 73.7, 65.8, 55.5, 49.4, 47.6, 31.9, 29.0, 29.0, 28.7, 
  
 
 
117 
22.8, 18.9, 14.3; IR (neat) 2929, 2856, 1724, 1613, 1515, 1463, 1367, 1334, 1304, 1248, 1177, 
1104, 1054, 1035, 946, 829 cm-1; HRMS (ESI) m/z calcd for C21H29O3 [M]
+ 329.2117, found 
329.2116. 
 
Cis-2-(4-Methoxyphenyl)-6-(non-1-yn-1-yl)tetrahydro-4H-pyran-4-one (2.59b) 
1H NMR (300 MHz, CDCl3)  7.35-7.29 (m, 2H), 6.93-6.88 (m, 2H), 
4.58 (dd, 1H, J = 3.3, 10.8 Hz), 4.53 (ddt, 1H, J = 1.8, 3.3, 11.1 Hz), 
3.81 (s, 3H), 2.80-2.54 (m, 4H), 2.23 (td, 2H, J = 2.1, 7.2 Hz), 1.55-
1.47 (m, 2H), 1.38-1.26 (m, 8H), 0.89 (t, 3H, J = 6.9 Hz); 13C NMR (100 MHz, CDCl3)  205.5, 
159.8, 132.4, 127.7, 114.2, 88.0, 78.6, 67.8, 55.6, 53.6, 49.4, 48.5, 31.9, 29.0, 29.0, 28.6, 22.8, 
19.0, 14.3; IR (neat) 2926, 2854, 1723, 1613, 1515, 1462, 1344, 1302, 1250, 1177, 1161, 1043, 
952, 830 cm-1; HRMS (ESI) m/z calcd for C21H29O3 [M]
+ 329.2117, found 329.2108. 
 
Trans-2-(Non-1-yn-1-yl)-6-(p-tolyl)tetrahydro-4H-pyran-4-one (trans-2.60) 
To a suspension of substrate 2.13 (29 mg, 0.08 mmol), 2,6-
dichloropypyridine (47 mg, 0.32 mmol), 4 Å molecular sieves (57 mg) 
in anhydrous DCE (1 mL) was added DDQ (36 mg, 0.16 mmol) in one 
portion at rt. The mixture was stirred at rt for 6 h, then was quenched with NEt3 (0.1 mL). The 
mixture was loaded directly onto a short plug of silica gel and eluted with CH2Cl2 and EtOAc. The 
filtrate was concentrated and the residue was purified by flash chromatography to give the desired 
product (18 mg, total mass, trans/cis = 3.3/1, 72% total yield) as yellowish oil. trans-2.60: 1H 
NMR (400 MHz, CDCl3)  7.28 (d, 2H, J = 8.4 Hz), 7.20 (d, 2H, J = 8.0 Hz), 5.27 (dd, 1H, J = 
4.0, 10.0 Hz), 5.20 (ddt, 1H, J = 1.6, 2.4, 5.2 Hz), 2.89 (dd, 1H, J = 6.8, 14.0 Hz), 2.68-2.57 (m, 
2H), 2.54 (dt, 1H, J = 1.6, 14.4 Hz), 2.36 (s, 3H), 2.23 (td, 2H, J = 2.0, 7.2 Hz), 1.55-1.47 (m, 2H), 
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1.39-1.33 (m, 2H), 1.31-1.28 (m, 6H), 0.89 (t, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3)  
205.3, 138.1, 137.7, 129.5, 126.2, 90.7, 76.5, 73.9, 65.8, 49.5, 47.6, 32.0, 29.0, 29.0, 28.7, 22.8, 
21.4, 18.9, 14.3; IR (neat) 2927, 2856, 1724, 1516, 1459, 1415, 1365, 1333, 1225, 1161, 1104, 
1055, 1021, 945, 809 cm-1; HRMS (ESI) m/z calcd for C21H29O2 [M]
+ 313.2168, found 313.2161. 
 
Cis-2-(Non-1-yn-1-yl)-6-(p-tolyl)tetrahydro-4H-pyran-4-one (cis-2.60) 
1H NMR (400 MHz, CDCl3)  7.29 (d, 2H, J = 8.0 Hz), 7.19 (d, 2H, J 
= 8.0 Hz), 4.60 (dd, 1H, J = 3.2, 10.8 Hz), 4.53 (ddt, 1H, J = 2.0, 2.8, 
8.4 Hz), 2.76 (dd, 1H, J = 11.6, 14.4 Hz), 2.68-2.57 (m, 3H), 2.35 (s, 
3H), 2.24 (td, 2H, J = 2.0, 7.2 Hz), 1.57-1.49 (m, 2H), 1.37-1.33 (m, 2H), 1.31-1.28 (m, 6H), 0.89 
(t, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3)  205.5, 138.3, 137.3, 129.5, 126.2, 88.0, 78.8, 
77.6, 67.8, 49.4, 48.5, 31.9, 29.0, 29.0, 28.6, 22.8, 21.4, 19.0, 14.3; IR (neat) 2927, 2856, 1724, 
1516, 1460, 1380, 1344, 1305, 1246, 1161, 1135, 1054, 953, 811, 719 cm-1; HRMS (ESI) m/z calcd 
for C21H29O2 [M]
+ 313.2168, found 313.2169. 
 
Ethyl 3-(6-(4-methoxyphenyl)-4-oxotetrahydro-2H-pyran-2-yl)propiolate (2.61) 
To a suspension of substrate 2.14 (56 mg, 0.16 mmol), 2,6-
dichloropypyridine (96 mg, 0.65 mmol), 4 Å molecular sieves (113 
mg) in anhydrous DCE (1.6 mL) was added DDQ (75 mg, 0.33 mmol) 
in one portion at rt. The mixture was stirred at rt for 9.5 h, then was quenched with NEt3 (0.1 mL). 
The mixture was loaded directly onto a short plug of silica gel and eluted with CH2Cl2 and EtOAc. 
The filtrate was concentrated and the residue was purified by flash chromatography 
(hexanes:EtOAc = 10:1 to 8:1) to give the desired product (22 mg, total mass, trans/cis = 1.6/1, 
45% total yield) as colorless oil. Mixture of trans-2.61 and cis-2.61: 1H NMR (400 MHz, CDCl3) 
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 7.34-7.30 (m, 2H), 6.94-6.91 (m, 2H), 5.29 (dd, 0.6H, J = 2.0, 7.6 Hz), 5.22 (dd, 0.6H, J = 5.2, 
9.2 Hz), 4.68 (dd, 0.4H, J = 3.2, 11.6 Hz), 4.62 (dd, 0.4H, J = 3.2, 10.8 Hz), 4.25 (q, 2H, J = 7.2 
Hz), 3.82 (s, 1.8H), 3.82 (s, 1.2H), 2.94 (dd, 0.6H, J = 7.6, 14.8 Hz), 2.82 (dd, 0.4H, J = 12.0, 14.8 
Hz), 2.75-2.62 (m, 3H), 1.33 (t, 1.8H, J = 6.8 Hz), 1.31 (t, 1.2H, J = 6.8 Hz); 13C NMR (100 MHz, 
CDCl3)  203.6, 203.5, 160.0, 159.9, 153.1, 152.9, 131.8, 131.7, 127.7, 127.5, 114.3, 83.0, 82.6, 
80.2, 79.1, 78.0, 74.8, 66.7, 64.9, 62.6, 62.6, 55.5, 49.2, 49.0, 46.5, 45.7, 14.2; IR (neat) 2980, 
2934, 2840, 1716, 1643, 1613, 1587, 1516, 1464, 1367, 1337, 1302, 1252, 1178, 1152, 1059, 1033, 
950, 833, 751 cm-1; HRMS (ESI) m/z calcd for C17H19O5 [M]
+ 303.1232, found 303.1238. 
 
Macrocyclic benzylic ether 2.62 
To a suspension of macrolactone substrate 2.15 (46 mg, 0.12 mmol), 2,6-
dichloropypyridine (77 mg, 0.52 mmol), 4 Å molecular sieves (92 mg) in 
anhydrous DCE (1.3 mL) was added DDQ (59 mg, 0.26 mmol) in one 
portion at rt. The mixture was stirred at rt for 4 h, then was quenched with NEt3 (0.1 mL). The 
mixture was loaded directly onto a short plug of silica gel and eluted with CH2Cl2 and EtOAc. The 
filtrate was concentrated and the residue was purified by flash chromatography (hexanes:EtOAc = 
5:1 to 3:1) to give the desired product (29 mg, 72%) as yellow oil. 1H NMR (400 MHz, CDCl3)  
7.34 (d, 1H, J = 8.4 Hz), 6.81 (dd, 1H, J = 2.8, 8.8 Hz), 6.76 (d, 1H, J = 2.8 Hz), 5.36 (dd, 1H, J = 
2.0, 12.4 Hz), 5.10 (dt, 1H, J = 1.2, 7.2 Hz), 4.84 (dd, 1H, J = 3.2, 15.2 Hz), 4.69 (dd, 1H, J = 1.6, 
14.8 Hz), 3.81 (s, 3H), 2.98-2.81 (m, 3H), 2.62-2.49 (m, 4H), 2.40 (ddd, 1H, J = 3.6, 11.2, 12.4 
Hz), 2.01-1.79 (m, 2H); 13C NMR (100 MHz, CDCl3)  204.7, 172.6, 159.9, 142.5, 128.3, 127.4, 
115.8, 111.8, 84.2, 82.6, 69.2, 65.5, 55.2, 51.7, 46.8, 46.2, 34.5, 31.4, 29.1; IR (neat) 2923, 2851, 
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1740, 1611, 1579, 1504, 1441, 1368, 1334, 1275, 1255, 1233, 1158, 1131, 1110, 1048, 1024, 996, 
952, 818, 733 cm-1; HRMS (ESI) m/z calcd for C19H20O5Na [M+Na]
+ 351.1208, found 351.1199. 
 
Macrocyclic benzylic ether 2.63 
To a suspension of macrolactone substrate 2.16 (32 mg, 0.080 mmol), 2,6-
dichloropypyridine (48 mg, 0.32 mmol), 4 Å molecular sieves (65 mg) in 
anhydrous DCE (0.85 mL) was added DDQ (37 mg, 0.16 mmol) in one 
portion at rt. The mixture was stirred at rt for 1 h, then was quenched with 
NEt3 (0.1 mL). The mixture was loaded directly onto a short plug of silica gel and eluted with 
CH2Cl2 and EtOAc. The filtrate was concentrated and the residue was purified by flash 
chromatography (hexanes:EtOAc = 8:1 to 3:1) to give the desired product (23 mg, 81%) as yellow 
oil. 1H NMR (400 MHz, CDCl3)  7.40 (d, 1H, J = 8.8 Hz), 6.80 (dd, 1H, J = 2.8, 8.4 Hz), 6.71 
(d, 1H, J = 2.8 Hz), 5.43 (dd, 1H, J = 2.8, 11.6 Hz), (d, 1H, J = 6.8 Hz), 4.83 (dd, 1H, J = 2.0, 15.2 
Hz), 4.72 (dd, 1H, J = 3.2, 15.6 Hz), 3.80 (s, 3H), 2.92 (dd, 1H, J = 7.2, 14.4 Hz), 2.73-2.52 (m, 
5H), 2.39 (t, 2H, J = 6.4 Hz), 1.81-1.75 (m, 1H), 1.73-1.57 (m, 3H), 1.53-1.46 (m, 2H); 13C NMR 
(100 MHz, CDCl3)  204.9, 172.7, 159.7, 142.0, 130.0, 127.2, 115.0, 111.8, 83.2, 82.5, 70.7, 65.7, 
55.4, 51.6, 49.1, 46.6, 33.7, 33.2, 30.7, 28.6, 24.4; IR (neat) 2934, 2861, 1739, 1610, 1580, 1503, 
1458, 1371, 1333, 1266, 1229, 1158, 1113, 1056, 1023, 984, 947, 816, 731 cm-1; HRMS (ESI) m/z 
calcd for C21H24O5Na [M+Na]
+ 379.1521, found 379.1543. 
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Macrocyclic benzylic ether trans-2.64 
To a suspension of macrolactone substrate 2.17 (50 mg, 0.11 mmol), 2,6-
dichloropypyridine (63 mg, 0.42 mmol), 4 Å molecular sieves (100 mg) in 
anhydrous DCE (1.3 mL) was added DDQ (48 mg, 0.21 mmol) in one 
portion at rt. The mixture was stirred at rt for 40 min, then was quenched 
NEt3 (0.1 mL). The mixture was loaded directly onto a short plug of silica gel and eluted with 
CH2Cl2 and EtOAc. The filtrate was concentrated and the residue was purified by flash 
chromatography (hexanes:EtOAc = 15:1 to 5:1) to give the desired product (30 mg, trans/cis = 
6/1, 65% total yield) as yellow oil.1H NMR (400 MHz, CDCl3)  7.39 (d, 1H, J = 8.4 Hz), 6.80 
(dd, 1H, J = 2.8, 8.4 Hz), 6.74 (d, 1H, J = 2.8 Hz), 5.47 (dd, 1H, J = 2.8, 11.2 Hz), 5.25 (d, 1H, J 
= 6.0 Hz), 4.80 (dd, 1H, J = 1.2, 16.0 Hz), 4.70 (dd, 1H, J = 2.0, 16.0 Hz), 3.81 (s, 3H), 2.94 (dd, 
1H, J = 7.2, 14.0 Hz), 2.77-2.70 (m, 2H), 2.63-2.55 (m, 3H), 2.39 (t, 2H, J = 6.8 Hz), 1.72-1.58 
(m, 4H), 1.41-1.26 (m, 12H); 13C NMR (100 MHz, CDCl3)  204.9, 173.4, 159.6, 142.5, 129.8, 
127.7, 115.3, 111.8, 83.6, 83.4, 70.6, 65.5, 55.5, 52.3, 48.9, 46.9, 33.7, 33.2, 31.8, 29.7, 28.3, 27.5, 
27.2, 26.9, 26.2, 24.1; IR (neat) 2928, 2855, 1739, 1610, 1579, 1504, 1461, 1335, 1230, 1160, 
1052, 946, 816, 732, 705 cm-1; C26H35O5 [M]
+ 427.2484, found 427.2493. 
 
Macrocyclic allylic ether 2.65 
To a suspension of macrolactone substrate 2.18 (36 mg, 0.11 mmol), 2,6-
dichloropypyridine (100 mg, 0.674 mmol), LiClO4 (3.0 mg, 0.028 mmol), 4 Å 
molecular sieves (72 mg) in anhydrous DCE (1.4 mL) was added DDQ (76 mg, 
0.34 mmol) in one portion at rt. The mixture was stirred at rt for 23 h, then 1.0 equiv. DDQ (26 
mg , 0.11 mmol) was added. The resulting mixture was stirred for 3 h at rt, then was quenched 
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with NEt3 (0.1 mL). The black mixture was loaded directly onto a short plug of silica gel and 
eluted with CH2Cl2 and EtOAc. The filtrate was concentrated and the residue was purified by flash 
chromatography (hexanes:EtOAc = 10:1 to 6:1) to give the desired trans-product 2.65 (17 mg, 
54%). 1H NMR (400 MHz, CDCl3)  5.31 (dd, 1H, J = 1.2, 8.8 Hz), 5.08 (dd, 1H, J = 1.2, 7.6 Hz), 
4.95 (td, 1H, J = 5.6, 8.8 Hz), 4.28-4.23 (m, 1H), 4.14-4.09 (m, 1H), 2.78 (dd, 1H, J = 7.2, 14.0 
Hz), 2.57-2.32 (m, 9H), 1.90-1.83 (m, 2H), 1.80 (d, 3H, J = 1.2 Hz); 13C NMR (100 MHz, CDCl3) 
 205.4, 172.8, 142.7, 125.4, 89.1, 77.8, 68.5, 65.9, 64.4, 48.2, 47.0, 34.7, 29.1, 26.2, 23.5, 16.9; 
IR (neat) 2922, 2852, 1731, 1436, 1380, 1332, 1249, 1154, 1106, 1051, 937, 893 cm-1; HRMS 
(ESI) m/z calcd for C16H20O4Na [M+Na]
+ 299.1259, found 299.1248. To a suspension of 
macrocyclic substrate 2.44 (20 mg, 0.062 mmol), 2,6-dichloropypyridine (55 mg, 0.37 mmol), 
LiClO4 (1.7 mg, 0.016 mmol), 4 Å molecular sieves (40 mg) in anhydrous DCE (0.8 mL) was 
added DDQ (42 mg, 0.19 mmol) in one portion at rt. The mixture was stirred at rt for 43 h, then 
was quenched with NEt3 (0.1 mL). The black mixture was loaded directly onto a short plug of 
silica gel and eluted with CH2Cl2 and EtOAc. The filtrate was concentrated and the residue was 
purified by flash chromatography to give the trans-product 2.65 (6.0 mg, 35%). 
 
Macrocyclic allylic ether 2.66 
To a suspension of macrolactone 2.19 (38 mg, 0.096 mmol), 2,6-
dichloropypyridine (57 mg, 0.38 mmol), LiClO4 (3 mg, 0.03 mmol), and 4 Å 
molecular sieves (76 mg) in anhydrous DCE (1 mL) was added DDQ (44 mg, 
0.19 mmol) in one portion at rt. The mixture was stirred at rt for 15 min, then was quenched with 
NEt3 (0.1 mL). The mixture was loaded directly onto a short plug of silica gel and eluted with 
CH2Cl2 and EtOAc. The filtrate was concentrated and the residue was purified by flash 
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chromatography (hexanes:EtOAc = 8:1 to 4:1) to give the desired product 2.66 (24 mg, 72%). 22: 
1H NMR (400 MHz, CDCl3)  7.40-7.28 (m, 5H), 5.73 (d, 1H, J = 8.4 Hz), 5.14-5.10 (m, 2H), 
4.37-4.24 (m, 2H), 2.83 (dd, 1H, J =7.2, 14.0 Hz), 2.63 (td, 2H, J = 4.0, 7.6 Hz), 2.56-2.37 (m, 
6H), 2.32-2.25 (m, 1H), 1.93-1.81 (m, 2H), 1.80-1.68 (m, 2H); 13C NMR (100 MHz, CDCl3)  
204.9, 173.6, 144.6, 141.2, 128.7, 128.0, 127.3, 126.9, 88.5, 78.3, 69.2, 65.9, 63.4, 48.2, 47.2, 33.9, 
29.5, 25.8, 23.9, 16.1; IR (neat) 2926, 1726, 1493, 1444, 1358, 1334, 1246, 1227, 1157, 1112, 
1047, 937, 887, 764 cm-1; HRMS (ESI) m/z calcd for C22H24O4Na [M+Na]
+ 375.1572, found 
375.1584. 
 
Macrocyclic propargylic ether 2.67 
To a suspension of macrolactone substrate 2.20 (177 mg, 0.60 mmol, 2.20/enol 
acetate regioisomer = 8/1), 2,6-dichloropypyridine (888 mg, 6.0 mmol), LiClO4 
(51 mg, 0.48 mmol), 4 Å molecular sieves (355 mg) in anhydrous DCE (7 mL) 
was added DDQ (817 mg, 3.6 mmol) in one portion at rt. The mixture was stirred at 50 °C for 41.5 
h, then was added DDQ (0.27 g 1.2 mmol) and LiClO4 (19 mg, 0.18 mmol). The resulting mixture 
was stirred at the same temperature for 20.5 h, then was quenched with NEt3 (1.5 mL). The mixture 
was loaded directly onto a short plug of silica gel and eluted with CH2Cl2 and EtOAc. The filtrate 
was concentrated and the residue was purified by flash chromatography (hexanes:EtOAc = 10:1 
to 4:1) to give the desired product 2.67 (49 mg, 36%) as colorless crystal. 1H NMR (400 MHz, 
CDCl3)  5.09-5.07 (m, 1H), 4.62-4.55 (m, 1H), 4.39-4.33 (m, 1H), 4.06 (dt, 1H, J = 4.0, 10.8 Hz), 
2.74 (dd, 1H, J = 8.0, 14.8 Hz), 2.49 (ddd, 1H, J = 3.2, 6.8, 14.0 Hz), 2.45 (dt, 1H, J = 1.2, 14.4 
Hz), 2.42-2.37 (m, 2H), 2.33-2.18 (m, 2H), 2.04 (ddt, 1H, J = 2.0, 11.2, 16.8 Hz), 1.96-1.79 (m, 
4H), 1.76-1.66 (m, 1H), 1.51-1.40 (m, 1H); 13C NMR (125 MHz, CDCl3)  205.4, 173.2, 89.0, 
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77.8, 67.2, 65.7, 60.0, 48.4, 46.2, 35.2, 34.4, 28.1, 24.7, 18.8; IR (neat) 2921, 2851, 1724, 1704, 
1334, 1258, 1230, 1152, 1109, 1057, 1026, 860, 780  cm-1; HRMS (ESI) m/z calcd for C14H18O4Na 
[M+Na]+ 273.1103, found 273.1097. 
 
Macrocyclic propargylic ether trans-2.70 
To a suspension of macrolactone substrate 2.21 (30 mg, 0.090 mmol), 2,6-
dichloropypyridine (53 mg, 0.36 mmol), LiClO4 (2.8 mg, 0.03 mmol), 4 Å 
molecular sieves (60 mg) in anhydrous DCE (1 mL) was added DDQ (81 mg, 
0.36 mmol) in one portion at rt. The mixture was stirred at 40 °C for 60 h, then quenched with 
NEt3. The mixture was loaded directly onto a short plug of silica gel and eluted with CH2Cl2 and 
EtOAc. The filtrate was concentrated and the residue was purified by flash chromatography 
(hexanes:EtOAc = 10:1 to 4:1) to give both trans- and cis-products (12 mg total mass, trans/cis = 
2/1, 46% total yield) as pale yellow oil. Trans-2.70: 1H NMR (400 MHz, CDCl3)  5.11 (dd, 1H, 
J = 1.6, 6.8), 4.48 (ddt, 1H, J = 2.4, 8.8, 13.6 Hz), 4.26-4.17 (m, 2H), 2.80 (dd, 1H, J = 6.8, 13.6 
Hz), 2.49-2.43 (m, 2H), 2.34 (t, 2H, J = 6.8 Hz), 2.32-2.29 (m, 2H), 2.21 (dd, 1H, J = 7.2, 14.0 
Hz), 2.04-1.96 (m, 1H), 1.90-1.82 (m, 1H), 1.71 (p, 2H, J = 6.8 Hz), 1.51-1.44 (m, 4H), 1.41-1.28 
(m, 4H); 13C NMR (100 MHz, CDCl3)  205.0, 174.0, 90.0, 77.1, 68.3, 66.0, 59.7, 47.9, 47.8, 35.7, 
33.6, 27.8, 26.8, 26.7, 26.0, 24.4, 18.0; IR (neat) 2929, 2857, 1729, 1459, 1337, 1226, 1187, 1147, 
1097, 1053, 980, 932, 863 cm-1; HRMS (ESI) m/z calcd for C17H25O4 [M]
+ 293.1753, found 
292.1720. 
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Macrocyclic propargylic ether cis-2.70 
1H NMR (400 MHz, CDCl3)  4.38-4.21 (m, 3H), 3.78 (ddt, 1H, J = 2.4, 9.2, 
11.2 Hz), 2.63-2.52 (m, 2H), 2.46-2.38 (m, 2H), 2.36-2.24 (m, 4H), 2.13-2.04 
(m, 1H), 1.85-1.68 (m, 3H), 1.60-1.34 (m, 8H); 13C NMR (100 MHz, CDCl3) 
 205.3, 174.4, 86.7, 78.8, 67.5, 62.1, 48.1, 47.7, 35.2, 33.7, 26.4, 25.7, 24.8, 24.5, 22.5, 17.9; 
HRMS (ESI) m/z calcd for C17H24O4 [M]
+ 292.1675, found 292.1700. 
 
Macrocyclic propargylic ether 2.71 
To a suspension of macrolactone substrate 2.22 (36 mg, 0.12 mmol), 2,6-
dichloropypyridine (72 mg, 0.49 mmol), LiClO4 (3.9 mg, 0.037 mmol), 4 Å 
molecular sieves (72 mg) in anhydrous DCE (1.5 mL) was added DDQ (56 mg, 
0.25 mmol) in one portion at rt. The mixture was stirred at rt for 24 h, then was added DDQ (56 
mg, 0.25 mmol). The resulting mixture was stirred for 53 h at 40 °C, then quenched with NEt3 (0.1 
mL). The black mixture was loaded directly onto a short plug of silica gel and eluted with CH2Cl2 
and EtOAc. The filtrate was concentrated and the residue was purified by flash chromatography 
to give the desired product 2.71 (11 mg, 36%). 1H NMR (400 MHz, CDCl3)  5.06 (app d, 1H, J 
= 7.2 Hz), 4.57 (ddd, 1H, J = 3.2, 4.8, 11.6 Hz), 4.42 (ddt, 1H, J = 2.4, 10.4, 11.6 Hz), 3.95 (td, 
1H, J = 1.6, 11.2 Hz), 2.73 (dd, 1H, J = 7.6, 14.4 Hz), 2.52 (ddd, 1H, J = 2.8, 8.8, 16.8 Hz), 2.14 
(app d, 2H, J = 14.4 Hz), 2.38-2.17 (m, 4H), 2.06-1.97 (m, 1H), 1.92-1.77 (m, 2H), 1.65-1.57 (m, 
3H); 13C NMR (100 MHz, CDCl3)  205.7, 173.8, 87.6, 78.6, 70.9, 67.0, 65.6, 49.2, 47.0, 35.5, 
33.0, 23.3, 21.1, 18.8; IR (neat) 2922, 2852, 1727, 1554, 1452, 1390, 1341, 1230, 1196, 1159, 
1110, 1052, 967, 910 cm-1; HRMS (ESI) m/z calcd for C14H19O4 [M]
+ 251.1283, found 251.1314. 
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Macrocyclic propargylic ether 2.72 
To a suspension of macrolactone substrate 2.23 (51 mg, 0.17 mmol, 2.23/enol 
acetate regioisomer = 4/1), 2,6-dichloropypyridine (102 mg, 0.690 mmol), 
LiClO4 (5.5 mg, 0.050 mmol), 4 Å molecular sieves (112 mg) in anhydrous DCE 
(2 mL) was added DDQ (157 mg, 0.69 mmol) in one portion at rt. The mixture was stirred at 50 
°C for 119.5 h, then was added DDQ (78 mg, 0.35 mmol). After stirring at the same temperature 
for a period of 54.5 h, another 78 mg DDQ (0.35 mmol) was added. The resulting mixture was 
stirred for 18 h at 50 °C, then was quenched with NEt3 (0.5 mL). The mixture was loaded directly 
onto a short plug of silica gel and eluted with CH2Cl2 and EtOAc. The filtrate was concentrated 
and purified by flash chromatography (hexanes:EtOAc = 10:1 to 4:1) to give the desired trans-
product 2.72 (8.0 mg, 24% extrapolated yield) as white foam. 1H NMR (400 MHz, CDCl3)  5.11 
(dd, 1H, J = 0.8, 8.0 Hz), 4.85 (ddt, 1H, J = 3.2, 9.6, 11.2 Hz), 4.44-4.38 (m, 1H), 3.91 (dt, 1H, J 
= 4.0, 11.2 Hz), 2.74 (dd, 1H, J = 8.0, 15.2 Hz), 2.61-2.50 (m, 2H), 2.47-2.35 (m, 3H), 2.30-2.15 
(m, 2H), 1.74-1.55 (m, 5H), 1.53-1.44 (m, 1H); 13C NMR (100 MHz, CDCl3)  204.7, 170.1, 88.6, 
78.6, 69.7, 65.7, 63.8, 48.0, 45.7, 42.2, 27.4, 26.4, 23.3, 18.5; IR (neat) 2928, 2863, 1818, 1731, 
1420, 1379, 1337, 1313, 1272, 1232, 1153, 1110, 1066, 1040, 972, 940, 868, 823 cm-1; HRMS 
(ESI) m/z calcd for C14H18O4Na [M+Na]
+ 273.1105, found 273.1097. 
 
Macrocyclic propargylic ether 2.73 
To a suspension of macrolactone substrate 2.25 (40 mg, 0.12 mmol), 2,6-
dichloropypyridine (73 mg, 0.50 mmol), LiClO4 (4.0 mg, 0.037 mmol), 4 Å 
molecular sieves (80 mg) in anhydrous DCE (1.5 mL) was added DDQ (56 mg, 
0.25 mmol) in one portion at rt. The mixture was stirred at rt for 8 h, then was warmed to 30 °C. 
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After the reaction was stirred at 30 °C for 26 h, 27 mg DDQ (0.12 mmol) was added. The resulting 
mixture was stirred for 14 h at 30 °C, then quenched with NEt3. The black mixture was loaded 
directly onto a short plug of silica gel and eluted with CH2Cl2 and EtOAc. The filtrate was 
concentrated and the residue was purified by flash chromatography to give the desired product 
2.73 (13.4 mg, 39%). 1H NMR (400 MHz, CDCl3)  4.50-4.37 (m, 2H), 4.05 (dt, 1H, J = 4.0, 11.2 
Hz), 2.53 (dd, 1H, J = 2.0, 14.0 Hz), 2.48-2.36 (m, 3H), 2.36-2.25 (m. 2H), 2.24-2.20 (m, 1H), 
2.18-2.12 (m, 1H), 1.93-1.88 (m, 2H), 1.72-1.61 (m, 2H), 1.58 (s, 1H), 1.56-1.41 (m, 4H); 13C 
NMR (100 MHz, CDCl3)  205.8, 173.9, 87.5, 80.7, 72.4, 68.3, 60.3, 54.0, 47.5, 34.9, 34.7, 30.2, 
27.2, 26.8, 24.8, 18.1; IR (neat) 2928, 2859, 1728, 1441, 1357, 1303, 1254, 1166, 1142, 1085, 
1033, 1001, 865, 784 cm-1; HRMS (EI) m/z calcd for C16H23O4 [M]
+ 279.1596, found 279.1582.  
 
Macrocyclic propargylic ether 2.74 
To a suspension of macrolactone substrate 2.25 (36 mg, 0.11 mmol), 2,6-
dichloropypyridine (66 mg, 0.45 mmol), LiClO4 (3.6 mg, 0.034 mmol), 4 Å 
molecular sieves (72 mg) in anhydrous DCE (1.4 mL) was added DDQ (51 mg, 
0.22 mmol) in one portion at rt. The mixture was stirred at rt for 10 h, then was warmed to 30 °C. 
After stirring at 30 °C for 43 h, 25 mg DDQ (0.11 mmol) was added. The resulting mixture was 
stirred for 43 h at 30 °C, then quenched with NEt3 (0.1 mL). The black mixture was loaded directly 
onto a short plug of silica gel and eluted with CH2Cl2 and EtOAc. The filtrate was concentrated 
and the residue was purified by flash chromatography (hexanes:EtOAc = 10:1 to 8:1) to give the 
desired product 2.74 (12.4 mg, 40%). 1H NMR (400 MHz, CDCl3)  4.80-4.73 (m, 1H), 4.21-4.07 
(m, 2H), 2.57 (d, 1H, J = 1.6 Hz), 2.56 (s, 1H), 2.52 (dd, 1H, J = 2.0, 14.0 Hz), 2.43 (d, 1H, J = 
13.6 Hz), 2.39 (dt, 1H, J = 2.0, 14.0 Hz), 2.27-2.20 (m, 3H), 1.84-1.75 (m, 1H), 1.68-1.62 (m, 3H), 
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1.59 (s, 3H), 1.56-1.39 (m, 4H); 13C NMR (100 MHz, CDCl3)  205.2, 170.3, 87.3, 80.7, 72.6, 
70.2, 64.5, 53.6, 47.1, 42.7, 30.6, 27.6, 26.7, 26.3, 24.8, 17.5; IR (neat) 2920, 2858, 1731, 1468, 
1449, 1426, 1375, 1316, 1275, 1259, 1204, 1162, 1129, 1100, 1071, 1029, 968 cm-1; HRMS (EI) 
m/z calcd for C16H22O4 [M]
+ 278.1518, found 278.1505. 
 
Macrocyclic E-alkene 2.75 
To a solution of macrocyclic benzylic ether 2.62 (14 mg, 0.044 mmol) in 
dry CH2Cl2 (0.1 mL) was added HSi(OEt)3 (9.7 µL, 0.053 mmol) under 
argon atmosphere. The resulting solution was cooled to 0 °C and added 
[Cp*Ru(NCCH3)3]PF6 (cat.). The reaction was warmed to rt and stirred at rt 
for 30 min before diluted with dry Et2O (2 mL). The resulting mixture was filtered through a plug 
of Florisil® (2 cm), wash with dry Et2O (2 mL), and concentrated in vacuo. The residue was re-
dissolved in dry THF (0.3 mL). Under argon atmosphere, CuI (1mg, cat.) was added, followed by 
the addition of TBAF (84 µL, 0.084 mmol) at rt. The resulting mixture was stirred at rt for 4 h, 
then was diluted with EtOAc, filtered through a pad of silica gel and the filtrate was concentrated 
in vacuum. The residue was purified by flash chromatography (hexanes:EtOAc = 6:1 to 4:1) to 
give the desired alkene 2.75 (7.2 mg, 49%) as yellowish oil. 1H NMR (400 MHz, C6D6)  7.25 (d, 
1H, J = 8.4 Hz), 6.68 (dd, 1H, J = 2.8, 8.4 Hz), 6.59 (d, 1H, J = 2.8 Hz), 5.92 (ddd, 1H, J = 0.8, 
4.4, 16.0 Hz), 5.81 (dddd, 1H, J = 0.8, 4.4, 5.6, 16.4 Hz), 4.90 (dd, 1H, J = 2.4, 12.0 Hz), 4.44-
4.43 (m, 1H), 4.36 (dd, 1H, J = 6.4, 12.4 Hz), 4.07 (ddt, 1H, J = 1.2, 4.4, 12.0 Hz), 2.61-2.48 (m, 
2H), 2.43-2.29 (m, 4H), 2.04 (ddd, 1H, J = 3.2, 9.6, 12.4 Hz), 1.94 (ddd, 1H, J = 3.2, 9.6, 12.4 Hz), 
1.62-1.58 (m, 1H), 1.50-1.43 (m, 1H); 13C NMR (100 MHz, C6D6)  205.0, 172.8, 160.4, 142.4, 
135.7, 131.9, 130.6, 116.0, 112.3, 72.6, 67.6, 61.5, 55.1, 48.6, 43.5, 34.8, 32.1, 30.6, 29.2; IR (neat) 
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2923, 2852, 1730, 1611, 1579, 1504, 1459, 1375, 1264, 1235, 1156, 1133, 1101, 1042, 995, 954, 
810 cm-1; HRMS (EI) m/z calcd for C19H22O5Na [M+Na]
+ 353.1365, found 353.1374. 
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APPENDIX B 
 
ONE-POT STRATEGY FOR SPIROKETAL SYNTHESIS 
 
General Experimental: Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded on a Bruker Avance 300 spectrometer at 300 MHz and 75 MHz, a Bruker 
Avance 400 spectrometer at 400 MHz and 100 MHz, a Bruker Avance 500 spectrometer at 500 
MHz and 125 MHz. The chemical shifts are reported in parts per million (ppm) on the delta (δ) 
scale. The solvent peak was used as a reference value, for 1H NMR: CDCl3 = 7.27 ppm, C6D6 = 
7.16 ppm, for 13C NMR: CDCl3 = 77.23, C6D6 = 128.4 ppm. Data are reported as follows: (s = 
singlet; d = doublet; t = triplet; q = quartet; qunit = quintet; sept = septet; dd = doublet of doublets; 
ddd = doublet of doublet of doublets; dddd = doublet of doublet of doublet of doublet; td = triplet 
of doublets; dtd = doublet of triplet of doublets; br = broad). High resolution and lowresolution 
mass spectra were recorded on a VG 7070 spectrometer. Infrared (IR) spectra were collected on a 
Mattson Cygnus 100 spectrometer. Samples for IR were prepared as a thin film on a NaCl plate 
by dissolving the compound in CH2Cl2 and then evaporating the CH2Cl2. Tetrahydrofuran and 
diethyl ether were distilled from sodium and benzophenone. Methylene chloride was distilled 
under N2 from CaH2. Analytical TLC was performed on E. Merck pre-coated (25 mm) silica gel 
60F-254 plates. Visualization was done under UV (254 nm). Flash chromatography was done 
using ICN SiliTech 32-63 60 Å silica gel. Reagent grade ethyl acetate, diethyl ether, toluene and 
hexanes (commercial mixture) were purchased from EM Science and used as is for 
chromatography. 
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(E)-8-((4-Methoxybenzyl)oxy)oct-3-en-2-one (3.29) 
To a solution of hex-5-en-1-ol (5.2 mL, 43 mmol) in THF (80 mL) was 
added NaH (60% in mineral oil, 1.7 g, 43 mmol) in one portion at rt. The 
resulting mixture was stirred for 30 min at rt, followed by the addition of nBu4NI (1.6 g, 4.3 mmol) 
and p-methoxybenzyl chloride (5.9 mL, 43 mmol). The reaction mixture was stirred at rt overnight, 
then was quenched with NH4Cl aq. The aqueous layer was extracted with Et2O (3x). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated. The residue was purified by 
flash chromatography (hexanes:EtOAc = 50:1) to afford 1-((hex-5-en-1-yloxy)methyl)-4-
methoxybenzene (9.6 g, quantitative). To a solution of 1-((hex-5-en-1-yloxy)methyl)-4-
methoxybenzene (15.8 g, 71.7 mmol) in CH2Cl2 (250 mL) were added vinylmethylketone (15.1 g, 
215 mmol) and Hoveyda-Grubbs catalyst (2nd generation, 45 mg, 0.072 mmol). The resulting 
solution was stirred at rt for 21 h, then was concentrated directly. The residue was purified by flash 
chromatography (hexanes:EtOAc = 20:1 to 10:1 to 6:1) to afford the desired product (17 g, 91%) 
as an oily liquid. 1H NMR (400 MHz, CDCl3):  7.26 (d, 2H, J = 7.2 Hz), 6.89 (d, 2H, J = 8.4 Hz), 
6.79 (td, 1H, J = 6.8, 16.0 Hz), 6.07 (d, 1H, J = 16.0 Hz), 3.81 (s, 3H), 3.46 (t, 2H, J = 6.0 Hz), 
2.27-2.22 (m, 5H), 1.67-1.53 (m, 4H). 
 
(E)-Triethyl((8-((4-methoxybenzyl)oxy)octa-1,3-dien-2-yl)oxy)silane (3.30) 
To a solution of 3.29 (1.1 g, 4.1 mmol) and NEt3 (1.1 mL, 8.2 mmol) was 
added TESOTf (1.0 mL, 4.5 mmol) dropwise at 0 °C. The resulting solution 
was stirred at 0 °C for 2 h, then was quenched with H2O. The aqueous layer was extracted with 
CH2Cl2 (2x). The combined organic layers were dried over Na2SO4, filtered, and concentrated. The 
residue was purified by flash chromatography (hexanes:EtOAc = 100:1, hexanes contained 1% 
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NEt3) to afford desired product (1.4 g, quantitative) as a colorless oil. 
1H NMR (400 MHz, CDCl3) 
 7.28-7.25 (m, 2H), 6.90-6.87 (m, 2H), 6.00 (td, 1H, J = 6.8, 15.2 Hz), 5.87 (td, 1H, J = 0.8, 15.2 
Hz), 4.44 (s, 2H), 4.21 (d, 2H, J = 12.8 Hz), 3.81 (s, 3H), 3.45 (t, 2H, J = 6.4 Hz), 2.11 (q, 2H, J = 
7.2 Hz), 1.67-1.60 (m, 2H), 1.52-1.45 (m, 2H), 1.00 (t, 9H, J = 8.4 Hz), 0.73 (q, 6H, J = 8.0 Hz); 
1H NMR (400 MHz, CDCl3)  159.3, 155.3, 131.5, 131.0, 129.4, 128.2, 114.0, 93.8, 72.7, 70.1, 
55.5, 32.1, 29.5, 26.0, 7.0, 5.2. 
 
(E)-tert-Butyl((8-((4-methoxybenzyl)oxy)octa-1,3-dien-2-yl)oxy)dimethylsilane (3.31) 
Same procedure with the preparation of 3.30. 1H NMR (400 MHz, CDCl3) 
 7.28-7.26 (m, 2H), 6.90-6.87 (m, 2H), 5.99 (td, 1H, J = 6.8, 15.2 Hz), 5.87 
(d, 1H, J = 15.2 Hz), 4.44 (s, 2H), 4.21 (d, 2H, J = 4.0 Hz), 3.81 (s, 3H), 3.45 (t, 2H, J = 6.8 Hz), 
2.11 (q, 2H, J = 7.2 Hz), 1.66-1.59 (m, 2H), 1.52-1.45 (m, 2H), 0.97 (s, 9H), 0.18 (s, 6H). 
 
(E)-((8-((4-Methoxybenzyl)oxy)octa-1,3-dien-2-yl)oxy)trimethylsilane (3.32) 
Same procedure with the preparation of 3.30. 1H NMR (300 MHz, CDCl3) 
 7.26-7.21 (m, 2H), 6.84-6.79 (m, 2H), 6.19 (td, 1H, J = 7.2, 15.3 Hz), 5.93 
(td, 1H, J = 1.2, 15.3 Hz), 4.31 (d, 2H, J = 14.1 Hz), 4.30 (d, 2H, J = 15.3 Hz), 3.31 (s, 3H), 3.29 
(t, 2H, J = 6.3 Hz), 2.02 (q, 2H, J = 7.5 Hz), 1.62-1.50 (m, 2H), 1.49-1.40 (m, 2H), 0.03 (s, 9H).  
 
(E)-3,3,13,13-Tetraethyl-5-methylene-4,12-dioxa-3,13-disilapentadec-6-ene (3.34) 
To the solution of hex-5-en-1-ol (2.0 mL, 17 mmol) in CH2Cl2 (40 mL) were 
added imidazole (1.7 g, 25 mmol) and TESCl (3.3 mL, 20 mmol) at rt. The 
resulting mixture was stirred at rt for 5 h, then was quenched with H2O. The aqueous layer was 
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extracted with Et2O (3x). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated. The residue was purified by flash chromatography (hexanes:EtOAc = 200:1 to 
100:1) to afford triethyl(hex-5-en-1-yloxyl)silane (4.0 g, quantitative) as a colorless oil. To the 
solution of vinylmethylketone (1.8 mL, 22 mmol) and triethyl(hex-5-en-1-yloxyl)silane (1.6 g, 7.5 
mmol) in CH2Cl2 (40 mL) was added Hoveyda-Grubbs catalyst (2
nd generation, 24 mg, 0.038 
mmol) at rt. The resulting solution was stirred at rt for 1.5 h, then was concentrated directly. The 
residue was purified by flash chromatography (hexanes:EtOAc = 20:1) to afford desired enone 
3.33 (1.7 g, 87%). To a solution of enone 3.33 (1.6 g, 6.2 mmol) in dry CH2Cl2 (10 mL) was added 
NEt3 (1.7 mL, 12 mmol) and TESOTf (1.5 mL, 6.9 mmol) successively at 0 °C. The resulting 
solution was stirred at the same temperature for 30 min, then was quenched with H2O and the 
aqueous layer was extracted with CH2Cl2 (2x). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated. The residue was purified by flash column chromatography on 
silica gel (pre-treated with 1% NEt3 in hexanes) to afford diene 3.34 (2.3 g, 99%). 
1H NMR (400 
MHz, C6D6)  6.24 (td, 1H, J = 7.2, 15.2 Hz), 5.93 (d, 1H, J = 15.2 Hz), 4.32 (s, 1H), 4.25 (s, 1H), 
3.52 (t, 2H, J = 6.0 Hz), 2.05 (q, 2H, J = 7.2 Hz), 1.56-1.41 (m, 4H), 1.04-0.99 (m, 18H), 0.70 (q, 
6H, J = 8.0 Hz), 0.59 (q, 6H, J = 8.0 Hz); 13C NMR (100 MHz, C6D6)  155.7, 131.6, 128.6, 93.6, 
62.7, 32.8, 32.2, 26.0, 7.1, 7.0, 5.4, 4.9; IR (neat) 2955, 2912, 2878, 1591, 1459, 1414, 1382, 1319, 
1239, 1100, 1017, 964, 808, 743 cm-1; HRMS (ESI) m/z calcd for C20H43O2Si2 [M+H]
+ 371.2802, 
found 371.2813.  
 
2-(Benzyloxy)acetaldehyde (3.35) 
To a solution of ethane-1,2-diol (11.2 g, 200 mmol) in THF (120 mL) was added NaH 
(60% in mineral oil, 2.8 g, 67 mmol) in one portion at rt. The resulting mixture was stirred for 30 
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min at rt, followed by addition of nBu4NI (2.4 g, 6.7 mmol) and benzyl bromide (11 mL, 200 
mmol). The reaction mixture was refluxed overnight, then was quenched with NH4Cl aq. The 
aqueous layer was extracted with Et2O (3x). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated. The residue was purified by flash chromatography (hexanes:EtOAc = 
10:1 to 4:1) to afford 2-(benzyloxy)ethan-1-ol (8.3 g, 81%). To a solution of 2-(benzyloxy)ethan-
1-ol (1.7 g, 11 mmol), NEt3 (4.7 mL, 34 mmol), and DMSO (11 mL) in CH2Cl2 (7.8 mL) was 
added SO3•Py (2.7 g, 17 mmol) in one portion at rt. The resulting yellow solution was stirred at rt 
for 1 h, then was quenched with H2O. The aqueous layer was extracted with Et2O (3x). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated. The residue was 
purified by flash chromatography (hexanes:EtOAc = 20:1) to afford desired product (1.0 g, 61%). 
1H NMR (400 MHz, CDCl3)  9.74 (t, 1H, J = 0.8 Hz), 7.40-7.31 (m, 5H), 4.64 (s, 2H), 4.11 (d, 
2H, J = 0.8 Hz). 
 
2-((tert-Butyldiphenylsilyl)oxy)acetaldehyde (3.36) 
To a solution of ethane-1,2-diol (5.6 mL, 100 mmol) were added imidazole (2.0 
g, 30 mmol) and TBDPSCl (5.2 mL, 30 mmol) at rt. The resulting mixture was stirred at rt for 24 
h, then was quenched with H2O. The aqueous layer was extracted with Et2O (3x). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated. The residue was purified by 
flash chromatography (hexanes:EtOAc = 10:1 to 4:1) to afford 2-((tert-
butyldiphenylsilyl)oxy)ethan-1-ol (5.1 g, 85%) as a colorless oil. To a solution of 2-((tert-
butyldiphenylsilyl)oxy)ethan-1-ol (1.2 g, 4.0 mmol) in CH2Cl2 (2.8 mL) were added NEt3 (1.7 mL, 
12 mmol), DMSO (3.9 mL), and SO3•Py (0.95 g, 6.0 mmol) at rt successively. The resulting 
solution was stirred at rt for 2 h, then was quenched with H2O. The aqueous layer was extracted 
with Et2O (3x) and the combined organic layers were dried over Na2SO4, filtered, and 
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concentrated. The residue was purified by flash chromatography (hexanes:EtOAc = 20:1 to 10:1) 
to afford the desired aldehyde (0.98 g, 82%) as a yellowish oil. 1H NMR (400 MHz, CDCl3)  9.74 
(t, 1H, J = 0.8 Hz), 7.70-7.65 (m. 4H), 7.48-7.39 (m, 6H), 4.22 (d, 2H, J = 0.8), 1.12 (s, 9H); 13C 
NMR (100 MHz, CDCl3)  201.9, 135.7, 132.7, 130.3, 128.1, 70.2, 53.6, 26.9, 19.5; IR (neat) 
3071, 2932, 2892, 2858, 1738, 1472, 1428, 1362, 1113, 899, 823, 741, 702, 611 cm-1; HRMS (ESI) 
m/z calcd for C18H23O2Si [M+H]
+ 299.1462, found 299.1454. 
 
(2R,6R)-2-((Benzyloxy)methyl)-1,7-dioxaspiro[5.5]undecan-4-one (3.39) 
To a mixture of diene 3.34 (0.37 g, 1.0 mmol), aldehyde 3.35 (300 mg, 2.0 
mmol), and 4 Å molecular sieves was added Jacobsen catalyst 3.37 (26 mg, 0.05 
mmol) at rt. The resulting slurry was stirred at rt for 18 h, then was diluted with CH2Cl2 (8 mL). 
DDQ (0.23 g, 1.0 mmol) was added in one portion. The resulting mixture was stirred at rt for 0.5 
h. Then, p-TsOH•H2O (0.38 g, 2.0 mmol) was added to the reaction in one portion. The resulting 
mixture was stirred at rt for 1.5 h, then was filtered through a short pad of silica gel. The filtrate 
was concentrated, then was purified by flash chromatorgraphy (hexanes:EtOAc = 20:1 to 15:1 to 
10:1 to 5:1) to afford desired spiroketal 3.39 (212 mg, 73% yield, 73% ee as determined by HPLC 
with a Lux cellulose-3 column). []25D -39.1 (c 1.45, CHCl3); 1H NMR (400 MHz, CDCl3)  7.38-
7.28 (m, 5H), 4.65 (d, 2H, J = 2.4 Hz), 4.16-4.10 (m, 1H), 3.67-3.59 (m, 4H), 2.48-2.33 (m, 4H), 
2.00-1.87 (m, 2H), 1.66-1.49 (m, 4H); 13C NMR (100 MHz, CDCl3)  205.9, 138.3, 128.6, 127.8, 
127.7, 73.6, 72.4, 68.6, 61.3, 52.0, 43.3, 34.8, 24.6, 18.8; IR (neat) 2943, 1722, 1602, 1453, 1364, 
1311, 1273, 1174, 1074, 1045, 989, 951, 739, 699 cm-1; HRMS (ESI) m/z calcd for C17H23O4 
[M+H]+ 291.1591, found 291.1580.  
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(2R,6R)-2-(((tert-Butyldiphenylsilyl)oxy)methyl)-1,7-dioxaspiro[5.5]undecan-4-one (3.40) 
4 Å molecular sieves (150 mg) and Jacobsen’s catalyst 3.37 (13 mg, 0.025 
mmol) were added into the mixture of diene 3.34 (0.18 g, 0.50 mmol) and 
aldehyde 3.36 (0.30 mg, 1.0 mmol) successively under argon at rt. The resulting mixture was 
stirred overnight at rt, then was diluted with CH2Cl2 (5 mL). DDQ (0.14 g, 0.61 mmol) was added 
in one portion. The resulting mixture was stirred at rt for 20 min, then was added p-TsOH•H2O 
(0.19 g, 1.0 mmol). After stirring at rt for 2 h, the reaction was quenched with NEt3 and filtered 
through a short pad of silica gel. The filtrate was concentrated and the residue was purified by 
flash column chromatography to afford the desired spiroketal 3.40 (0.17 g, 78% yield, 91% ee as 
determined by HPLC with a Lux cellulose-3 column based on (2R,6R)-2-(benzyloxymethyl)-1,7-
dioxaspiro[5.5]undecan-4-one). []25D -23.0 (c 1.31, CHCl3); 1H NMR (400 MHz, CDCl3)  7.73 
(d, 4H, J = 6.8 Hz), 7.47-7.38(m, 6H), 4.06 (q, 1H, J = 4.8 Hz), 3.84-3.77 (m, 2H), 3.66-3.56 (m, 
2H), 2.46-2.37 (m, 4H), 2.00-1.91 (m, 1H), 1.86 (d, 1H, J = 13.6 Hz), 1.66-1.60 (m, 2H), 1.55-
1.47 (m, 2H), 1.07 (s, 9H); 13C NMR (100 MHz, CDCl3)  206.3, 135.9, 135.8, 133.7, 133.6, 
130.0, 127.9, 99.2, 69.9, 66.6, 61.2, 52.2, 43.2, 35.0, 27.0, 24.6, 19.5, 18.8; IR (neat) 3050, 3071, 
2999, 2932, 2858, 1738, 1589, 1472, 1428, 1391, 1362, 1261, 1113, 1008, 939, 900, 823, 741, 
703, 611 cm-1; HRMS (ESI) m/z calcd for C26H35O4Si [M + H]
+ 439.2287, found 439.2305.. 
 
(E)-3,3,12,12-Tetraethyl-5-methylene-4,11-dioxa-3,12-disilatetradec-6-ene (3.41)  
Same procedure with the preparation of 3.34. 1H NMR (400 MHz, C6D6)  
6.28 (td, 1H, J = 7.2, 15.2 Hz), 5.97 (d, 1H, J = 15.2 Hz), 4.34 (s, 1H), 4.26 (s, 
1H), 3.54 (t, 2H, J = 6.4 Hz), 2.19 (q, 2H, J = 7.2 Hz), 1.66-1.59 (m, 2H), 1.04-0.99 (m, 18H), 
0.71 (q, 6H, J = 7.6 Hz), 0.60 (q, 6H, J = 7.6 Hz); 13C NMR (100 MHz, C6D6)  155.6, 131.2, 
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128.8, 93.6, 62.2, 32.8, 28.7, 7.1, 7.0, 5.4, 4.8; IR (neat) 2955, 2912, 2877, 1591, 1459, 1414, 1382, 
1320, 1239, 1103, 1017, 963, 806, 744 cm-1; HRMS (ESI) m/z calcd for C19H41O2Si2 [M+H]
+ 
356.2645, found 356.2644. 
 
(S)-Hept-6-en-2-ol (3.42) 
To a suspension of magnesium (0.19 g, 7.7 mmol) and iodine (cat.) in Et2O (5 mL) 
was added 4-bromobut-1-ene (1.0 g, 7.4 mmol) dropwise. The resulting suspension was refluxing 
spontaneously and stirred for 1 h. The freshly prepared Grignard reagent was added to a solution 
of CuCN (66 mg, 0.74 mmol) in THF (6 mL) at –20 °C. The resulting mixture was stirred at –
20 °C for 20 min, then (S)-(–)-propylene oxide (0.41 mL. 5.9 mmol) was added to this mixture. 
The reaction was warmed to 0 °C and stirred at this temperature for 12 h. The reaction was 
quenched with NH4Cl aq. The aqueous layer was extracted with EtOAc (3x) and the combined 
organic layers were washed with brine, dried over Na2SO4, filtered, and concentrated. The residue 
was purified by flash chromatography (hexanes:EtOAc = 10:1 to 8:1) to afford desired alcohol 
3.42 (0.57 g, 85% yield, >99% ee as determined by Mosher ester analysis). 1H NMR (400 MHz, 
CDCl3)  5.82 (dddd, 1H, J = 6.8, 6.8, 10.4, 17.2 Hz), 5.02 (tdd, 1H, J = 1.6, 2.0, 17.2 Hz), 4.96 
(tdd, 1H, J = 1.2, 2.0, 10.0 Hz), 3.85-3.78 (m, 1H), 2.09 (dq, 2H, J = 1.2, 7.2 Hz), 1.56-1.40 (m, 
4H), 1.20 (d, 3H, J = 6.4 Hz). 
 
(S,E)-8-((Triethylsilyl)oxy)non-3-en-2-one (3.43) 
To a solution of 3.42 (0.57 g, 5.0 mmol) in THF (10 mL) were added imidazole 
(0.68 g, 10 mmol) and TESCl (1.1 g, 7.5 mmol) at rt. The resulting mixture 
was stirred at rt for 1.5 h, then was quenched with H2O. The aqueous layer was extracted with 
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Et2O (3x). The combined organic layers were dried over Na2SO4, filtered, and concentrated. The 
residue was purified by flash chromatography (hexanes:EtOAc = 100:1) to afford (S)-triethyl(hept-
6-en-2-yloxy)silane (0.92 g, 80%). To a solution of (S)-triethyl(hept-6-en-2-yloxy)silane (0.92 g, 
4.0 mmol) and vinylmethylketone (0.84 g, 12 mmol) in CH2Cl2 (16 mL) was added Hoveyda-
Grubbs catalyst (2nd generation, 25 mg, 0.04 mmol). The resulting solution was stirred at rt for 13 
h, then was concentrated directly. The residue was purified by flash chromatography 
(hexanes:EtOAc = 20:1) to afford enone 3.43 (0.78 g, 72%) as a colorless oil. 1H NMR (400 MHz, 
CDCl3)  6.80 (td, 1H, J = 6.8, 16.0 Hz), 6.08 (td, 1H, J = 1.6, 16.0 Hz), 3.83-3.79 (m, 1H), 2.25 
(s, 3H), 2.27-2.21 (m, 2H), 1.64-1.56 (m, 1H), 1.54-1.41 (m, 3H), 1.15 (d, 3H, J = 6.0 Hz), 0.97 
(t, 9H, J = 8.0 Hz), 0.60 (q, 6H, J = 8.0 Hz); 13C NMR (100 MHz, CDCl3)  198.9, 148.5, 131.6, 
68.3, 39.4, 32.7, 27.1, 24.5, 24.1, 7.1, 5.2. 
 
(S,E)-3,3,13,13-Tetraethyl-11-methyl-5-methylene-4,12-dioxa-3,13-disilapentadec-6-ene 
(3.44) 
To a solution of enone 3.43 (0.18 g, 0.67 mmol) in dry CH2Cl2 (2 mL) was 
added NEt3 (0.19 mL, 1.3 mmol) and TESOTf (0.17 mL, 0.73 mmol) 
successively at 0 °C. The resulting solution was stirred at the same temperature for 30 min, then 
was quenched with H2O and the aqueous layer was extracted with CH2Cl2 (2x). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated. The residue was purified by 
flash column chromatography on silica gel (pre-treated with 1% NEt3 in hexanes) to afford diene 
3.44 (0.24 g, 94%). []25D +3.3 (c 1.37, CHCl3); 1H NMR (400 MHz, C6D6)  6.28 (td, 1H, J = 
7.2, 15.2 Hz), 5.97 (d, 1H, J = 15.2 Hz), 4.35 (s, 1H), 4.28 (s, 1H), 3.74-3.67 (m, 1H), 2.06 (q, 1H, 
J = 2.8 Hz), 1.59-1.46 (m, 2H), 1.44-1.33 (m, 2H), 1.10 (d, 3H, J = 6.4 Hz), 1.04 (t, 9H, J = 8.0 
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Hz), 1.03 (t, 9H, J = 8.0 Hz), 0.72 (q, 6H, J = 8.0 Hz), 0.61 (q, 6H, J = 8.0 Hz); 13C NMR (400 
MHz, C6D6)  155.7, 131.7, 128.6, 128.2, 93.6, 68.5, 39.7, 32.5, 25.8, 24.1, 7.2, 7.0, 5.5, 5.4; IR 
(neat) 2954, 1655, 1592, 1459, 1414, 1377, 1318, 1239, 1137, 1095, 1016, 963, 817, 744, 672 cm-
1; HRMS (ESI) m/z calcd for C21H45O2Si2 [M+H]
+ 385.2960, found 385.2958.  
 
(3R,4S)-3-Methyldec-1-en-4-ol (3.45) 
To a suspension of KOtBu (3.8 g, 34 mmol) in THF (18 mL) was added (E)-but-2-
ene (5.2 mL, 60 mmol) at –78 °C, followed by addition of nBuLi (1.6 M in THF, 
19 mL, 30 mmol) at the same temperature. The reaction was warmed to –45 °C and stirred at –45 
°C for 20 min, then was cooled to –78 °C. A pre-cooled (–30 °C) solution of (+)-(Ipc)2BOMe (11 
g, 35 mmol) in Et2O (25 mL) was added to the reaction mixture dropwise. The resulting mixture 
was stirred at –78 °C for 30 min, then BF3•OEt2 (4.8 mL) was added. After addition, the reaction 
mixture was stirred at –78 °C for 4.5 h, then NaOH (aq., 3.0 M, 21 mL) and H2O2 (aq., 30%, 9 
mL) were added. The reaction was refluxed for 1 h, then was poured into a separatory funnel. The 
organic layer was collected, washed with H2O and brine, dried over Na2SO4, filtered, and 
concentrated. The residue was purified by flash chromatography (hexanes:EtOAc = 100:1 to 50:1 
to 20:1) to afford desired alcohol 3.45 (2.9 g, 57% yield, 83% ee as determined by Mosher ester 
analysis) as a colorless oil. 1H NMR (400 MHz, CDCl3)  5.75 (ddd, 1H, J = 8.4, 11.2, 16.8 Hz), 
5.11 (s, 1H), 5.09-5.07 (m, 1H), 3.40-3.36 (m, 1H), 2.20 (dq, 1H, J = 6.8, 14.0 Hz), 1.63 (s, 1H), 
1.54-1.40 (m, 2H), 1.38-1.28 (m, 10H), 1.02 (d, 3H, J = 6.8 Hz), 0.88 (t, 3H, 6.8 Hz); 13C NMR 
(100 MHz, CDCl3)  71.8, 48.0, 47.9, 42.0, 39.2, 38.4, 34.6, 27.9, 23.9, 20.9. 
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(5R,6S,E)-5-Methyl-6-((triethylsilyl)oxy)dodec-3-en-2-one (3.46) 
To a solution of 3.45 (1.0 g, 5.9 mmol) were added imidazole (0.80 g, 12 
mmol) and TESCl (1.5 mL, 8.8 mL) at rt. The resulting solution was stirred 
at rt for 2 h, then was quenched with H2O. The aqueous layer was extracted 
with Et2O and the combined organic layers were dried over Na2SO4, filtered, and concentrated. 
The residue was purified by flash chromatography (hexanes:EtOAc = 500:1) to afford 
triethyl(((3R,4S)-3-methyldec-1-en-4-yl)oxy)silane (1.5 g, 87%) as a colorless oil. To a solution 
of 9-BBN dimer (448 mg, 1.84 mmol) in THF (2 mL) was added a solution of triethyl(((3R,4S)-3-
methyldec-1-en-4-yl)oxy)silane (580 mg, 2.04 mmol) in THF (2 mL) at rt under argon. The 
resulting solution was stirred at rt for 4.5 h, then was quenched with H2O (0.5 mL). To the reaction 
mixture were added a solution of K3PO4•H2O (705 mg, 3.06 mmol) in H2O (1 mL), a solution of 
(E)-4-iodobut-3-en-2-one (799 mg, 4.08 mmol) in THF (3 mL), and [Pd(dppf)Cl2]•CH2Cl2 (83.3 
mg, 0.102 mmol) at rt. The resulting dark brown mixture was stirred at rt for 16 h, then was 
quenched with H2O. The aqueous layer was extracted with Et2O (3x) and combined organic layers 
were dried over Na2SO4, filtered, and concentrated. The residue was purified by flash 
chromatography (hexanes:EtOAc = 50:1) to afford enone 3.46 (720 mg, 99%) as a yellowish oil. 
1H NMR (400 MHz, CDCl3)  6.81 (td, 1H, J = 6.8, 16.0 Hz), 6.09 (d, 1H, J = 16.0 Hz), 3.54-3.51 
(m, 1H), 2.41-2.27 (m, 1H), 2.25 (s, 3H), 2.21-2.14 (m, 1H), 1.58-1.51 (m, 3H), 1.42-1.32 (m, 2H), 
1.28-1.21 (m, 8H), 0.96 (t, 9H, J = 12.0 Hz), 0.90 (t, 3H, J = 6.8 Hz), 0.59 (q, 6H, J = 8.0 Hz). 
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(10R,11S,E)-3,3,13,13-Tetraethyl-11-hexyl-10-methyl-5-methylene- 4,12-dioxa-3,13-
disilapentadec-6-ene (3.47) 
To a solution of enone 3.46 (0.15 g, 0.41 mmol) in dry CH2Cl2 (1 mL) was 
added NEt3 (0.12 mL, 0.83 mmol) and TESOTf (0.10 mL, 0.46 mmol) 
successively at 0 °C. The resulting solution was stirred at the same 
temperature for 30 min, then was quenched with H2O and the aqueous layer was extracted with 
CH2Cl2 (2x). The combined organic layers were dried over Na2SO4, filtered, and concentrated. 
The residue was purified by flash column chromatography on silica gel (pre-treated with 1% NEt3 
in hexanes) to afford diene 3.47 (0.18 g, 92%). []25D -1.7 (c 1.30, CHCl3); 1H NMR (400 MHz, 
C6D6)  6.30 (td, 1H, J = 7.2, 15.2 Hz), 6.00 (d, 1H, J = 15.2 Hz), 4.35 (s, 1H), 4.27 (s, 1H), 3.62-
3.58(m, 1H), 2.25-2.16(m, 1H), 2.11-2.02(m, 1H), 1.73-1.66 (m, 1H), 1.61-1.45 (m, 3H), 1.40-
1.22 (m, 9H), 1.06 (t, 9H, J = 8.0 Hz), 1.04 (t, 9H, J = 8.0 Hz), 0.96 (d, 3H, J = 6.8 Hz), 0.92 (t, 
3H, J = 6.8 Hz), 0.73 (q, 6H, J = 8.0 Hz), 0.67 (q, 6H, J = 8.0 Hz); 13C NMR (400 MHz, C6D6)  
155.7, 131.7, 128.6, 93.4, 76.5, 38.4, 32.9, 32.5, 32.4, 30.4, 30.0, 26.3, 23.1, 14.8, 14.3, 7.3, 7.0, 
5.7, 5.4; IR (neat) 2955, 2876, 1591, 1459, 1414, 1378, 1318, 1238, 1120, 1016, 964, 809, 742, 
673 cm-1; HRMS (ESI) m/z calcd for C27H56O2Si2 [M]
+ 468.3819, found 468.3822.  
 
Hex-5-enamide (3.48) 
To a solution of hex-5-enoic acid (1.0 mL, 8.4 mmol) in benzene (16 mL) was 
added oxalyl chloride (1.4 mL, 17 mmol) dropwise at 0 °C. The resulting 
solution was stirred at rt for 1 h. Then the solvent was removed under reduced pressure. The residue 
was re-dissolved in THF (16 mL) and treated with aqueous ammonium hydroxide (16 mL) 
dropwise at 0 °C. The resulting mixture was stirred at rt for 18 h, then was diluted with H2O and 
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EtOAc. The aqueous layer was extracted with EtOAc (3x) and combined organic layers (included 
the original portion of organic layer) were dried over Na2SO4, filtered, and concentrated. The 
residue was purified by flash chromatography to afford desired amide (0.46 g, 48%). 1H NMR 
(400 MHz, CDCl3)  6.42 (s, 1H), 6.02 (s, 1H), 5.72 (tdd, 1H, J = 6.8, 10.0, 12.8 Hz), 4.96 (dd, 
1H, J = 1.2, 13.2 Hz), 4.92 (d, 1H, J = 10.4 Hz), 2.16 (t, 2H, J = 7.6 Hz), 2.04 (q, 2H, J = 7.2 Hz), 
1.66 (quint, 2H, J = 7.6 Hz); 13C NMR (100 MHz, CDCl3)  176.3, 137.8, 115.4, 35.1, 33.1, 24.6. 
 
Triethylsilyl (E)-7-((triethylsilyl)oxy)octa-5,7-dienimidate (3.49) 
 To a solution of 3.48 (47 mg, 0.42 mmol) and vinylmethylketone (0.1 mL, 
1.26 mmol) in CH2Cl2 (1.7 mL) was added Hoveyda-Grubbs catalyst (2
nd 
generation, 1.3 mg, 0.0021 mmol) at rt. The resulting solution was stirred at rt for 2 h, then was 
concentrated directly. The residue was purified by flash chromatography to afford (E)-7-oxooct-
5-enamide (30 mg, 46%). This freshly prepared enone (30 mg, 0.19 mmol) was dissolved in 
CH2Cl2 (0.5 mL). To this solution were added NEt3 (0.1 mL, 0.76 mmol) and TESOTf (106 mg, 
0.40 mmol) at 0 °C. The resulting solution was stirred at 0 °C for 1 h, then was quenched with 
H2O and extracted with CH2Cl2 (3x). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated. The residue was purified by flash chromatography to afford desired 
diene 3.49 (58 mg, 79%). 1H NMR (400 MHz, CDCl3)  6.21 (td, 1H, J = 6.8, 15.2 Hz), 5.95 (d, 
1H, J = 15.2 Hz), 4.34 (s, 1H), 4.26 (s, 1H), 4.17 (s, 1H), 2.06 (q, 2H, J = 6.8 Hz), 1.86 (t, 2H, J = 
7.2 Hz), 1.69 (quint, 2H, J = 7.2 Hz), 1.03-0.98 (m, 18H), 0.76-0.67 (m, 12H). 
 
 
 
  
 
 
143 
(5R,7R)-7-((tert-Butyldiphenylsilyloxy)methyl)-1,6-dioxaspiro[4.5]decan-9-one (3.50) 
4 Å molecular sieves (80 mg) and Jacobsen’s catalyst 3.37 (13 mg, 0.02 
mmol) were added into the mixture of diene 3.41 (0.14 g, 0.39 mmol) and 
aldehyde 3.36 (0.23 g, 0.78 mmol) successively under argon at rt. The 
resulting mixture was stirred overnight at rt, then was diluted with CH2Cl2 (3.2 mL). DDQ (0.11 
g, 0.47 mmol) was added in one portion. The resulting mixture was stirred at rt for 20 min, then 
was added p-TsOH•H2O (0.15 g, 0.78 mmol). After stirring at rt for 2 h, the reaction was quenched 
with NEt3 (0.1 mL) and filtered through a short pad of silica gel. The filtrate was concentrated and 
the residue was purified by flash column chromatography to afford the desired spiroketal 3.50 
(0.12 g, 72% yield, 85% ee as determined by HPLC with a Lux cellulose-3 column based on 
(5R,7R)-7-(benzyloxymethyl)-1,6-dioxaspiro[4.5]decan-9-one). []25D -24.1 (c 1.16, CHCl3); 1H 
NMR (400 MHz, CDCl3)  7.70 (d, 4H, J = 6.8 Hz), 7.46-7.37 (m, 6H), 4.16-4.13 (m, 1H), 3.94 
(q, 1H, J = 7.2 Hz), 3.85 (q, 1H, J = 7.2 Hz), 3.79-3.72 (m, 2H), 2.74 (d, 1H, J = 14.4 Hz), 2.47 
(d, 1H, J = 14.4 Hz), 2.44-2.42 (m, 2H), 2.20-2.14 (m, 1H), 2.11-2.05 (m. 1H), 1.94-1.92 (m, 1H), 
1.77 (q, 1H, J = 9.6 Hz), 1.07 (s, 9H); 13C NMR (100 MHz, CDCl3)  206.1, 135.9, 135.8, 133.7, 
133.7, 129.9, 127.9, 127.8, 107.8, 70.1, 67.8, 66.6, 49.5, 43.3, 37.7, 27.0, 23.7, 19.5; IR (neat) 
3070, 3049, 2958, 2930, 2890, 2857, 1726, 1472, 1461, 1428, 1362, 1335, 1292, 1256, 1113, 1082, 
1000, 823, 741, 704, 610 cm-1; HRMS (ESI) m/z calcd for C25H33O4Si [M + H]
+ 425.2148, found 
425.2138. 
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(2R,6R,8S)-2-((tert-Butyldiphenylsilyloxy)methyl)-8-methyl-1,7-dioxaspiro[5.5]undecan-4-
one (3.51) 
4 Å molecular sieves (70 mg) and Jacobsen’s catalyst 3.37 (6.7 mg, 0.013 
mmol) were added into the mixture of diene 3.44 (0.10 g, 0.26 mmol) and 
aldehyde 3.36 (0.16 g, 0.52 mmol) successively under argon at rt. The resulting mixture was stirred 
overnight at rt, then was diluted with CH2Cl2 (2 mL). DDQ (71 mg, 0.31 mmol) was added in one 
portion. The resulting mixture was stirred at rt for 20 min, then was added p-TsOH•H2O (74 mg, 
0.39 mmol). After stirring at rt for 2 h, the reaction was quenched with NEt3 (0.1 mL) and filtered 
through a short pad of silica gel. The filtrate was concentrated and the residue was purified by 
flash column chromatography to afford the desired spiroketal 3.51 (84 mg, 71% yield). []25D -
22.3 (c 1.50, CHCl3); 
1H NMR (400 MHz, CDCl3)  7.74-7.72 (m, 4H), 7.47-7.38 (m, 6H), 4.02-
3.95 (m, 1H), 3.83-3.68 (m, 3H), 2.46-2.36 (m, 4H), 1.96 (tq, 1H, J = 4.0, 13.2 Hz), 1.83 (d, 1H, 
J = 13.2 Hz), 1.64 (d, 1H, J = 12.8 Hz), 1.55 (d, 1H, J = 15.2 Hz), 1.46 (dt, 1H, J = 4.8, 13.2 Hz), 
1.25-1.14 (m, 1H), 1.08 (d, 3H, J = 4.8 Hz), 1.07 (s, 9H); 13C NMR (100 MHz, CDCl3)  206.5, 
135.9, 135.8, 133.7, 133.6, 130.0, 127.9, 99.6, 69.6, 66.6, 66.5, 52.2, 43.2, 34.4, 32.0, 27.0, 21.8, 
19.5, 19.2; IR (neat) 3071, 2931, 2857, 1724, 1472, 1428, 1383, 1304, 1256, 1220, 1177, 1113, 
1083, 996, 965, 823, 798, 741, 703 cm-1; HRMS (ESI) m/z calcd for C27H37O4Si [M + H]
+ 
425.2461, found 453.2450. 
 
(2R,6R,8S)-2-((tert-Butyldiphenylsilyloxy)methyl)-8-methyl-1,7-dioxaspiro[5.5]undecan-4-
one (3.52)  
4 Å molecular sieves (100 mg) and Jacobsen’s catalyst 3.37 (14 mg, 
0.026 mmol) were added into the mixture of diene 3.47 (0.25 g, 0.53 
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mmol) and aldehyde 3.36 (0.32 g, 1.1 mmol) successively under argon at rt. The resulting mixture 
was stirred overnight at rt, then was diluted with CH2Cl2 (5 mL). DDQ (0.14 g, 0.64 mmol) was 
added in one portion. The resulting mixture was stirred at rt for 20 min, then was added p-
TsOH•H2O (0.20 g, 1.1 mmol). After stirring at rt for 2 h, the reaction was quenched with NEt3 
(0.1 mL) and filtered through a short pad of silica gel. The filtrate was concentrated and the residue 
was purified by flash column chromatography to afford the desired spiroketal 3.52 (0.21 g, 75% 
yield). []25D -32.2 (c 0.95, CHCl3); 1H NMR (400 MHz, CDCl3)  7.76-7.72 (m, 4H), 7.47-7.37 
(m, 6H), 4.08-4.02 (m, 1H), 3.80 (dd, 1H, J = 5.6, 10.4 Hz), 3.74 (dd, 1H, J = 3.6, 10.4 Hz), 3.26 
(dt, 1H, J = 2.4, 9.6 Hz), 2.46-2.35 (m, 4H), 1.90-1.86 (m, 1H), 1.74-1.63 (m, 1H), 1.60-1.52 (m, 
2H), 1.48-1.41 (m, 1H), 1.36-1.23 (m, 10H), 1.08 (s, 9H), 0.88 (t, 3H, J = 6.8 Hz), 0.82 (d, 3H, J 
= 6.8 Hz); 13C NMR (100 MHz, CDCl3)  206.4, 135.9, 133.6, 133.6, 130.0, 129.9, 129.9, 128.0, 
127.9, 99.3, 75.8, 69.9, 66.7, 53.6, 52.1, 43.2, 35.5, 34.2, 33.0, 32.1, 29.8, 28.2, 27.0, 26.8, 25.4, 
22.9, 19.5, 17.9, 14.3; IR (neat) 3049, 2930, 2858, 1727, 1589, 1461, 1428, 1361, 1310, 1247, 
1113, 998, 822, 794, 741, 703, 606 cm-1; HRMS (ESI) m/z calcd for C33H49O4Si [M + H]
+ 
537.3400, found 537.3390. 
 
(2S,6R)-2-Hexyl-1,7-dioxaspiro[5.5]undecan-4-one (3.53) 
4 Å molecular sieves (150 mg) and Jacobsen’s catalyst 3.37 (39 mg, 0.075 mmol) 
were added into the mixture of diene 3.34 (0.18 g, 0.50 mmol) and freshly 
distilled heptanal (0.14 mL, 1.0 mmol) successively under argon at rt. The 
resulting mixture was stirred at rt for 13 h, 1.0 equiv. heptanal (0.07 mL, 0.5 mmol) was added to 
the reaction. The resulting reaction mixture was stirred at rt for 24 h, then was diluted with CH2Cl2 
(4 mL). DDQ (0.11 g, 0.50 mmol) was added in one portion. The resulting mixture was stirred at 
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rt for 20 min, then was added p-TsOH•H2O (0.19 g, 1.0 mmol). After stirring at rt for 2 h, the 
reaction was quenched with NEt3 (0.1 mL) and filtered through a short pad of silica gel. The filtrate 
was concentrated and the residue was purified by flash column chromatography to afford the 
desired spiroketal 3.53 (65 mg, 50% yield, >99% ee as determined by HPLC with a Lux cellulose-
3 column). []25D -70.7 (c 1.42, CHCl3); 1H NMR (400 MHz, CDCl3)  3.92-3.86 (m, 1H), 3.60-
3.58 (m, 2H), 2.43-2.34 (m, 3H), 2.19 (dd, 1H, J = 7.6, 14.0 Hz), 1.91 (td, 1H, J = 4.4, 12.8 Hz), 
1.85-182 (m, 1H), 1.70-1.48 (m, 7H), 1.41-1.26 (m, 7H), 0.90 (t, 3H, J = 6.4 Hz); 13C NMR (100 
MHz, CDCl3)  206.6, 99.0, 69.1, 61.2, 52.3, 47.4, 36.5, 35.2, 32.0, 29.5, 25.8, 24.7, 22.8, 19.0, 
14.3; IR (neat) 2931, 2858, 1726, 1464, 1362, 1309, 1275, 1251, 1208, 1173, 1096, 1074, 1045, 
988, 949 cm-1; HRMS (ESI) m/z calcd for C15H27O3 [M + H]
+ 255.1960, found 255.1942. 
 
(2R,6R)-2-Phenyl-1,7-dioxaspiro[5.5]undecan-4-one (3.54) 
4 Å molecular sieves (150 mg) and Jacobsen’s catalyst 3.37 (39 mg, 0.075 mmol) 
were added into the mixture of diene 3.47 (0.25 g, 0.53 mmol) and freshly 
distilled benzaldehyde (0.11 g, 1.0 mmol) successively under argon at rt. The 
resulting mixture was stirred at rt for 72 h, then was diluted with CH2Cl2 (4 mL). DDQ (0.11 g, 
0.50 mmol) was added in one portion. The resulting mixture was stirred at rt for 20 min, then was 
added p-TsOH•H2O (0.19 g, 1.0 mmol). After stirring at rt for 2 h, the reaction was quenched with 
NEt3 (0.1 mL) and filtered through a short pad of silica gel. The filtrate was concentrated and the 
residue was purified by flash column chromatography to afford the desired spiroketal 3.54 (65 mg, 
53% yield, 84% ee as determined by HPLC with a Lux cellulose-3 column). []25D -19.7 (c 2.24, 
CHCl3); 
1H NMR (400 MHz, CDCl3)  7.46-7.39 (m, 4H), 7.36-7.32 (m, 1H), 4.99 (dd, 1H, J = 
1.2, 11.6 Hz), 3.67 (dd, 1H, J = 2.0, 9.2 Hz), 2.69-2.64 (m, 1H), 2.57-2.50 (m, 3H), 2.01-1.89 (m, 
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2H), 1.68-1.50 (m, 4H); 13C NMR (100 MHz, CDCl3)  205.6, 141.1, 128.8, 128.1, 126.0, 99.5, 
70.7, 61.4, 52.2, 48.7, 35.2, 24.6, 18.9; IR (neat) 2944, 2872, 1725, 1452, 1370, 1310, 1258, 1212, 
1172, 1132, 1077, 1039, 985, 948, 872, 750 cm-1; HRMS (ESI) m/z calcd for C15H19O3 [M + H]
+ 
247.1334, found 247.1324. 
 
Synthesis of the bridged bicyclic ether through the one-pot process 
 
Jacobsen’s catalyst 3.37 (20 mg, 0.042 mmol) was added into the mixture of 4 Å molecular sieves 
(300 mg), (E)-(deca-1,3-dien-2-yloxy)triethylsilane (0.23 g, 0.84 mmol), and 2-((4-
methoxybenzyl)oxy)acetaldehyde (0.23 g, 1.3 mmol) successively under argon at rt. The resulting 
mixture was stirred at rt for 18 h, then was added 0.5 equiv. of 2-((4-
methoxybenzyl)oxy)acetaldehyde (76 mg, 0.42 mmol). The resulting mixture was stirred at rt for 
28 h, then was diluted with dry CH2Cl2 (4 mL). The first portion of DDQ (0.19 g, 0.84 mmol) was 
added. After stirring at rt for 5 min, the second portion of DDQ (0.29 g, 1.3 mmol) was added and 
the reaction was diluted with wet CH2Cl2 (2 mL). The resulting mixture was stirred at rt for 14 h, 
followed by the addition of the third portion of DDQ (0.19 g, 0.84 mmol). The reaction was stirred 
at rt for 2 h, then was added HF (70% in pyridine, 0.05 mL) and p-TsOH•H2O (80 mg, 0.42 mmol). 
After stirring at rt for 30 min, to the reaction were added 1.0 equiv. p-TsOH•H2O (0.16 g, 0.84 
mmol), HF (70% in pyridine, 0.1 mL), and 1.0 equiv. p-TsOH•H2O (0.16 g, 0.84 mmol) 
successively. The resulting reaction mixture was stirred at rt for 1.5 h, then was quenched with 
NEt3 (0.1 mL) and filtered through a short pad of silica gel. The filtrate was concentrated and the 
residue was purified by flash column chromatography to afford bridged bicyclic ether 3.68 (44 
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mg, 25%), enone 3.69 (95 mg, 53%), and trace amount of furan 3.70 (a significant amount of furan 
3.70 was obtained when the reaction was stirred at rt overnight).  
 
(1R,5S)-5-Hexyl-6,8-dioxabicyclo[3.2.1]octan-3-one (3.68) 
1H NMR (400 MHz, CDCl3)  4.85 (t, 1H, J = 4.8 Hz), 3.89 (ddd, 1H, J = 2.0, 4.8, 
7.2 Hz), 3.84 (d, 1H, J = 7.2 Hz), 2.74 (ddd, 1H, J = 2.0, 5.2, 16.8 Hz), 2.60 (dd, 
1H, J = 0.8, 16.8 Hz), 2.54 (d, 1H, J = 16.4 Hz), 2.44 (td, 1H, J = 1.2, 16.4 Hz), 1.86-1.74 (m, 2H), 
1.50-1.42 (m, 2H), 1.38-1.26 (m, 6H), 0.90 (t, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3)  
205.7, 109.2, 73.3, 70.6, 51.6, 46.4, 37.3, 31.9, 29.5, 23.2, 22.8, 14.3; IR (neat) 2929, 2858, 1727, 
1466, 1378, 1317, 1280, 1241, 1186, 1156, 1079, 1040, 1008 cm-1; HRMS (ESI) m/z calcd for 
C12H21O3 [M + H]
+ 213.1485, found 213.1479. 
 
(R)-6-Hexyl-2-(hydroxymethyl)-2,3-dihydro-4H-pyran-4-one (3.69) 
1H NMR (400 MHz, CDCl3)  5.33 (s, 1H), 4.45 (tdd, 1H, J = 3.2, 5.2, 14.0 
Hz), 3.90 (dd, 1H, J = 3.2, 12.4 Hz), 3.78 (dd, 1H, J = 5.2, 12.0 Hz), 2.63 (dd, 
1H, J = 14.0, 16.0 Hz), 2.59 (br, 1H), 2.32 (ddd, 1H, J = 0.8, 3.6, 12.8 Hz), 2.25 (dt, 2H, J = 2.8, 
7.2 Hz), 1.58-1.51 (m, 2H), 1.33-1.23 (m, 6H), 0.87 (t, 3H, J = 6.8 Hz); 13C NMR (100 MHz, 
CDCl3)  192.9, 177.9, 104.3, 79.6, 64.1, 37.1, 34.9, 31.6, 28.9, 26.5, 22.6, 14.2; IR (neat) 3408, 
2956, 2929, 2859, 1654, 1601, 1459, 1404, 1340, 1239, 1026, 984, 919, 811 cm-1; HRMS (ESI) 
m/z calcd for C12H21O3 [M + H]
+ 213.1485, found 213.1477. 
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1-(Furan-2-yl)octan-2-one (3.70) 
1H NMR (400 MHz, CDCl3)  7.37 (dd, 1H, J = 0.4, 1.2 Hz), 6.35 (dd, 1H, J = 
2.0, 3.2 Hz), 6.20 (dd, 1H, J = 0.4, 2.8 Hz), 3.70 (s, 2H), 2.45 (t, 2H, J = 7.2 Hz), 
1.60-1.53 (m, 2H), 1.32-1.24 (m, 6H), 0.88 (t, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3)  
206.7, 148.6, 142.3, 110.9, 108.4, 42.7, 42.1, 31.8, 29.0, 23.8, 22.7, 14.2; IR (neat) 2957, 2928, 
2857, 1721, 1598, 1505, 1464, 1380, 1287, 1146, 1075, 1011, 936, 731, 413 cm-1; HRMS (ESI) 
m/z calcd for C12H19O2 [M + H]
+ 195.1380, found 195.1376. 
 
General procedure for the Mosher ester analysis 
The secondary alcohol substrate (1.0 eq.) was treated with Mosher acid solution in dry CH2Cl2 
(0.12 M, 1.5 eq.), DCC solution in dry CH2Cl2 (0.069 M, 2.0 eq.), and DMAP solution in dry 
CH2Cl2 (0.11 M, 0.1 eq.) successively at rt. The resulting mixture was stirred at rt overnight, then 
filtered through a Celite® pad. The filtrate was concentrated under reduced pressure. The residue 
was purified by flash column chromatography to afford the desired Mosher ester. 
 
(R)-((S)-Hept-6-en-2-yl) 3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (S3.1) 
1H NMR (400 MHz, CDCl3)  7.56-7.54 (m, 2H), 7.43-7.38 (m, 3H), 5.77-
5.66 (m, 1H), 5.22-5.14 (m, 1H), 5.00-4.94 (m, 2H), 3.58 (d, 3H, J = 1.2 
Hz), 2.03-1.97 (m, 2H), 1.69-1.47 (m, 2H), 1.35 (d, 3H, J = 6.0 Hz), 1.33-1.27 (m, 2H). 
 
(S)-((S)-Hept-6-en-2-yl) 3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (S3.2) 
1H NMR (400 MHz, CDCl3)  7.55-7.53 (m, 2H), 7.43-7.39 (m, 3H), 5.82-
5.72 (m, 1H), 5.20-5.12 (m, 1H), 5.04-4.96 (m, 2H), 3.56 (d, 3H, J = 0.8 
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Hz), 2.07 (q. 2H, J = 7.2 Hz), 1.76-1.66 (m, 1H), 1.63-1.55 (m, 1H), 1.53-1.40 (m, 1H), 1.38-1.31 
(m, 1H), 1.27 (d, 3H, J = 6.0 Hz). 
 
(R)-((3R,4S)-3-Methyldec-1-en-4-yl) 3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (S3.3) 
1H NMR (400 MHz, CDCl3)  7.58-7.56 (m, 2H), 7.42-7.38 (m, 3H), 5.72-5.63 
(m, 1H), 5.09-5.04 (m, 2H), 5.01 (s, 1H), 3.56 (d, 3H, J = 1.2 Hz), 2.52-2.43 (m, 
1H), 1.67-1.51 (m, 2H), 1.29-1.25 (m, 8H), 0.95 (d, 3H, J = 5.6 Hz), 0.88 (t, 3H, 
J = 6.8 Hz). 
 
(S)-((3R,4S)-3-Methyldec-1-en-4-yl) 3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (S3.4) 
1H NMR (400 MHz, CDCl3)  7.58-7.56 (m, 2H), 7.42-7.38 (m, 3H), 5.77-5.68 
(m, 1H), 5.09-5.05 (m, 3H), 3.56 (d, 3H, J = 0.8 Hz), 2.56-2.47 (m, 1H), 1.62-
1.47 (m, 2H), 1.29-1.16 (m, 8H), 1.03 (d, 3H, J = 6.8 Hz), 0.87 (t, 3H, J = 7.2 
Hz). 
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HPLC data 
 
Figure S3-1. HPLC anaylsis report of racemic 3.39 
  
 
 
152 
 
Figure S3-2. HPLC anaylsis report of enantioenriched 3.39 
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Figure S3-3. HPLC anaylsis report of racemic 3.39 (derived from 3.40) 
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Figure S3-4. HPLC anaylsis report of enantioenriched 3.39 (derived from 3.40) 
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Figure S3-5. HPLC anaylsis report of racemic S3.5 (derived from 3.50) 
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Figure S3-6. HPLC anaylsis report of enantioenriched S3.5 (derived from 3.50) 
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Figure S3-7. HPLC anaylsis report of racemic 3.53 
  
 
 
158 
 
Figure S3-8. . HPLC anaylsis report of enantioenriched 3.53 
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Figure S3-9. HPLC anaylsis report of racemic 3.54 
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Figure S3-10. HPLC anaylsis report of enantioenriched 3.54 
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APPENDIX C 
 
TOTAL SYNTHESIS OF BISTRAMIDE A 
 
General Experimental: Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded on a Bruker Avance 300 spectrometer at 300 MHz and 75 MHz, a Bruker 
Avance 400 spectrometer at 400 MHz and 100 MHz, a Bruker Avance 500 spectrometer at 500 
MHz and 125 MHz. The chemical shifts are reported in parts per million (ppm) on the delta (δ) 
scale. The solvent peak was used as a reference value, for 1H NMR: CDCl3 = 7.27 ppm, C6D6 = 
7.16 ppm, for 13C NMR: CDCl3 = 77.23, C6D6 = 128.4 ppm. Data are reported as follows: (s = 
singlet; d = doublet; t = triplet; q = quartet; quint = quintet; sept = septet; dd = doublet of doublets; 
ddd = doublet of doublet of doublets; dddd = doublet of doublet of doublet of doublet; td = triplet 
of doublets; dtd = doublet of triplet of doublets; br = broad). High resolution and lowresolution 
mass spectra were recorded on a VG 7070 spectrometer. Infrared (IR) spectra were collected on a 
Mattson Cygnus 100 spectrometer. Samples for IR were prepared as a thin film on a NaCl plate 
by dissolving the compound in CH2Cl2 and then evaporating the CH2Cl2. Tetrahydrofuran and 
diethyl ether were distilled from sodium and benzophenone. Methylene chloride was distilled 
under N2 from CaH2. Analytical TLC was performed on E. Merck pre-coated (25 mm) silica gel 
60F-254 plates. Visualization was done under UV (254 nm). Flash chromatography was done 
using ICN SiliTech 32-63 60 Å silica gel. Reagent grade ethyl acetate, diethyl ether, toluene and 
hexanes (commercial mixture) were purchased from EM Science and used as is for 
chromatography. 
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4-Chlorobutanal (4.62) 
To a solution of oxalyl chloride (5.9 mL, 69 mmol) in dry CH2Cl2 (200 mL) was 
added a solution of DMSO (6.8 mL, 92 mmol) in dry CH2Cl2 (35 mL) dropwise at –78 °C under 
an atmosphere of argon. The resulting solution was stirred at -78 °C for 30 min, then a solution of 
4-chlorobutan-1-ol (5.0 g, 46 mmol) in dry CH2Cl2 (70 mL) was added dropwise. The resulting 
mixture was stirred at –78 °C for 30 min, then NEt3 (32 mL, 230 mmol) was added dropwise. The 
reaction was allowed to warm to rt. After stirring at rt for 30 min, the mixture was quenched with 
H2O and extract with CH2Cl2 (3x). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated. The residue was purified by flash column chromatography on silica gel 
(Pentane:Et2O =10:1 to 4:1) to afford desired aldehyde (4.1 g, 83% yield) as a pale yellow oil. 
1H 
NMR (400 MHz, CDCl3):  9.78 (s, 1H), 3.57 (t, 2H, J = 6.4 Hz), 2.64 (t, 2H, J = 6.8 Hz), 2.07 
(m, 2H); 13C NMR (100 MHz, CDCl3):  201.1, 44.3, 41.1, 25.0; IR (neat) 2962, 2831, 2728, 1724, 
1439, 1411, 1391, 1371, 1310, 1205, 1160, 1120, 1065, 934, 676, 648 cm-1. 
 
(E)-4-Iodobut-3-en-2-one (4.55) 
LiI (1.6 g, 12 mmol) was dissolved in AcOH (10  mL) under argon, followed by the 
addition of but-3-yn-2-one (0.78 mL, 10 mmol) at rt. The resulting mixture was stirred at 
rt for 18.5 h, then was quenched with H2O. The aqueous layer was extracted with Et2O (3x). The 
combined organic layers were wash with H2O, dried over Na2SO4, filtered, and concentrated. The 
residue was purified by flash chromatography (hexanes:EtOAc = 50:1 to 20:1) to afford desired 
product 4.55 (1.5 g, 78%). 1H NMR (400 MHz, CDCl3)  7.84 (d, 1H, J = 15.2 Hz), 7.16 (d, 1H, 
J = 14.8 Hz), 2.25 (s, 3H). 
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(S)-4-Methylhex-5-enal (4.53) 
Ozone was bubbled into the solution of (+)--citronellene (4.7 g, 34 mmol) in 
CH2Cl2 (200 mL) at –78 °C until the trisubstituted double bond was fully consumed. 5 mL of Me2S 
was added. The resulting solution was warmed to rt slowly, then was stirred at rt for 7 h. The 
reaction mixture was concentrated directly and the residue was purified by flash chromatography 
(pentane:Et2O = 10:1) to afford desired aldehyde 4.53 (3.2 g, 84%). 
1H NMR (300 MHz, CDCl3) 
 9.78 (s, 1H), 5.64 (quint, 1H, J = 9.3 Hz), 5.00 (d, 1H, J = 6.6 Hz), 4.96 (s, 1H), 2.44 (t, 2H, J = 
7.5 Hz), 2.21-2.11 (m, 1H), 1.74-1.53 (m, 2H), 1.03 (d, 3H, J = 6.6 Hz). 
 
(3S,4R)-7-Chloro-3-methylhept-1-en-4-ol (4.56) 
To a suspension of KOtBu (6.3 g, 56 mmol) in THF (25 mL) were added trans-2-
butene (10 mL) and nBuLi (35 mL, 1.6 M in hexanes, 56 mmol) dropwise 
successively at –78 °C under an atmosphere of argon. The resulting mixture was warmed to –45 
°C and stirred at –45 °C for 10 min. The mixture was cooled to –78 °C again and a solution of (–
)-(Ipc)2BOMe (17.8 g, 56.3 mmol) in Et2O (30 mL) was added dropwise over 20 min. The resulting 
mixture was stirred at –78 °C for 30 min, then BF3•Et2O (17.4 mL, 84.5 mmol) and a solution of 
4.62 (9.0 g, 84 mmol) in Et2O (10 mL) were added dropwise successively. After stirring at –78 °C 
for 8.5 h, NaOH (3M, 30 mL) was added into the reaction, followed by H2O2 (30%, 15 mL). Then 
reaction was refluxed for 1 h. After cooling to rt, the organic layer was separated and the aqueous 
layer was extracted with Et2O (3x). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated. The residue was purified by flash column chromatography (hexanes:EtOAc = 
100:1 to 20:1) to afford desired product (6.1 g, 67% yield, 83% ee as determined by Mosher ester 
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analysis). []25D +2.6 (c 2.54, CHCl3); 1H NMR (400 MHz, CDCl3):  5.74 (ddd, 1H, J = 8.4, 10.4, 
16.8 Hz), 5.16-5.15 (m, 1H), 5.13-5.10 (m, 1H), 3.59 (dt, 2H, J = 1.2, 6.4 Hz), 3.43-3.38 (m, 1H), 
2.24-2.16 (m, 1H), 2.05-1.95 (m, 1H), 1.91-1.81 (m, 1H), 1.76-1.68 (m, 1H), 1.66 (s, 1H), 1.53-
1.44 (m, 1H), 1.04 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3):  140.3, 117.0, 74.1, 45.5, 
44.7, 31.6, 29.2, 16.4; IR (neat) 3400, 2962, 2873, 1639, 1446, 1418, 1375, 1302, 1116, 1083, 
1000, 917, 724, 650 cm-1. 
 
((3S,4R)-7-Chloro-3-methylhept-1-en-4-yloxy)triethylsilane (4.64) 
To a solution of 4.56 (4.3 g, 26 mmol) and imidazole (3.6 g, 53 mmol) in CH2Cl2 
(50 mL) was added TESCl (5.8 mL, 34 mmol) dropwise at rt. The resulting 
suspension was stirred at rt for 3 h, was quenched with H2O, extracted with CH2Cl2 (2x). The 
combined organic layers were dried over Na2SO4, filtered, concentrated. The residue was purified 
by flash column chromatography (hexanes:EtOAc = 200:1 to 100:1) to afford desired product (7.3 
g, quantitative). []25D +1.8 (c 1.61, CHCl3); 1H NMR (400 MHz, CDCl3):  5.83-5.74 (m, 1H), 
5.05-5.03 (m, 1H), 5.01-5.00 (m, 1H), 3.64-3.60 (m, 1H), 3.53 (dt, 2H, J = 0.4, 6.4 Hz), 2.35-2.27 
(m, 1H), 1.93-1.82 (m, 1H), 1.80-1.69 (m, 1H), 1.55-1.48 (m, 2H), 1.02 (d, 3H, J = 6.8 Hz), 0.98 
(t, 9H, J = 8.0 Hz), 0.62 (q, 6H, J = 8.0 Hz); 13C NMR (100 MHz, CDCl3):  141.0, 114.8, 75.5, 
45.6, 43.6, 31.0, 29.4, 14.9, 7.2, 5.4; IR (neat) 2957, 2912, 2877, 1459, 1416, 1377, 1239, 1089, 
1041, 1006, 914, 741, 654 cm-1; HRMS (ESI) m/z calcd for C14H28OSiCl [M - H]
+ 275.1598, found 
275.1606. 
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(7S,8R,E)-11-Chloro-7-methyl-8-(triethylsilyloxy)undec-3-en-2-one (4.65) 
To a solution of 9-BBN dimer (1.7 g, 6.8 mmol) in THF (10 mL) was added 
a solution of 4.64 (2.1 g, 7.6 mmol) in THF (10 mL) dropwise at 0 °C under 
an atmosphere of argon. The resulting mixture was stirred for 4 h at rt, and 
then quenched with H2O (1.0 mL). An aqueous solution of K3PO4•H2O (2.6 g, 11 mmol, in 4 mL 
H2O) was added into the mixture, followed by 4.55 (1.6 g, 8.0 mmol) and [Pd(dppf)Cl2]•CH2Cl2 
(62 mg, 0.076 mmol). The flask was covered with alumina foil. After stirring at rt for 2 h, the 
mixture was poured into H2O and extracted with Et2O (3x). The combined organic layers were 
dried over Na2SO4, filtered, and concentrated. The residue was purified by flash column 
chromatography (hexanes:EtOAc = 50:1 to 10:1) to afford desired product ( 1.9 g, 73% yield). 
[]25D +2.0 (c 1.53, CHCl3); 1H NMR (400 MHz, CDCl3):  6.79 (td, 1H, J = 6.8, 16.0 Hz), 6.09 
(d, 1H, J = 16.0 Hz), 3.57-3.56 (m, 3H), 2.37-2.28 (m, 1H), 2.25 (s, 3H), 2.21-2.12 (m, 1H), 1.93-
1.85 (m, 1H), 1.80-1.69 (m, 1H), 1.61-1.49 (m, 3H), 1.31-1.22 (m, 1H), 0.96 (t, 9H, J = 8.0 Hz), 
0.89 (d, 3H, J = 6.4 Hz), 0.59 (q, 6H, J = 8.0 Hz); 13C NMR (100 MHz, CDCl3):  198.8, 148.5, 
131.6, 75.6, 45.7, 38.4, 31.3, 30.7, 30.0, 29.1, 27.0, 14.5, 7.2, 5.4; IR (neat) 2955, 2876, 1698, 
1677, 1627, 1571, 1459, 1415, 1361, 1252, 1085, 1008, 980, 742 cm-1; HRMS (ESI) m/z calcd for 
C18H36O2SiCl [M + H]
+ 347.2168, found 347.2151. 
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(10S,11R,E)-11-(3-Chloropropyl)-3,3,13,13-tetraethyl-10-methyl-5-methylene-4,12-dioxa-
3,13-disilapentadec-6-ene (4.54) 
To a solution of 4.65 (0.39 g, 1.1 mmol) and NEt3 (0.32 mL, 2.2 mmol) was 
added TESOTf (0.28 mL, 1.2 mmol) at 0 °C. The resulting solution was 
stirred for 30 min at 0 °C. Then the reaction was quenched with H2O and 
extracted with CH2Cl2 (2x). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated. The residue was purified by flash column chromatography (hexanes:EtOAc = 200:1 
to 100:1, column was pre-treated with 1% NEt3 hexanes solution) to afford desired product ( 0.50 
g, 96% yield). []25D +1.6 (c 1.31, CHCl3); 1H NMR (500 MHz, C6D6):  6.27 (td, 1H, J = 7.0, 
15.5 Hz), 5.98 (d, 1H, J = 15.0 Hz), 4.35 (s, 1H), 4.28 (s, 1H), 3.48-3.45 (m, 1H), 3.23-3.15 (m, 
2H), 2.19-2.12 (m, 1H), 2.05-1.97 (m, 1H), 1.82-1.74 (m, 1H), 1.63-1.55 (m, 2H), 1.49-1.30 (m, 
3H), 1.20-1.13 (m, 1H), 1.04 (t, 9H, J = 8.0 Hz), 1.01 (t, 9H, J = 8.0 Hz), 0.86 (d, 3H, J = 7.0 Hz), 
0.73 (q, 6H, J = 8.0 Hz),  0.60 (q, 6H, J = 8.0 Hz); 13C NMR (100 MHz, C6D6):  154.6, 130.5, 
127.7, 92.5, 74.7, 44.3, 37.4, 31.6, 29.3, 28.8, 28.4, 13.3, 6.2, 6.0, 4.6, 4.4; IR (neat) 2955, 2877, 
1656, 1591, 1459, 1414, 1379, 1317, 1239, 1085, 1016, 964, 813, 742, 672 cm-1; HRMS (ESI) m/z 
calcd for C24H50O2Si2Cl [M + H]
+ 461.3032, found 461.3016. 
 
(2R,6R,8R,9S)-8-(3-Chloropropyl)-9-methyl-2-((S)-3-methylpent-4-enyl)-1,7-
dioxaspiro[5.5]undecan-4-one (4.66) 
A flame dried 10 ml round-bottom flask was charged with 4 Å 
molecular sieves (150 mg) and 4.68 (24 mg, 0.033 mmol), and 
aldehyde 4.53 (247 mg, 2.2 mmol). The resulting mixture was stirred for 5 min at rt under argon. 
Diene 4.54 (507 mg, 1.1 mmol) was added through a 1 mL syringe. Another 2.0 eq. of aldehyde 
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4.53 (2467 mg, 2.2 mmol) was used to rinse the one drum vial that contained 4.54, and then 
transferred into the reaction. The brown slurry was stirred at rt for 24 h, then was diluted with 
CH2Cl2 (8 mL) and treated with DDQ (300 mg, 1.32 mmol). The resulting mixture was stirred at 
rt for 30 min, then TsOH•H2O (418 mg, 2.2 mmol) was added in one portion. The brown 
suspension was stirred at rt for 2 h then was quenched with NEt3 (0.5 mL). The black slurry was 
filtered by a short silica gel pad and further purified by flash column chromatography 
(hexanes:EtOAc = 20:1 to 10:1) to afford desired spiro ketal 4.66 (218.1 mg, 58% yield). []25D 
+42.7 (c 1.30, CHCl3); 
1H NMR (400 MHz, CDCl3):  5.71 (ddd, 1H, J = 7.6, 10.4, 17.6 Hz), 5.01-
4.95 (m, 2H), 3.79-3.72 (m, 1H), 3.59-3.47 (m, 2H), 3.16 (dt, 1H, J = 2.8, 9.6 Hz), 2.39 (s, 1H),  
2.36 (dd, 1H, J = 2.8, 14.4 Hz), 2.20 (dd, 1H, J = 11.6, 14.4 Hz), 2.20-2.14 (m, 1H), 2.01-1.91 (m, 
1H), 1.87-1.83 (m, 1H), 1.82-1.75 (m, 1H), 1.70-1.62 (br.m, 2H), 1.62-1.50 (br.m, 6H), 1.49-1.26 
(br.m, 3H), 1.04 (d, 3H, J = 6.8 Hz), 0.87 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3):  
206.4, 144.4, 113.3, 99.2, 75.5, 69.1, 52.1, 47.4, 45.8, 37.9, 35.5, 34.1, 34.0, 32.5, 30.5, 28.7, 28.1, 
20.5, 18.0; IR (neat) 2925, 2853, 1726, 1458, 1378, 1312, 1245, 1176, 1082, 1031, 981, 911 cm-1; 
HRMS (ESI) m/z calcd for C19H32O3Cl [M + H]
+ 343.2040, found 343.2040. 
 
(2R,3S,6S,8S)-2-(3-Chloropropyl)-3-methyl-8-((S)-3-methylpent-4-enyl)-1,7-
dioxaspiro[5.5]undecane (4.74) 
To a solution of 4.66 (292 mg, 0.85 mmol) in MeOH (11 mL) was 
added TsNHNH2 (317, 1.70 mmol) in one portion. The resulting 
solution was stirred at rt for 6 h, then was concentrate under reduced pressure. The residue was 
diluted with 30% EtOAc hexanes solution and filtered through a short silica gel pad. The filtrate 
was concentrated and re-dissolved in MeOH/THF (1/1, 16 mL). A solution of NaBH3CN (53 mg, 
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0.85 mmol) in MeOH (0.9 mL) was added at 0 °C. To the resulting solution was carefully added 
a 1N HCl stock solution in EtOH dropwise at 0 °C until TLC analysis indicated the total 
consumption of starting material. The reaction was diluted with Et2O and washed with H2O, sat. 
NaHCO3, and brine successively. The organic layer was dried over Na2SO4, filtered, and 
concentrated. The residue was dissolved in EtOH (20 mL) and degassed with N2 for 5 min. NaOAc 
(1.8 g) was added, followed by 1.5 mL H2O. The resulting mixture was degassed for another 5 
min with N2 and then transferred into a pre-heated oil bath (75 
oC). The reaction was stirred at 75 
oC for 30 min, then was cooled to rt, diluted with Et2O, then washed with H2O and brine 
successively. The organic layer was dried over Na2SO4, filtered, and concentrated. The residue 
was purified by flash column chromatography (hexanes:EtOAc = 100:1 to 50:1) to afford the 
desired product (151 mg, 54% yield for three steps). []25D +39.9 (c 0.76, CHCl3); 1H NMR (400 
MHz, CDCl3):  5.76-5.68 (m, 1H), 4.97 (d, 1H, J = 18.0 Hz), 4.93 (d, 1H, J = 10.8 Hz), 3.66-3.54 
(m, 2H), 3.48-3.40 (m, 1H), 3.18 (t, 1H, J = 10.0 Hz), 2.14-2.08 (m, 2H), 1.84-1.74 (m, 3H), 1.64-
1.38 (m, 11H), 1.35-1.26 (m, 3H), 1.21-1.12 (m, 1H), 1.01 (d, 3H, J = 6.8 Hz), 0.85 (d, 3H, J = 
6.4 Hz); 13C NMR (100 MHz, CDCl3):  144.9, 112.8, 95.7, 74.3, 69.4, 45.9, 37.9, 36.3, 35.7, 
35.2, 34.2, 32.9, 31.6, 30.9, 29.5, 28.1, 20.4, 19.4, 18.2; IR (neat) 2930, 2867, 1457, 1385, 1272, 
1225, 1181, 1094, 1033, 987, 956, 910 cm-1; HRMS (ESI) m/z calcd for C19H34O2Cl [M + H]
+ 
329.2247, found 329.2250. 
 
(S,E)-6-((2S,6S,8R,9S)-8-(3-Chloropropyl)-9-methyl-1,7-dioxaspiro[5.5]undecan-2-yl)-2,4-
dimethylhex-2-enal (4.76) 
To a solution of 4.74 (28 mg, 0.085 mmol) in freshly distilled 
methacrolein/dry CH2Cl2 (5/1, 1.2 mL) was added Grela-
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Grubbs metathesis catalyst (7.1 mg, 0.011 mmol). The reaction was stirred at 40 °C for 4 h, then 
was cooled to rt and stirred overnight. The resulting dark green solution was concentrated and 
purified by flash column chromatography (hexanes:EtOAc = 50:1 to 20:1) to afford 4.76 (21.7 mg, 
E/Z = 8.8/1, 68% yield). []25D +18.6 (c 1.45, CHCl3); 1H NMR (400 MHz, CDCl3):  9.41 (s, 
1H), 6.28 (d, 1H, J = 10.0 Hz), 3.66-3.53 (m, 2H), 3.48-3.43 (m, 1H), 3.15 (dt, 1H, J = 2.0, 10.0 
Hz), 2.74-2.67 (m, 1H), 2.16-2.10 (m, 1H), 1.88-1.73 (m, 2H), 1.76 (s, 3H), 1.64-1.26 (m, 15H), 
1.21-1.11 (m, 1H), 1.09 (d, 3H, J = 6.8 Hz), 0.85 (d, 3H, J = 6.4 Hz); 13C NMR (100 MHz, CDCl3): 
 195.8, 160.5, 138.3, 95.7, 74.4, 69.1, 45.8, 36.2, 35.6, 35.2, 34.4, 33.8, 33.0, 31.5, 30.9, 29.5, 
28.1, 20.1, 19.3, 18.2, 9.7; IR (neat) 2932, 2870, 1690, 1640, 1457, 1386, 1272, 1225, 1183, 1095, 
1030, 987, 957, 918, 878, 820, 652 cm-1; HRMS (ESI) m/z calcd for C21H36O3Cl [M + H]
+ 
371.2353, found 371.2344. 
 
(2S,5S,E)-7-((2S,6S,8R,9S)-8-(3-Chloropropyl)-9-methyl-1,7-dioxaspiro[5.5]undecan-2-yl)-
3,5-dimethylhept-3-en-2-ol (4.78) 
A flame dried Schlenk flask was charged with (–)-MIB (38 
mg, 0.16 mmol), hexanes (0.5 mL), and a freshly prepared 
solution of ZnMe2 (75 mg, 0.79 mmol) in hexanes (0.5 mL) successively at rt under argon. A 
solution of 4.76 (29 mg, 0.079 mmol) in hexanes (0.5 mL) was added dropwise at rt. The resulting 
milky mixture was stirred at rt overnight. The reaction was quenched by adding sat. NH4Cl (1 mL), 
then was extracted with Et2O (3x). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated. The residue was purified by flash column chromatography (hexanes:EtOAt = 
10:1 to 4:1) to afford desired product (26 mg, 86%). []25D +33.0 (c 0.66, CHCl3); 1H NMR (400 
MHz, CDCl3):  5.19 (d, 1H, J = 9.6 Hz), 4.25-4.20 (m, 1H), 3.66-3.54 (m, 2H), 3.46-3.41 (m, 
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1H), 3.17 (dt, 1H, J = 2.4, 10.0 Hz), 2.40-2.33 (m, 1H), 2.19-2.08 (m, 1H), 1.87-1.76 (m, 3H), 1.64 
(d, 3H, J = 1.6 Hz), 1.62-1.45 (m, 5H), 1.44-1.29 (m, 9H), 1.26 (d, 3H, J = 6.4 Hz), 0.97 (d, 3H, J 
= 6.8 Hz), 0.85 (d, 3H, J = 9.2 Hz); 13C NMR (100 MHz, CDCl3):  137.4, 131.8, 95.7, 74.3, 73.8, 
69.3, 45.8, 36.3, 35.7, 35.2, 34.4, 33.8, 32.1, 31.6, 30.9, 29.5, 28.1, 21.9, 21.2, 19.4, 18.2, 11.8; IR 
(neat) 3419, 2931, 2868, 1456, 1386, 1272, 1225, 1182, 1090, 1032, 986 cm-1; HRMS (ESI) m/z 
calcd for C22H40O3Cl [M + H]
+ 387.2547, found 387.2666. 
 
(2S,5S,E)-7-((2S,6S,8R,9S)-8-(3-Azidopropyl)-9-methyl-1,7-dioxaspiro[5.5]undecan-2-yl)-
3,5-dimethylhept-3-en-2-ol (4.83) 
To a solution of 4.78 (10 mg, 0.027 mmol) in DMF (0.2 mL) 
was added NaN3 in one portion. The resulting mixture was 
stirred at 60 °C for 8 h, then was purified directly by flash chromatography (hexanes:EtOAc = 10:1 
to 5:1) to afford 4.83 (10.6 mg, quantitative). []25D +28.7 (c 0.47, CHCl3); 1H NMR (400 MHz, 
CDCl3):  5.19 (d, 1H, J = 9.2 Hz), 4.22 (q, 1H, J = 6.4 Hz), 3.46-3.44 (m, 1H), 3.40-3.27 (m, 2H), 
3.17 (dt, 1H, J = 2.4 Hz), 2.38-2.33 (m, 1H), 2.00-1.90 (m, 1H), 1.88-1.71 (m, 2H), 1.64 (d, 3H, J 
= 1.2 Hz), 1.63-1.29 (m, 15H), 1.26 (d, 3H, J = 6.4 Hz), 0.97 (d, 3H, J = 6.8 Hz), 0.85 (d, 3H, J = 
6.4 Hz); 13C NMR (100 MHz, CDCl3):  137.4, 131.8, 95.7, 74.4, 73.7, 69.4, 52.2, 36.3, 35.6, 
35.2, 34.4, 33.8, 32.1, 31.6, 30.6, 28.1, 25.7, 21.9, 21.2, 19.4, 18.2, 11.8; IR (neat) 3424, 2930, 
2867, 1456, 1385, 1225, 1095, 1034, 985 cm-1; HRMS (ESI) m/z calcd for C22H38O2N3 [M – OH]+ 
376.2964, found 376.2964. 
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(3S,4S)-1-(tert-Butyldimethylsilyloxy)-4-methylhex-5-en-3-ol (4.60) 
To a solution of 1,3-propanediol (10 mL, 0.14 mol) in THF (150 mL) were added 
imidazole (3.8 g, 0.055 mol) and TBSCl (4.2 g, 0.028 mol) successively. The 
resulting mixture was stirred at rt overnight, then quenched with H2O and extracted with Et2O (3x). 
The combined organic layers were dried over Na2SO4, filtered, and concentrated. The residue was 
purified by flash column chromatography to afford 3-(tert-butyldimethylsilyloxy)propan-1-ol (5.1 
g, 95% yield) as colorless oil. This freshly prepared mono-protected diol was re-dissolved in 
CH2Cl2 (20 mL) and treated with DMSO (26 mL), NEt3 (11 mL, 0.081 mol), SO3•Py (6.4 g, 0.04 
mol) successively. The resulting yellow solution was stirred at rt for 4 h, then was quenched with 
H2O. The aqueous layer was extracted with CH2Cl2 (3x). The combined organic layers were dried 
over Na2SO4, filtered, and purified by flash column chromatography (hexanes:EtOAc = 50:1 to 
20:1) to afford 3-(tert-butyldimethylsilyloxy)propanal (4.5 g, 88% yield). To a suspension of 
KOtBu (2.2 g, 20 mmol) in THF (45 mL) were added cis-2-butene (8 mL, 90 mmol) and nBuLi 
(1.6 M in hexanes, 12 mL, 20 mmol) successively at –78 °C under argon. The resulting orange 
solution was warmed to –45 °C and stirred for 10 min at this temperature. The reaction was cooled 
to –78 °C and a solution of (+)-(Ipc)2BOMe (6.3 g, 20 mmol) in THF (20 mL) was added dropwise. 
After stirring at –78 °C for 30 min, BF3•OEt2 (2.5 mL, 20 mmol) was added dropwise, followed 
by 3-(tert-butyldimethylsilyloxy)propanal (3.4 g, 18 mmol). The resulting mixture was stirred at 
–78 °C for 3.5 h. Then NaOH (3.0 M aqueous solution, 25 mL) and H2O2 (30%, 15 mL) were 
added successively and the reaction was stirred at rt overnight. The organic layer was separated 
and the aqueous layer was extracted with Et2O (3x). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated. The residue was purified by flash column chromatography 
(hexanes:EtOAc = 100:1 to 20:1) to afford desired product (2.94 g, 67% yield, 87% ee as 
  
 
 
172 
determined by Mosher ester analysis). []25D –6.2 (c 1.10, CHCl3); 1H NMR (400 MHz, CDCl3): 
 5.79 (ddd, 1H, J = 7.6, 10.4, 17.6 Hz), 5.09-5.02 (m, 2H), 3.93-3.88 (m, 1H), 3.82-3.78 (m, 1H), 
3.68 (ddd, 1H, J = 2.4, 6.0, 8.8 Hz), 3.36 (s, 1H), 2.31-2.22 (m, 1H), 1.73-1.57 (m, 2H), 1.07 (d, 
3H, J = 6.8 Hz), 0.91 (s, 9H), 0.08 (s, 6H); 13C NMR (100 MHz, CDCl3):  141.4, 115.0, 75.6, 
63.2, 44.2, 35.7, 26.1, 18.4, 15.4, –5.3, –5.3; IR (neat) 3450, 2956, 2930, 2858, 1471, 1388, 1362, 
1256, 1086, 1005, 939, 912, 836, 777 cm-1; HRMS (ESI) m/z calcd for C13H27OSi [M – OH]+ 
227.1816, found 227.1831. 
 
(5S,6S)-6-(2-(tert-Butyldimethylsilyloxy)ethyl)-5-methyltetrahydro-2H-pyran-2-yl acetate 
(4.84) 
Warning: The CO/H2 mixture must be handled in a well-ventilated fume 
hood and the reaction should be conducted behind a blast shield because 
high pressure is required. 
To a solution of 6-diphenylphosphanyl-2-pyridone 4.85 (6-DPPon, 1.94 g, 6.95 mmol) in THF (40 
mL) was added [Rh(CO)2acac] (359 mg, 1.39 mmol) in three portions, followed by a solution of 
4.60 (6.8 g, 28 mmol) in THF (10 mL). The resulting dark brown mixture was sealed in a high-
pressure reactor under an atmosphere of CO/H2 gas (1/1, 120 psi) and stirred at rt for 48 h. The 
mixture was exposed in air and diluted with CH2Cl2 (200 mL). NEt3 (5.8 mL, 42 mmol), DMAP 
(170 mg, 1.4 mmol) and Ac2O (3.2 mL, 33 mmol) were added successively at rt. The resulting 
brown solution was stirred for 3 h at rt, then quenched with sat. NaHCO3, extracted with Et2O (3x). 
The combined organic layers were dried over NasSO4, filtered, and concentrated. The residue was 
purified by flash column chromatography (hexanes:EtOAc = 20:1 to 10:1) to afford desired 
product (8.0 g, d.r. = 6/1, 91% yield) as a pale yellow oil. []25D  (c , CHCl3); 1H NMR (400 MHz, 
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CDCl3):  6.02 (d, 0.16H, J = 3.2 Hz), 5.61 (dd, 1H, J = 3.2, 8.4 Hz), 4.10-4.06 (m, 0.16H), 3.75 
(ddd, 1H, J = 2.4, 4.0, 9.2 Hz), 3.69-3.59 (m, 2.32 H), 2.04 (s, 3H), 2.02 (s, 0.48H), 1.81-1.48 (m, 
8.12H), 0.93 (d, 3H, J = 7.2 Hz), 0.93 (d, 0.48H, J = 7.2 Hz), 0.85 (s, 10.6H), 0.01 (d, 6.96H, J = 
4.0 Hz); 13C NMR (100 MHz, CDCl3):  169.8, 169.3, 95.5, 92.6, 75.8, 69.6, 59.7, 59.6, 36.1, 
35.9, 30.4, 30.2, 29.1, 26.0, 25.5, 25.5, 21.3, 18.4, 18.4, 12.1, 11.3, –5.2, –5.3, –5.3; IR (neat) 2952, 
2739, 1754, 1471, 1440, 1364, 1304, 1235, 1038, 1008, 955, 888, 838, 777, 734, 681, 663, 605 
cm-1; HRMS (ESI) m/z calcd for C16H32O4NaSi [M + Na]
+ 339.1962, found 339.1954. 
 
(E)-1-((2R,5S,6S)-6-(2-Hydroxyethyl)-5-methyltetrahydro-2H-pyran-2-yl)pent-3-en-2-one 
(4.88) 
To a solution of (E)-pent-3-en-2-one (40 mg, 0.48 mmol) in dry CH2Cl2 
(3 mL) was added freshly distilled NEt3 (0.11 mL, 0.80 mmol) and 
freshly distilled TMSOTf (0.12 mL, 0.64 mmol) successively at 0 °C under an atmosphere of 
argon. The resulting solution was stirred at 0 °C for 1 h, then the reaction was cooled to -78 °C, 
and a solution of 4.84 (102 mg, 0.32 mmol) in dry CH2Cl2 (4 mL) was added. After stirring at -78 
°C for 10 min, freshly distilled TMSOTf (0.07 mL, 0.38 mmol) was added. The resulting solution 
was stirred at -78 °C for 10 min, then was quenched with sat. NH4Cl and extracted with CH2Cl2 
(3x). The combined organic layers were dried over Na2SO4, filtered, and concentrated. The residue 
was purified by flash column chromatography (hexanes:EtOAc = 4:1 to 2:1) to afford the desired 
product (41 mg, 57%). []25D -50.8 (c 1.08, CHCl3); 1H NMR (400 MHz, CDCl3):  6.93-6.84 (m, 
1H), 6.15 (dd, 1H, J = 1.2, 16.0 Hz), 4.21-4.14 (m, 1H), 3.95-3.91 (m, 1H), 3.75 (td, 2H, J = 1.6, 
5.2 Hz), 2.87 (dd, 1H, J = 8.8, 15.6 Hz), 2.77 (t, 1H, J = 2.4 Hz), 2.53 (dd, 1H, J = 4.4, 15.6 Hz), 
2.02-1.93 (m, 1H), 1.90 (dd, 3H, J = 1.2, 6.8 Hz), 1.87-1.81 (m, 1H), 1.77-1.71 (m, 1H), 1.67-1.61 
  
 
 
174 
(m, 1H), 1.50-1.39 (m, 2H), 1.36-1.26 (m, 1H), 0.84 (d, 3H, J = 7.2 Hz); 13C NMR (100 MHz, 
CDCl3):  198.9, 143.8, 132.4, 75.6, 66.3, 60.9, 45.8, 33.2, 30.4, 28.8, 26.7, 18.5, 16.6; IR (neat) 
3436, 2932, 1672, 1630, 1440, 1380, 1292, 1057, 970 cm-1; HRMS (ESI) m/z calcd for C13H23O3 
[M + H]+ 227.1647, found 227.1665. 
 
2,5-Dioxopyrrolidin-1-yl 2-((2S,3S,6R)-3-methyl-6-((E)-2-oxopent-3-enyl)tetrahydro-2H-
pyran-2-yl)acetate (4.59) 
To a solution of 4.88 (142 mg, 0.625 mmol) in wet CH3CN (0.75 v 
%, water, 3.4 mL) was slowly added a stock solution of H5IO6/CrO3 
in wet CH3CN (5.7 g H5IO6 and 12.5 mg CrO3 in 57 mL wet CH3CN, 3.4 mL) dropwise at 0 °C 
over 30 min. The resulting mixture was stirred at 0 °C for 30 min. A solution of Na2HPO4 (0.8 g) 
in H2O (10 mL) was added, followed by EtOAc (20 mL). The reaction mixture was stirred at rt for 
1 h. The organic layer was separated. The remaining aqueous layer was acidified by conc. HCl 
(0.3 mL) and extract with EtOAc (3x). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated. The residue was re-dissolved in CH3CN (7.4 mL) and treated with N-
hydroxysuccinimide (79 mg, 0.69 mmol) and DCC (129 mg, 0.625 mmol) successively. The 
resulting mixture was stirred at rt for 11 h then was filtered. The filtrate was concentrated and 
purified by flash column chromatography (DCM:MeOH = 50:1) to afford desired product (172 
mg, 81% yield). []25D -41.6 (c 1.31, CHCl3); 1H NMR (400 MHz, CDCl3):  6.90-6.82 (m, 1H), 
6.11 (d, 1H, J = 16.0 Hz), 4.37-4.36 (m, 1H), 4.13-4.09 (m, 1H), 3.05-2.95 (m, 2H), 2.82 (s, 4H), 
2.71-2.60 (m, 2H), 2.04-2.00 (m, 1H), 1.89 (d, 3H, J = 6.8 Hz), 1.82 (d, 1H, J = 12.8 Hz), 1.68 (d, 
1H, J = 12.4 Hz), 1.44-1.24 (m, 2H), 0.87 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3):  
198.3, 168.9, 167.0, 143.3, 132.5, 73.7, 67.0, 45.3, 32.5, 30.4, 29.8, 26.3, 25.6, 18.3, 16.4; IR (neat) 
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2934, 2876, 1815, 1785, 1741, 1693, 1668, 1630, 1435, 1364, 1294, 1205, 1065, 992, 972, 867, 
815, 648 cm-1; HRMS (ESI) m/z calcd for C17H23NO6Na [M + Na]
+ 360.1423, found 360.1416. 
 
tert-Butyl 2-oxoethylcarbamate (4.89) 
To a solution of allylamine (9.0 g, 0.16 mol) in CH2Cl2 (250 mL) was slowly added 
di-tert-butyl dicarbonate (28.6 mL, 0.158 mol) at rt, followed by NEt3 (20.7 mL, 0.148 mol). The 
resulting solution was stirred at rt overnight, then was concentrated under reduced pressure to yield 
tert-butyl allylcarbamate (24.6 g, quantitative) as white crystal. The allylcarbamate (10 g, 0.064 
mol) was dissolved in CH2Cl2 (200 mL). The reaction solution was cooled to -78 °C, then ozone 
gas was bubbled into the solution until it turned to blue. Me2S (9.4 mL, 0.13 mol) was added in 
one portion. After stirring at rt for 4 h, the reaction mixture was concentrated and purified by flash 
columne chromatography (hexanes:EtOAc = 4:1 to 2:1) to afford the desired product (7.2 g, 71% 
yield for two steps). 1H NMR (400 MHz, CDCl3):  9.65 (s, 1H), 5.22 (br.s, 1H), 4.06 (d, 2H, J = 
5.2 Hz), 1.45 (s, 9H); 13C NMR (100 MHz, CDCl3):  197.3, 155.8, 80.4, 51.6, 28.5; IR (neat) 
3361, 2979, 2933, 1693, 1519, 1456, 1393, 1368, 1251, 1170, 1090, 1040, 974, 855, 782 cm-1. 
 
tert-Butyl (2R,3R)-2-hydroxy-3-methylpent-4-enylcarbamate (4.58) 
To a suspension of KOtBu (2.3 g, 20.7 mmol) in THF (50 mL) under argon was 
added trans-2-butene (10 mL, 113 mmol) and nBuLi (1.6 M in hexanes, 12.9 
mL, 20.7 mmol) successively at –78 °C. The resulting orange solution was warmed to –45 °C and 
stirred for 10 min at this temperature. Then the reaction was cooled to –78 °C and a solution of 
(+)-(Ipc)2BOMe (6.5 g, 21 mmol) in THF (20 mL) was added dropwise. After stirring at –78 °C 
for 30 min, BF3•OEt2 (2.6 mL, 21 mmol) was added dropwise, followed by a solution of 4.89 (3.0 
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g, 19 mmol) in THF (8 mL).  The resulting mixture was stirred at –78 oC for 3 h. Then NaOH (3.0 
M aqueous solution, 20 mL) and H2O2 (30%, 20 mL) were added successively and the reaction 
was stirred at rt overnight. The organic layer was separated and the aqueous layer was extracted 
with Et2O (3x). The combined organic layers were dried over Na2SO4, filtered, and concentrated. 
The residue was purified by flash column chromatography (hexanes:EtOAc = 8:1 to 2:1) to afford 
desired product (2.27 g, 56% yield, 90% ee as determined by Mosher ester analysis). []25D -1.9 
(c 1.19, CHCl3); 
1H NMR (400 MHz, CDCl3):  5.81-5.72 (m, 1H), 5.16 (s, 1H), 5.13-5.11 (m, 
1H), 4.94 (br.s, 1H), 3.49 (dt, 1H, J = 2.8, 7.2 Hz), 3.38-3.35 (m, 1H), 3.08 (ddd, 1H, J = 4.8, 8.0, 
14.0 Hz), 2.29-2.20 (m, 1H), 1.45 (s, 9H), 1.06 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3): 
 156.8, 140.1, 117.0, 79.7, 74.4, 44.5, 42.6, 28.6, 16.3; IR (neat) 3374, 3076, 2976, 2932, 1692, 
1518, 1455, 1392, 1367, 1252, 1172, 1095, 1042, 1002, 915, 887, 781 cm-1; HRMS (ESI) m/z calcd 
for C11H22O3N [M + H]
+ 216.1600, found 216.1586. 
 
(R)-tert-Butyl 5-((R)-but-3-en-2-yl)-2,2-dimethyloxazolidine-3-carboxylate (4.90) 
To a solution of 4.89 (170 mg, 0.79 mmol) in 2,2-dimethoxypropane (2.0 mL) and 
acetone (8.0 mL) was added p-TsOH•H2O (15 mg, 0.08 mmol) in one portion. The 
resulting solution was stirred at rt for 5 min, then was quenched with sat. NaHCO3, extracted with 
Et2O, dried over Na2SO4, filtered, and concentrated. The residue was purified by flash column 
chromatography (hexanes:EtOAc = 100:1 to 50:1) to afford desired product (159 mg, 79% yield). 
[]25D -16.9 (c 1.33, CHCl3); 1H NMR (400 MHz, CDCl3):  5.88-5.80 (m, 1H), 5.11-5.06 (m, 
2H), 3.92 (td, 1H, J = 6.4, 9.6Hz), 3.65-3.52 (m, 1H), 3.18-3.10 (m, 1H), 2.41-2.33 (m, 2H), 1.52 
(t, 3H, J = 15.2 Hz), 1.47 (s, 12H), 1.03 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3):  179.5, 
152.6, 152.1, 94.2, 93.2, 80.7, 80.0, 74.5, 48.6, 48.4, 43.3, 43.1, 28.6, 27.3, 26.3, 25.4, 24.5, 13.1, 
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12.8; IR (neat) 3080, 2978, 2935, 2876, 1703, 1642, 1478, 1457, 1394, 1255, 1214, 1178, 1095, 
1053, 1005, 916, 876, 770, 679 cm-1; HRMS (ESI) m/z calcd for C14H26O3N [M + H]
+ 256.1913, 
found 256.1894. 
 
(2R,3S)-3-Carboxy-2-hydroxybutan-1-aminium chloride (4.57) 
To a solution of 4.90 (1.01 g, 3.96 mmol) in CH3CN (7.3 mL) was added CCl4 
(7.3 mL), H2O (9.1 mL), NaIO4 (3.46 g, 16.2 mmol) and RuCl3 (41 mg, 0.20 
mmol) at rt. The resulting mixture was stirred at rt overnight, then was diluted with CH2Cl2 and 
H2O. After filtering through a Celite
® pad, the organic layer in the filtrate was separated and 
aqueous layer was extracted with CH2Cl2 (3x). The combined organic layers (include the original 
organic layer) were dried over MgSO4, filtered, and concentrated. A short silica column 
(CH2Cl2:MeOH = 20:1 to 10:1) was used to purify the crude acid. The residue was re-dissolved in 
EtOAc (15 mL) and treated with 3 N HCl (aq., 15 mL). After stirred at 35 °C for 1 h, the reaction 
mixture was diluted with EtOAc and H2O. The aqueous layer was washed with EtOAc three times, 
then was concentrated under reduced pressure to afford the desired salt (415 mg, 62% yield for 
two stpes). 1H NMR (400 MHz, D2O):  4.03 (ddd, 1H, J = 2.8, 7.6, 10.4 Hz), 3.29 (dd, 1H, J = 
2.4, 13.2 Hz), 3.06 (dd, 1H,  J = 10.4, 13.2 Hz), 2.70 (quint., 1H, J = 7.2 Hz), 1.21 (d, 3H, J = 7.2 
Hz); 13C NMR (125 MHz, D2O):  178.1, 69.2, 44.2, 42.4, 12.8. 
 
(2S,3R)-2,5-Dioxopyrrolidin-1-yl 3-hydroxy-2-methyl-4-(2-((2S,3S,6R)-3-methyl-6-((E)-2-
oxopent-3-enyl)tetrahydro-2H-pyran-2-yl)acetamido)butanoate (4.52) 
To a solution of 4.57 (70 mg, 0.41 mmol) in DMF (3 mL) 
was added diisopropylethylamine (0.48 mL, 2.7 mmol) 
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and a solution of 4.59 (92 mg, 0.27 mmol) in DMF (1 mL) successively at rt. The resulting mixture 
was stirred at rt for 1.5 h, then was diluted with EtOAc and H2O. The aqueous layer was separated 
and acidified with 0.05 M aq. HCl. The aqueous layer was extracted with EtOAc (3x). The 
combined organic layers (not included the original organic layer) were dried over Na2SO4, filtered, 
and concentrated. The residue was re-dissolved in CH3CN (5 mL). N-Hydroxysuccinimide (34 
mg, 0.30 mmol) and DCC (56 mg, 0.27 mmol) were added successively. The resulting suspension 
was filtered after stirred at rt for 16.5 h then was filtrated. The filtrate was concentrated and purified 
by flash column chromatography (CH2Cl2:MeOH = 50:1) to afford desired product (62 mg, 50% 
yield). []25D -18.4 (c 1.03, CHCl3); 1H NMR (400 MHz, CDCl3):  7.4 (s, 1H), 6.96-6.87 (m, 1H), 
6.15 (dd, 1H, J = 1.6, 16.0 Hz), 4.21 (t, 1H, J = 9.6 Hz), 4.08 (dd, 1H, J = 4.8, 11.6 Hz), 4.00 (dt, 
1H, J = 2.0, 7.2 Hz), 3.69 (ddd, 1H, J = 2.4, 6.0, 14.0 Hz), 3.38-3.32 (m, 1H), 2.97-2.88 (m, 2H), 
2.84 (s, 4H), 2.80 (dd, 1H, J = 11.6, 15.2 Hz), 2.56 (dd, 1H, J = 2.4, 16.8 Hz), 2.18 (dd, 1H, J = 
1.2, 15.6 Hz), 1.92 (dd, 3H, J = 1.2, 6.8 Hz), 1.69-1.61 (m, 2H), 1.43 (d, 3H, J = 3.6 Hz), 1.41-
1.22 (m, 3H), 0.87 (d, 3H, J = 7.2 Hz); 13C NMR (125 MHz, CDCl3):  199.6, 173.7, 170.2, 169.3, 
145.1, 132.3, 75.1, 73.2, 64.8, 45.6, 43.9, 42.5, 33.6, 32.2, 31.1, 29.9, 26.7, 25.8, 18.6, 17.5, 13.8; 
IR (neat) 3321, 2925, 2849, 1811, 1780, 1736, 1623, 1535, 1434, 1365, 1310, 1259, 1204, 1065, 
801, 641 cm-1; HRMS (ESI) m/z calcd for C22H33N2O8 [M + H]
+ 453.2237, found 453.2231. 
 
Bistramide A (4.1) 
To a solution of 4.83 (7.0 mg, 
0.018 mmol) in THF/H2O 
(3/1, 1.2 mL) was added PMe3 (1.0 M in THF, 0.089 mL, 0.089 mmol) at rt. The resulting solution 
was stirred for 1 h and poured into brine. The aqueous layer was extracted with Et2O (3x). The 
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combined organic layers were dried over MgSO4, filtered, and concentrated. The residue was 
dissolved in DMF (0.9 mL) and 4.52 (8.0 mg, 0.018 mmol) was added in one portion. The resulting 
light yellow solution was stirred at rt overnight. The reaction mixture was diluted with CH2Cl2 and 
washed with H2O (2x). The organic layer was dried over Na2SO4, filtered, and concentrated. The 
residue was purified by flash column chromatography (CH2Cl2:MeOH = 30:1 to 15:1) to afford 
bistramide A (8.7 mg, 69% yield). []25D +6.1 (c 0.61, CH2Cl2), the reported optical rotation value 
for natural Bistramide A is +10 (c 0.5, CH2Cl2); 1H NMR (400 MHz, CDCl3):  7.32 (br.t, 1H, J 
= 6.0 Hz), 6.96-6.94 (br.m, 1H), 6.91 (dd, 1H, J = 6.8, 15.6 Hz), 6.13 (dd, 1H, J = 1.6, 15.6 Hz), 
5.19 (d, 1H, J = 9.6 Hz), 4.62 (br.s, 1H), 4.22-4.18 (m, 2H), 4.07 (dd, 1H, J = 4.8, 11.2 Hz), 3.72 
(q, 1H, J = 4.8 Hz), 3.51 (dt, 1H, J = 5.4, 14.0 Hz), 3.45 (m, 1H), 3.31 (dt, 2H, J = 6.8, 12.8 Hz), 
3.24 (dt, 1H, J = 6.0, 14.0 Hz), 3.16 (dt, 1H, J = 2.0, 9.6 Hz), 2.91 (dd, 1H, J = 8.8, 16.8 Hz), 2.76 
(dd, 1H, J = 11.6, 14.8 Hz), 2.53 (dd, 1H, J = 2.8, 17.2 Hz), 2.42-2.34 (m. 2H), 2.15 (dd, 1H, J = 
1.2, 15.2 Hz), 1.93 (dd, 3H, J = 1.6, 6.8 Hz), 1.86-1.30 (br.m, 28H), 1.26 (t, 6H, J = 6.8 Hz), 0.96 
(d, 3H, J = 6.8 Hz), 0.89 (d, 3H, J = 7.6 Hz), 0.82 (d, 3H, J = 6.4 Hz); 13C NMR (125 MHz, 
CDCl3):  199.1, 175.4, 173.7, 144.7, 137.4, 132.3, 131.6, 95.7, 75.0, 74.5, 74.1, 73.5, 69.3, 65.0, 
45.5, 44.9, 43.6, 39.7, 36.3, 35.7, 35.1, 34.3, 33.7, 33.6, 32.5, 32.1, 31.6, 31.0, 30.7, 28.1, 26.7, 
26.1, 22.0, 21.2, 19.4, 18.6, 18.2, 17.4, 15.8, 12.0; IR (neat) 3600-3200 (brs), 2927, 2856, 1649, 
1550, 1456, 1378, 1295, 1225, 986, 733 cm-1; HRMS (ES) m/z calcd for C40H69N2O8 [M + H]
+ 
705.5054, found 705.5065. 
 
General procedure for the Mosher ester analysis 
The secondary alcohol substrate (1.0 eq.) was treated with Mosher acid solution in dry CH2Cl2 
(0.12 M, 1.5 eq.), DCC solution in dry CH2Cl2 (0.069 M, 2.0 eq.), and DMAP solution in dry 
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CH2Cl2 (0.11 M, 0.1 eq.) successively at rt. The resulting mixture was stirred at rt overnight, then 
filtered through a Celite® pad. The filtrate was concentrated under reduced pressure. The residue 
was purified by flash column chromatography to afford the desired Mosher ester. 
 
(R)-((3S,4R)-7-Chloro-3-methylhept-1-en-4-yl)-3,3,3-trifluoro-2-methoxy-2-
phenylpropanoate (S4.1) 
1H NMR (400 MHz, CDCl3)  7.58-7.55 (m, 2H), 7.43-7.39 (m, 3H), 5.72 (ddd, 
1H, J = 8.0, 10.0, 17.6 Hz), 5.12-5.07 (m, 3H), 3.56 (d, 3H, J = 1.2 Hz), 3.44 (t, 
2H, J = 6.0 Hz), 2.57-2.48 (m, 1H), 1.78-1.60 (m, 4H), 1.04 (d, 3H, J = 6.8 Hz). 
 
(S)-((3S,4R)-7-Chloro-3-methylhept-1-en-4-yl)-3,3,3-trifluoro-2-methoxy-2-
phenylpropanoate (S4.2) 
1H NMR (400 MHz, CDCl3)  7.57-7.55 (m, 2H), 7.44-7.40 (m, 3H), 5.68 (ddd, 
1H, J = 8.0, 10.0, 18.0 Hz), 5.11-5.06 (m, 2H), 5.03 (d, 1H, J = 0.4 Hz), 3.55 (d, 
3H, J = 1.2 Hz), 3.53-3.50 (m, 2H), 2.53-2.45 (m, 1H), 1.79-1.76 (m, 4H), 0.96 
(d, 3H, J = 6.8 Hz). 
 
(R)-((3R,4S)-1-(tert-Butyldimethylsilyloxy)-4-methylhex-5-en-3-yl)-3,3,3-trifluoro-2-
methoxy-2-phenylpropanoate (S4.3) 
1H NMR (400 MHz, CDCl3)  7.57-7.55 (m, 2H), 7.43-7.38 (m, 3H), 5.87 (ddd, 
1H, J = 7.2, 10.4, 17.6 Hz), 5.23 (quint. 1H, J = 4.4 Hz), 5.01 (td, 1H, J = 1.6, 
11.2 Hz), 4.97 (td, 1H, J = 1.6, 17.2 Hz), 3.68-3.58 (m, 2H), 3.57-3.56 (m, 1H), 
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3.55 (d, 3H, J = 1.2 Hz), 2.58-2.53 (m, 1H), 1.90-1.76 (m, 2H), 1.00 (d, 3H, J = 6.8 Hz), 0.89 (s, 
9H), 0.02 (s, 6H). 
 
(S)-((3R,4S)-1-(tert-Butyldimethylsilyloxy)-4-methylhex-5-en-3-yl)-3,3,3-trifluoro-2-
methoxy-2-phenylpropanoate (S4.4) 
1H NMR (400 MHz, CDCl3)  7.57-7.55 (m, 2H), 7.41-7.38 (m, 3H), 5.80 (ddd, 
1H, J = 6.8, 10.4, 17.2 Hz), 5.24 (quint., 1H, J = 4.4 Hz), 5.10 (td, 1H, J = 1.6, 
6.8 Hz), 5.06 (td, 1H, J = 1.6, 13.6 Hz), 3.58-3.53 (m, 2H), 3.55 (d, 3H, J = 1.2 
Hz), 3.51-3.44 (m, 1H), 2.65-2.58 (m, 1H), 1.85-1.73 (m, 2H), 1.04 (d, 3H, J = 6.8 Hz), 0.89 (s, 
9H), 0.02 (d, 6H, J = 3.6 Hz). 
 
(R)-((2R,3R)-1-(tert-Butoxycarbonylamino)-3-methylpent-4-en-2-yl)-3,3,3-trifluoro-2-
methoxy-2-phenylpropanoate (S4.5) 
1H NMR (400 MHz, CDCl3)  7.56-7.54 (m, 2H), 7.44-7.42 (m, 3H), 5.67 (ddd, 
1H, J = 8.4, 10.4, 18.4 Hz), 5.21-5.16 (m, 1H), 5.07 (d, 1H, J = 9.6 Hz), 5.03 (s, 
1H), 4.55 (br.s, 1H), 3.53 (d, 3H, J = 1.2 Hz), 3.45-3.41 (m, 1H), 3.27-3.20 (m, 
1H), 2.53-2.48 (m, 1H), 1.44 (s, 9H), 0.99 (d, 3H, J = 6.8 Hz). 
 
(S)-((2R,3R)-1-(tert-Butoxycarbonylamino)-3-methylpent-4-en-2-yl)-3,3,3-trifluoro-2-
methoxy-2-phenylpropanoate (S4.6) 
1H NMR (400 MHz, CDCl3)  7.57-7.56 (m, 2H), 7.44-7.41 (m, 3H), 5.74 (ddd, 
1H, J = 8.4, 10.0, 18.4 Hz), 5.22-5.18 (m, 1H), 5.11 (d, 1H, J = 8.0 Hz), 5.08 (s, 
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1H), 4.37 (br.s, 1H), 3.57 (d, 3H, J = 1.2 Hz), 3.47-3.42 (m. 1H), 3.10 (ddd, 1H, J = 5.6, 8.4, 14.4 
Hz), 2.56-2.51 (m, 1H), 1.44 (s, 9H), 1.08 (d, 3H, J = 6.8 Hz). 
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